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Abstract 
The effect of nanoparticle surface charge and conjugation to the cell penetrating 
peptide Tat on the uptake of nanoparticles into MRC-5 fibroblasts was investigated 
using a range of advanced imaging techniques including atomic force microscopy 
(AFM), scanning ion conductance microscopy (SICM) and fluorescence microscopy.  
New technologies are required to investigate the uptake of nanoparticles into cells 
since although many studies have examined their ultimate destination within cells, 
very little work has been done to look at the initial interaction between the 
nanoparticles and cell which also plays an important role in their uptake. 
Polyacrylamide nanoparticles (40-50nm) showed a clear correlation between 
increased positive charge and cellular uptake.  Uptake was particularly enhanced for 
nanoparticles with a charge >15mV.  These results obtained using fluorescence 
microscopy correlated well with those observed using AFM.  Nanoparticles with low 
levels of positive charge (6.9mV) caused minor effects on bilayer structure such as 
fusion of holes in the bilayer, whilst negatively charged nanoparticles had no effect 
on the bilayer.  Polyacrylamide nanoparticles conjugated to the cell penetrating 
peptide Tat, with a charge of 5.2mV, displayed greater cell uptake and increased 
effects on the bilayer depth and coverage than the similarly charged nanoparticles 
alone.  This indicated that the peptide leads to enhanced uptake by additional 
mechanisms other than just the presence of a positive charge. 
In contrast, silica nanoparticles (300nm), with high levels of positive (27mV) and 
negative charge (-25mV), entered cells to a similar extent.  However, when the 
interaction with the cell membrane was imaged using Scanning Surface Confocal 
Microscopy (SSCM), there appeared to be some differences.  Silica nanoparticles 
possessing a negative charge were often found to be associated with extensions of 
the membrane.  Positively charged particles were also found associated with 
membrane extensions in some cases but were also frequently observed isolated on 
the membrane.  Both caused the formation of defects in the cell membrane although 
these were larger and more widespread for the positively charged particles.  The 
results highlight the importance of using multiple imaging techniques to investigate 
cellular interaction and uptake in order to provide a complete picture of all the 
processes involved. 
iii 
 
List of publications 
x Welser K, Adsley R, Moore BM, Chan WC, Aylott JW.  Protease sensing with 
nanoparticle based platforms.  Analyst, 2001; 136: 29-41. 
List of posters/presentations 
Oral Presentations 
x SICM Workshop, Imperial College London.  2011.  Visualization of the 
cellular interaction and uptake of nanoparticles using AFM and SICM. 
 
x Nottingham Nanocentre and Nanoscience Centre Researchers Forum 
on particle sizing.  2011.  Particle sizing through differential 
centrifugation, The CPS Disc Centrifuge. 
 
x Bionanotechnology III, Cambridge 2012.  Visualization of the 
interaction and cellular uptake of nanosensors. 
 
Posters 
x AstraZeneca PhD Review Day 2012.  Visualization of the cellular 
uptake of nanoparticles using Atomic Force Microscopy and Scanning 
Ion Conductance Microscopy.  Awarded Best Science Prize. 
 
x Bionanotechnology III, Cambridge 2012.  Visualization of the 
interaction and cellular uptake of nanoparticles.  
iv 
 
Acknowledgements 
Thanks to my supervisors Dr Jon Aylott, Dr Stephanie Allen, Dr Weng Chan and Dr 
Kathryn Hill for their guidance and support over the last few years.  Also all the 
technicians and others I have worked with especially Dr Emma King and Ian Ward 
for help with fluorescence microscopy, Giovanna De Filippi at Ionscope Ltd and 
Professor Yuri Korchev and Dr Pavel Novak for help with SICM and the use of the 
SSCM at Imperial College.  Finally, Xinyong Chen, Kasia Nursynska and Delyan 
Ivanov for their help with the AFM work in this thesis. ǯ             
ǡ
Claudia Matz and all the DTC students in A03 along with all the other students in 
various lab groups I have worked in, especially those in D38 Ȃ Helen, Veeren, Arpan 
and Andrea. 
To all my friends and colleagues who have helped me to escape the lab and get 
through the past few years with copious amounts of tea, coffee and cake especially 
Rachel Doidge, Samantha Waite and Leigh-Anne Carroll, and all my friends from ǡǯ. 
Finally to Mum, Dad and Phil, for your constant love, support and encouragement 
and all the opportunities you have given me to get to where I am today, thank you. 
 
1 
 
Contents 
List of Figures ............................................................................................................... 4 
List of abbreviations ................................................................................................... 11 
Chapter 1 Ȃ Introduction ............................................................................................ 13 
1.1  Imaging the interaction and uptake of nanoparticles.......................................... 13 
1.2  Cellular uptake of nanoparticles ......................................................................... 14 
1.2.1 Phagocytosis ................................................................................................ 17 
1.2.2  Clathrin mediated endocytosis ..................................................................... 17 
1.2.3  Caveolae mediated endocytosis ................................................................... 19 
1.2.4  Flotillin dependent endocytosis .................................................................... 20 
1.2.5 Macropinocytosis ......................................................................................... 21 
1.2.6 Direct translocation ...................................................................................... 22 
1.3  Factors affecting cellular uptake of nanoparticles............................................... 23 
1.3.1  Size ............................................................................................................. 26 
1.3.2  Charge ........................................................................................................ 29 
1.3.3  Cell Penetrating Peptides (CPPs) .................................................................. 32 
1.4 MRC-5 cells ......................................................................................................... 35 
1.5  Advanced imaging techniques ............................................................................ 36 
1.5.1  Fluorescence microscopy ............................................................................. 37 
1.5.2  Atomic Force Microscopy (AFM) .................................................................. 42 
1.5.3  Scanning Ion Conductance Microscopy (SICM) ............................................. 46 
1.5.4  Scanning surface confocal microscopy (SSCM) ............................................. 48 
1.6  Aims and Thesis outline ...................................................................................... 49 
Chapter 2  ? Materials, Methods and Instrumentation .................................................. 50 
2.1 Materials ............................................................................................................ 50 
2.2 Instrumentation .................................................................................................. 50 
2.2.1  Dynamic Light Scattering ............................................................................. 50 
2.2.2  Zeta potential .............................................................................................. 52 
2.2.3   Disc Centrifuge ........................................................................................... 54 
2.2.4  Fluorescence ............................................................................................... 59 
2.3  Methods -Nanoparticle synthesis ....................................................................... 61 
2 
 
2.3.1  Polyacrylamide nanoparticles ...................................................................... 61 
2.3.2  Tat peptide conjugation .............................................................................. 62 
2.3.3  Silica nanoparticles ...................................................................................... 64 
2.4  Characterization methods .................................................................................. 65 
2.4.1  Zeta potential .............................................................................................. 65 
2.4.2  Size ............................................................................................................. 65 
2.4.3  Fluorescence ............................................................................................... 65 
2.5  Cell culture methods........................................................................................... 66 
2.6  Sample preparation............................................................................................ 66 
2.6.1  Atomic Force Microscopy ............................................................................. 66 
2.6.2  Scanning Ion Conductance Microscopy ........................................................ 68 
2.6.3  Fluorescence Microscopy ............................................................................. 69 
Chapter 3 - Nanoparticle characterisation .................................................................... 71 
3.1  Introduction ...................................................................................................... 71 
3.1.1  Polyacrylamide nanoparticles ...................................................................... 71 
3.1.2  Silica nanoparticles ...................................................................................... 72 
3.2  Results and Discussion........................................................................................ 75 
3.2.1  Nanoparticle charge .................................................................................... 75 
3.2.2  Nanoparticle size ......................................................................................... 79 
3.2.3  Calculating nanoparticle density using the CPS disc centrifuge ..................... 91 
3.2.4  Fluorescence ............................................................................................... 94 
3.3  Conclusion.......................................................................................................... 98 
Chapter 4 - Scanning Probe Microscopy ...................................................................... 100 
Atomic Force Microscopy and Scanning Ion Conductance Microscopy ........................ 100 
4.1 Introduction ...................................................................................................... 100 
4.1.1  Cell membranes ......................................................................................... 101 
4.1.2  Supported lipid bilayers ............................................................................. 102 
4.1.3  Atomic Force Microscopy ........................................................................... 102 
4.1.4  Scanning Ion Conductance Microscopy ...................................................... 107 
4.1.5  Comparison between AFM and SICM ......................................................... 109 
4.2  Results and Discussion...................................................................................... 111 
4.2.1  AFM results ............................................................................................... 111 
3 
 
4.2.2  SICM Results .............................................................................................. 126 
4.3   Conclusion ....................................................................................................... 135 
Chapter 5 - Fluorescence microscopy ......................................................................... 137 
5.1  Fluorescence microscopy and nanoparticle uptake ........................................... 137 
5.1.1  Imaging nanoparticle uptake with fluorescence ......................................... 137 
5.1.2  Cellular uptake of polyacrylamide nanoparticles ........................................ 137 
5.1.3  Cellular uptake of silica nanoparticles ........................................................ 140 
5.2  Results and Discussion...................................................................................... 144 
5.2.1  Polyacrylamide nanoparticles .................................................................... 144 
5.2.2  Tat conjugated polyacrylamide nanoparticles ............................................ 150 
5.2.3  Silica nanoparticles .................................................................................... 154 
5.3  Conclusion........................................................................................................ 159 
Chapter 6  ? Conclusions and Future Perspectives ....................................................... 161 
6.1  Conclusion........................................................................................................ 161 
6.2  Technical limitations of equipment and future advances .................................. 163 
6.2.1  Scanning Ion Conductance Microscopy ...................................................... 163 
6.2.2  Advances in Atomic Force Microscopy ....................................................... 164 
6.2.3  Fluorescence microscopy ........................................................................... 166 
6.3  Future work ..................................................................................................... 171 
Chapter 7 - References ............................................................................................... 174 
 
 
 
 
 
 
 
 
 
 
4 
 
List of Figures 
Figure 1.1:  Diagram showing the major pathways of endocytosis, subsequent 
intracellular trafficking and final destination within cells.  Inside the boxes are listed 
some of the main molecules involved in each pathway.  CCP (clathrin coated pit), CDC42 
(cell division cycle 42), CLIC-D (dynamin dependent clathrin independent carriers), CLIC-
DI (dynamin and clathrin-independent carriers), EPS15 (epidermal growth factor 
receptor substrate 15), ER (endoplasmic reticulum), LE (late endosome), mono-Ub 
(mono-ubiquitylation), MVB (multi-vesicular body), PKC (protein kinase C), RE (recycling 
endosomes), TGN (trans-Golgi network), TK (tyrosine kinase)16. ................................... 16 
Figure 1.2:   The cellular uptake of nanoparticles depends on a number of factors 
including the properties of the nanoparticle, how it interacts with the medium it is in 
and the biological surfaces that it encounters ............................................................... 27 
Figure 1.3:  B16-F10 cells incubated with nanoparticles of (A) 50nm for one hour, (B) 
200nm for three hours and (C) 500nm for three hours.  Insets are the corresponding 
phase contrast images .................................................................................................. 29 
Figure 1.4:  Amine functionalised cationic 50nm silica nanoparticles caused defect 
formation in model lipid bilayers (a) Schematic of an amine functionalised silica 
nanoparticle, (b) DMPC lipid bilayer, (c) addition of the nanoparticles caused defect 
formation97................................................................................................................... 31 
Table 1.1:  Table listing some of the commonly used CPPs along with their structure, 
sequence and proposed uptake mechanism.  Table adapted from 103, 106. ..................... 33 
Figure 1.5:  Tat peptide conjugated to Oregon Green accumulates in endosomes......... 35 
Figure 1.6:  Jablonski diagram showing the movement of electrons between the 
different energy levels involved in fluorescence ........................................................... 38 
Figure 1.7:  Basic set up of a filter cube indicating the excitation and emission filters and 
the dichromatic mirror ................................................................................................. 39 
Figure 1.8:  A-C are images of 6µm fluorescent beads obtained using a widefield 
microscope. (A) Fluorescent beads mounted in PBS with minimal background 
fluorescence, (B) shows the same beads mounted in PBS containing a fluorophore with 
the same spectral characteristics as the fluorophore in the bead to show effects of 
increased background and (C) shows image (B) after background subtraction .............. 40 
Figure 1.9:  Representation of the scattered light in the z plane from a point shaped 
object ........................................................................................................................... 41 
Figure 1.10:  Basic principle of AFM .............................................................................. 44 
Figure 1.11:  Layout of typical SICM equipment adapted from165.  An A6 monolayer is 
grown on a membrane filter which is mounted on a 3D piezo stage controlled by the 
scan control and feedback systems.  The modulated glass pipette scans the 
monolayer to produce images of the topography of the membrane. ......................... 46 
5 
 
Figure 1.12:  Schematic representation of the hopping mode of SICM .......................... 47 
Figure 1.13:  (A) SSCM set up, (B) Dotted line shows position where optical fluorescent 
image obtained as pipette moves over sample in SSCM, (C) Dotted line shows 
fluorescence image from same sample when using confocal alone ............................... 48 
Figure 2.1:  Typical setup of the Zetasizer Nano ZS for size determination using NIBS at 
173o to measure particle diameter179 ............................................................................ 52 
Figure 2.2:  Typical setup of a Zetasizer for measuring zeta potential180 ........................ 54 
Figure 2.3:  The design of the CPS Disc Centrifuge ......................................................... 55 
Figure 2.4:  Differential sedimentation. ......................................................................... 56 
Figure 2.5:  The low density disc. .................................................................................. 59 
Figure 2.6:  Structure of Alexa 488. ............................................................................... 60 
Figure 2.7:  Structure of 3-(acrylamidopropyl)-trimethylammonium chloride (ACTA). ... 62 
Figure 2.8:  Structure of N-acryloxysuccinimide. ........................................................... 62 
Figure 2.9: Conjugation of Tat peptide to nanoparticles via SMCC. Adapted from189 ..... 63 
Figure 3.1:  Increasing nanoparticle charge with increasing ACTA incorporation in PBS 
and serum free DMEM. ................................................................................................ 75 
Figure 3.2:  Decrease in nanoparticle charge caused by the incorporation of 5% N-
acryloxysuccinimide. .................................................................................................... 76 
Figure 3.3:  Zeta potential of Tat conjugated polyacrylamide nanoparticles compared to 
unfunctionalised polyacrylamide nanoparticles. ........................................................... 76 
Figure 3.4:  Zeta potential of negative and positively charged silica nanoparticles. ....... 77 
Figure 3.5:  Zeta potential of polyacrylamide (A) and silica (B) nanoparticles in serum 
containing DMEM. ........................................................................................................ 78 
Figure 3.6:  Intensity and volume distributions of (A) unfunctionalised (Intensity 54nm, 
Volume: 37nm) and (B) 15% ACTA (Intensity: 59nm, Volume: 42nm) polyacrylamide 
nanoparticle diameter in PBS........................................................................................ 80 
Figure 3.7:  Diameter of polyacrylamide nanoparticles with increasing proportion of 
ACTA in PBS and serum free DMEM. ............................................................................. 80 
Figure 3.8:  Intensity and volume distributions of polyacrylamide nanoparticle diameter 
containing 5% N-acryloxysuccinimide (Intensity 76nm, Volume 39nm). ........................ 81 
Figure 3.9:  Diameter of unfunctionalised and 5% N-acryloxysuccinimide polyacrylamide 
nanoparticles in PBS and serum free DMEM. ................................................................ 81 
Figure 3.10:  Intensity and volume distributions of Tat conjugated polyacrylamide 
nanoparticles in serum free DMEM. ............................................................................. 82 
6 
 
Figure 3.11:  Polyacrylamide nanoparticle diameter (A) unfunctionalised (33.8nm) and 
(B) 15% ACTA (33.2nm)................................................................................................. 83 
Figure 3.12:  Polyacrylamide nanoparticle diameter in PBS and serum free DMEM on disc 
centrifuge. .................................................................................................................... 84 
Figure 3.13:  (A) Negatively charged (290nm) and (B) positively charged (292nm) silica 
nanoparticle diameter in PBS........................................................................................ 86 
Figure 3.14:  Comparison of size of negative and positively charged silica nanoparticles in 
PBS and serum free DMEM. .......................................................................................... 87 
Figure 3.15:  Representative traces of (A) negative and (B) positively charged silica 
nanoparticle diameter in PBS measured using the CPS disc centrifuge. ......................... 88 
Figure 3.16:  Comparison of negatively charged and positively charged silica nanoparticle 
diameter in PBS and serum free DMEM. ....................................................................... 89 
Figure 3.17:  (A) Negatively charged and (B) positively charged silica nanoparticle 
diameter after three hours in serum free DMEM. ......................................................... 90 
Figure 3.18:  Diameter of silica nanoparticles in water and D2O calculated at different 
densities: (A) 1.3g/cm3, (B) 1.6g/cm3, (C) 2.0g/cm3. ...................................................... 92 
Figure 3.19:  Diameter of polyacrylamide nanoparticles in water and D2O calculated at 
different densities (A) 1.3g/cm3, (B) 1.7g/cm3, (C) 2.0g/cm3 and (D) 2.3g/cm3. .............. 93 
Figure 3.20:  Fluorescence intensity of polyacrylamide nanoparticles with different 
charge measured on fluorimeter. ................................................................................. 95 
Figure 3.21:  Fluorescence intensity of polyacrylamide nanoparticles on widefield 
microscope. .................................................................................................................. 95 
Figure 3.22:  Fluorescence intensity of silica nanoparticles on fluorimeter. ................... 96 
Figure 3.23:  Fluorescence intensity of silica nanoparticles on widefield fluorescent 
microscope. .................................................................................................................. 97 
Table 3.1:  Summary table of polyacrylamide and silica nanoparticle diameter (nm) in 
PBS and serum free DMEM (SF DMEM) measured using Dynamic Light Scattering (DLS) 
and the CPS Disc Centrifuge.  (-) indicates batches of nanoparticles not measured using 
the CPS Disc Centrifuge. ............................................................................................... 98 
Table 3.2:  Summary table of the zeta potential (mV) of polyacrylamide and silica 
nanoparticles in PBS, DMEM and serum free DMEM (SF DMEM). ................................. 98 
Figure 4.1:  The effect of the cationic polymer poly-L-lysine on a DMPC supported lipid 
bilayer.  The addition of the polymer caused the appearance of defects in the bilayer 
which are indicated by the white arrows 234. ............................................................... 103 
7 
 
Figure 4.2:  (a) Space filling model of Tat, (b) DMPC bilayer before addition of Tat, (c) and 
(d) are subsequent images taken over 20mins showing the formation and expansion of 
defects in the bilayer .................................................................................................. 106 
Figure 4.3:  COS-7 cells exposed to virus like particles (green fluorescence) showing 
uptake of the particles over a four hour time period.  The red star indicates the 
beginning of the scanning for fluorescence and VLPs indicates when the fluorescent 
virus like particles (VLPs) were added ......................................................................... 108 
Figure 4.4:  Diameter of DPPC liposomes obtained using the low density disc. ............ 111 
Figure 4.5: (A) DPPC bilayer, (B) cross section of DPPC bilayer as indicated by white line 
in (A).  Bilayer height is 6.3nm. ................................................................................... 112 
&ŝŐƵƌĞ ? ? ? ?&DŝŵĂŐĞŽĨ ? ? ?ʅŐ ?ŵůƐƵƐƉĞŶƐŝŽŶŽĨƉŽƐŝƚŝǀĞůǇĐŚĂƌŐĞĚƉŽůǇĂĐƌǇůĂŵŝĚĞ
ŶĂŶŽƉĂƌƚŝĐůĞƐŝŶǁĂƚĞƌŽŶĂŵŝĐĂƐƵƌĨĂĐĞ ?^ĐĂŶƐŝǌĞ ?ǆ ?ʅŵ ? ..................................... 113 
Figure 4.7: AFM images of a DPPC lipid bilayer exposed to increasing concentrations of 
positively charged polyacrylamide nanoparticles. (A) The DPPC bilayer was relatively 
stable over time and when exposed to 20µl of HPLC grade water (B).  Images C to F show 
the effect of exposure to increasing concentrations of positively charged nanoparticles 
(C) 1µg/ml, (D) 10µg/ml and (E) 25µg/ml.  (F) was taken 30 minutes after (E).  Scan size 5 
x 5 µm. ....................................................................................................................... 114 
Figure 4.8:  Cross sections of DPPC bilayer exposed to positively charged 
nanoparticles demonstrate the nanoparticle addition had no effect on bilayer 
thickness.  (A) DPPC bilayer before particle addition, height is 4.8nm.  (B) DPPC 
bilayer following the addition of 25µg/ml positively charged nanoparticles, height is 
5.0nm..  Scan size 5µm x 5µm. .................................................................................. 115 
Figure 4.9:  Enlarged area of Figure 4.8B to show detail of positively charged 
polyacrylamide nanoparticles associated with the edge of membrane defects and mica.  
Scan size 2 x 2 µm. ...................................................................................................... 116 
Figure 4.10: AFM images of the effects of Tat peptide on a lipid bilayer. (A) DPPC bilayer 
and (B) following addition of 20µl HPLC grade water shows some mobility but few 
changes in bilayer structure.  Images C to F show the bilayer following exposure to 
increasing concentrations of Tat peptide.  (C) 1µM, (D) 2.5µM, (E) 5µM and (F) 10µM.  
The formation of higher domains is observed around the edge of bilayer defects.  Scan 
ƐŝǌĞ ?ǆ ?ʅŵ ?............................................................................................................... 117 
Figure 4.11:  AFM images of a smaller area of the same DPPC bilayer as in Figure 4.10.  
(A) DPPC bilayer, (B) following addition of 20µl HPLC grade water, (C)  1µM Tat, (D) 
2.5µM Tat, (E) 5µM Tat showing raised domains around edge of defect.  (F) 10µM Tat 
with further coverage of raised domains.  White arrows indicate the same defect in the 
bilayer which gradually expands along with the merging of other defects. Scan size 2 x 
2µm. .......................................................................................................................... 118 
8 
 
Figure 4.12:  Cross sections of DPPC before (A) and after exposure (B) to 5µM Tat 
peptide.  Original height of bilayer is 3.6nm, in B1, bilayer height is 4.6nm and the height 
of the bilayer where Tat peptide acts is 5.7nm, approximately 1nm higher. Scan size 2 x 
2µm. .......................................................................................................................... 119 
Figure 4.13:  AFM images of the interaction between Tat conjugated polyacrylamide 
nanoparticles and a DPPC lipid bilayer. (A) DPPC, (B) following addition of 20µl HPLC 
grade water, (C) 1µg/ml Tat conjugated nanoparticles, (D) 10µg Tat conjugated 
nanoparticles caused the appearance of small holes in the bilayer and exposure to 
higher concentrations such as 25µg/ml (E) led to the formation of new defects and 
solubilisation of the bilayer over time.  Image (F) was taken one hour after (E) Scan size 5 
ǆ ?ʅŵ ?....................................................................................................................... 122 
Figure 4.14:  (A) DPPC bilayer before exposure to Tat conjugated nanoparticles, (A1) 
cross section indicated by white line on (A).  (B) DPPC bilayer following exposure to 
25µg/ml Tat conjugated nanoparticles, (B1) Cross section indicated by white line on (B) 
showing particles and changes in bilayer height.  Original bilayer height in (A) is 5.7nm 
and following exposure to Tat peptide conjugated nanoparticles, bilayer height reduces 
to 4.8nm and particle height is 21.5nm (B1). .............................................................. 123 
Figure 4.15: AFM images of the interaction between Tat conjugated polyacrylamide 
nanoparticles and a DPPC lipid bilayer. (A) DPPC, (B) following addition of 20µl   HPLC 
grade water, (C) 1µg/ml Tat conjugated nanoparticles, (D) 10µg Tat conjugated 
nanoparticles caused the appearance of small holes in the bilayer and exposure to 
higher concentrations such as 25µg/ml (E) led to the formation of new defects and 
solubilisation of the bilayer over time.  Image (F) was taken one hour after (E) Scan size 2 
ǆ ?ʅŵ ?....................................................................................................................... 124 
Figure 4.16:  MRC-5 cells control samples (A) large area of multiple MRC-5 cells and (B) a 
smaller area both showing relatively flat membrane.  The cytoskeleton can be observed 
in (A). ......................................................................................................................... 127 
Figure 4.17:  (A) Topography image of MRC-5 cell exposed to negatively charged silica 
nanoparticles, (B) Corresponding fluorescence images showing nanoparticles and 
aggregates of nanoparticles (green).  (C) Overlaid image of fluorescence and 
topography................................................................................................................. 128 
Figure 4.18:  Smaller area scan of MRC-5 cell exposed to negatively charged silica 
nanoparticles (A) Topography, (B) corresponding fluorescence and (C) overlaid image of 
fluorescence and topography showing multiple negatively charged silica nanoparticles 
(green) associated with the cell membrane. ............................................................... 130 
Figure 4.19:  A topography image that indicates the interaction of a single negatively 
charged silica nanoparticle with the cell membrane.  The nanoparticle is indicated by the 
arrow. ........................................................................................................................ 131 
9 
 
Figure 4.20:  Effect of 1.3µm silica nanoparticles on MRC-5 cells.  This image was taken 
using hopping mode only at Nottingham.  The arrow indicates the damaged area of the 
cell membrane. .......................................................................................................... 132 
Figure 4.21: (A) Topography image of MRC-5 cells exposed to positively charged silica 
nanoparticles, (B) corresponding fluorescence image.  (C) is the overlaid image showing 
holes visible in the cell membrane plus diffuse fluorescence from positively charged 
silica nanoparticles. .................................................................................................... 133 
Figure 4.22:  Positively charged silica nanoparticle (indicated by the arrow) partially 
embedded in membrane and also associated with a region of the membrane. ........... 134 
Figure 4.23:   Isolated positively charged silica nanoparticle partially embedded in the 
cell membrane. .......................................................................................................... 135 
Figure 5.1:  80nm silica nanoparticles in human dermal fibroblasts cells (A) bright field, 
(B) RITC-silica nanoparticles (red) (C) Merge of RITC-silica particles and LysoTracker 
Green, (D) Merge of RITC-silica particles and DAPI (blue) ............................................ 141 
Figure 5.2:  Representative images showing polyacrylamide nanoparticles (green) with 
increasing positive charge in MRC-5 cells.  Images are shown in pairs of green 
fluorescence alone beside the green fluorescence and brightfield merged images. (A) 
Control, (B) Unfunctionalised (-3.3mV), (C) 2% ACTA (1.8mV), (D) 5% ACTA (6.9mV), (E) 
10% ACTA (13.2mV), (F) 15% ACTA (17.6mV) (G) 20% ACTA (18.6mV)......................... 145 
Figure 5.3:  Example images of MRC-5 cells exposed to polyacrylamide nanoparticles to 
show perinuclear, punctate distributions of nanoparticles (green) indicating an 
endocytic route of uptake.  (A) 5% ACTA containing polyacrylamide particles and (B) 
enlarged area from white box in (A).  (C) 20% ACTA containing polyacrylamide 
nanoparticles and (D) enlarged area from white box in (C). ........................................ 146 
Figure 5.4:   Increase in cellular uptake of polyacrylamide nanoparticles with increasing 
charge ........................................................................................................................ 147 
Figure 5.5:  (A) Green fluorescence from Alexa 488 containing nanoparticles within MRC-
5 cells, (B) Brightfield and green fluorescence overlaid image showing intracellular 
localization of polyacrylamide nanoparticles containing 5% N-acryloxysuccinimide. ... 149 
Figure 5.6:  Comparison of the green fluorescence intensity of 5% N-acryloxysuccinimide 
(NAS) polyacrylamide nanoparticles (-5.5mV) and unfunctionalised polyacrylamide 
nanoparticles (-3.3mV) in MRC-5 cells. ....................................................................... 150 
Figure 5.7:  Representative image of MRC-5 cells containing Tat conjugated 
polyacrylamide nanoparticles (5.2mV). ....................................................................... 151 
Figure 5.8:  (A) MRC-5 cells with Tat conjugated nanoparticles and (B) enlarged area 
from (A) to show intracellular distribution of nanoparticles close to the nucleus. ....... 151 
Figure 5.9:  Comparison of the green fluorescence intensity in cells after exposure to 
nanoparticles containing increasing amounts of ACTA or conjugated to Tat peptide. 
10 
 
Unfunctionalised (-3.3mV), 15% ACTA (17.6mV), 20% ACTA (18.6mV), Tat peptide 
conjugated (5.2mV). ................................................................................................... 152 
Figure 5.10:  (A) Pair of images showing green fluorescence from negatively charged 
silica nanoparticles (-25mV) in MRC-5 cells and the merged green fluorescence and 
brightfield image.  (B) Green fluorescence from positively charged silica nanoparticles 
(27mV) in MRC-5 cells and merged green fluorescence and brightfield image. ........... 155 
Figure 5.11:  Images showing in greater detail the intracellular localization of silica 
nanoparticles in MRC-5 cells.  (A) Negative silica nanoparticles and (B) enlarged image of 
region in (A) showing perinuclear localization of nanoparticles.  (C) Positive 
nanoparticles and (D) enlarged region of (C) again showing a perinuclear distribution.
................................................................................................................................... 156 
Figure 5.12 Green fluorescence intensity within cells incubated with negative and 
positively charged silica nanoparticles. N=45 .............................................................. 157 
Figure 5.13: Confocal microscope images of (A) negatively charged phosphate 
functionalised and (B) positively charged quaternary ammonium functionalised silica 
nanoparticles in HeLa cells showing the nanoparticles (containing FITC and RITC), FM4-
64 is a marker for endosomes and the merged imaged shows colocalization of the 
negatively charged but not the positively charged nanoparticles with endosomes98. .. 158 
Figure 6.1:  Resolution of different microscopy techniques. ........................................ 167 
Figure 6.2:  Diagram to show basic principle of STED136. .............................................. 168 
Figure 6.3:  HeLa cells stained with antibodies against the nuclear pore complex protein 
Nup153 and secondary antibodies conjugated with ATT0647N on a standard confocal 
(CLSM) and a TCS STED Confocal microscope (Leica) ................................................... 169 
Figure 6.4:  Diagram of the basic principle of STORM .................................................. 170 
Figure 6.5:  TdEosFP-Pallaxin expressed in Hep G2 cells to label adhesion complexes on 
lower surface using TIRF and TIRF/STORM combined ................................................. 170 
 
 
 
  
11 
 
List of abbreviations 
ACTA Ȃ 3-(acrylamidopropyl)-trimethylammonium chloride 
AFM Ȃ Atomic Force Microscopy 
AMPA Ȃ N-(3-aminopropyl) methacrylamide hydrochloride 
APS Ȃ Ammonium persulfate 
APTES - Aminopropyltriethoxysilane 
CLSM Ȃ Confocal Laser Scanning Microscopy 
CPP Ȃ Cell Penetrating Peptides 
DLS Ȃ Dynamic Light Scattering 
DMEM Ȃ ǯ 
DPPC - Dipalmitoylphosphatidylcholine 
FACS Ȃ Fluorescence Activated Cell Sorting 
FCS Ȃ Fetal Calf Serum 
F-PALM Ȃ Fluorescence Photoactivated Localization Microscopy 
HPICM Ȃ Hopping Probe Ion Conductance Microscopy 
LDV Ȃ Laser Doppler Velocimetry 
NAS Ȃ N-acryloxysuccinimide 
NC  AFM Ȃ Non Contact Atomic Force Microscopy 
NIBS Ȃ Non Invasive Back Scatter 
NSOM Ȃ Near-field Scanning Optical Microscopy 
PALM Ȃ Photoactivated Localization Microscopy 
PALS Ȃ Phase Analysis Light Scattering 
PEBBLE Ȃ Probes Encapsulated by Biologically Localized Embedding 
PEG Ȃ Polyethylene glycol 
PBS Ȃ Phosphate Buffered Saline 
PSF Ȃ Point Source Function 
12 
 
SEM Ȃ Scanning Electron Microscopy 
SICM Ȃ Scanning Ion Conductance Microscopy 
SMCC Ȃ Sulfo-succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate 
SLB Ȃ Supported Lipid Bilayer 
STED Ȃ Stimulated Emission Depletion Microscopy 
STORM Ȃ Stochastic Optical Reconstruction Microscopy 
SSCM Ȃ Scanning Surface Confocal Microscopy 
Tat -  Transactivator of transcription 
TEM Ȃ Transmission Electron Microscopy 
TEMED Ȃ Tetramethylethylenediamine  
TEOS Ȃ Tetraethyl orthosilicate 
TIRF Ȃ Total internal reflectance microscopy 
TMAC Ȃ N-trimethoxysilylpropyl-N,N,N-trimethylammonium chloride 
 
 
 
  
13 
 
Chapter 1 Ȃ Introduction 
1.1  Imaging the interaction and uptake of nanoparticles 
It has been repeatedly demonstrated that many different types of nanoparticles will 
enter cells, but it is often unclear by which route this uptake occurs.  Learning more 
about the uptake processes involved will provide a greater degree of understanding 
and may help in experimental and formulation design, aiding the production of 
more efficient cellular delivery systems.  This could, for example, include 
nanoparticles that may target a certain route of uptake in order to avoid potentially 
disruptive subcellular compartments such as endosomes and lysosomes.   
Visual information about the interaction of nanoparticles with cell membranes on 
the nanoscale has been difficult to obtain in the past.  This is due to limitations in the 
resolution of imaging techniques, and the complex nature and relatively rapid speed 
of the uptake processes.  Imaging of the intracellular localization of nanoparticles 
following uptake has generally been performed using fluorescence microscopy, 
which has a limited maximum resolution of approximately 200nm.  However, 
imaging technology has improved and it is now possible to obtain some of this 
information using a combination of advanced imaging techniques.  These include 
scanning probe microscopy techniques such as Atomic Force Microscopy (AFM), 
which can be used to obtain nanoscale images of the interaction of nanoparticles 
with small regions of model cell membranes and increasingly, cells.  In addition, 
multiple new fluorescence microscopy techniques such as confocal microscopy and 
stimulated emission depletion microscopy enable the larger scale tracking of 
nanoparticles within multiple cells at high resolution.  Another technique, Scanning 
Ion Conductance Microscopy (SICM), is a scanning probe technique that works in a 
non contact manner.  It can also be used to obtain nanometre and micron scale 
resolution images of the interactions of nanoparticles with cell membranes and 
some advanced systems allow this process to be imaged in real time on live cells.  
Another advantage of SICM is that it can be combined with confocal microscopy in a 
technique known as Scanning Surface Confocal Microscopy (SSCM). This allows the 
uptake of nanoparticles into cells to be tracked using both topography and 
fluorescence imaging simultaneously.   
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1.2  Cellular uptake of nanoparticles 
Cells have the ability to internalize a range of substances, from small, single 
molecules through to larger particles such as bacteria.  This uptake can occur 
through a number of different pathways which are all important and work together 
in order to maintain life, allow cell signalling and migration and protect the cell from 
infectious agents.  Some of these routes of uptake are also exploited by 
nanoparticles.  Investigations into the internalization of nanoparticles into cells are 
important because of the human health effects of exposure to nanoparticles of 
various different shapes, sizes and compositions through, for example, air pollution 
and cosmetics1, 2.  Nanoparticles are also being used in an increasing range of 
applications including diagnostics, measurement of intracellular analytes such as 
calcium and oxygen, imaging, phototherapy and gene and small molecule drug 
delivery3-8.  Nanoparticles have unique properties due to their size and they often 
behave very differently to a bulk amount of the same material9.  Their small size, 
ranging from a few nanometres up to several hundred nanometres, enables them to 
be present inside cells with minimal disturbance of the cell itself.  Nanoparticles 
therefore have great potential for a variety of biological applications due to their 
ability to enter cells but this ability is also a potential risk since relatively little is 
known about the toxicity of some nanoparticles2.   
Methods of delivering nanoparticles to cells include gene gun, pico-injection, 
electroporation, liposomal delivery and conjugation to cell penetrating peptides and 
other targeting moieties10-12.  Some of these techniques, such as liposomal delivery 
and the use of cell penetrating peptides have been shown to be efficient and 
biocompatible.  However, others display low efficiency and reproducibility and may 
cause irreversible damage to the cell.  For example, picoinjection can only be 
performed on one cell at a time and causes more cell perturbation than the 
internalization of multiple nanoparticles10.  However, these delivery techniques are 
not always required.   Multiple studies have shown that nanoparticles can enter cells 
without the need for any delivery vehicle6, 8, 11, 12.  The size of nanoparticles means 
that they can usually not freely diffuse into cells as single molecules and ions can, 
instead, they need to engage with some form of cellular machinery in order to enter 
the cell12. 
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Different pathways of cellular uptake enable cells to maintain life via the 
internalization of molecules required for many cellular processes including 
development, neurotransmission, cell-cell communication and signalling.  Small 
molecules and ions do not require a carrier system, they can diffuse or cross the 
membrane using protein pumps and channels in the bilayer. Larger molecules, 
greater than a few nanometres in size in general do not have this ability, therefore 
they need to be transported into the cell in a different way.  This transport can occur 
via a number of different endocytic pathways including phagocytosis, clathrin 
mediated endocytosis, caveolae mediated endocytosis and macropinocytosis.  These 
pathways are often distinct in the molecules they transport into the cell and they are 
highly regulated by a number of proteins.  However, they have the potential to be 
upregulated depending on the cellular environment, inhibition of one of the other 
endocytic pathways, and the needs of the cell13.  Phagocytosis, macropinocytosis, 
clathrin and caveolae mediated endocytosis have all been implicated in the energy 
dependent uptake of nanoparticles into cells (Figure 1.1)2, 14.   
The route of uptake that is used by nanoparticles to enter cells is important because 
it can influence their subsequent intracellular trafficking and final destination 
within the cell9.  In some cases, where nanoparticles are used as drug delivery tools, 
or for the imaging of specific analytes or processes within cells, targeting of the 
nanoparticle to a specific internalization route or intracellular organelle may be 
beneficial.  In addition to the targeting of certain uptake routes, learning more about 
the mechanisms by which to avoid other routes may also be of use.  For instance, 
phagocytosis is a destructive mechanism usually used for the removal of infectious 
agents such as bacteria, and large, micron sized particles have been shown to be 
cleared from the body by this process.  Other uptake routes, for instance clathrin 
mediated endocytosis, direct nanoparticles via the degradative endolysosomal 
pathway therefore this route should be avoided for certain, sensitive molecules such 
as DNA and proteins. 
There are a number of different ways that the different endocytic routes have been 
classified in the past but as more is discovered about the pathways and the 
molecules involved in regulating them, it can become difficult to separate them 
completely.  This is because there is often some degree of overlap in the molecules 
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involved and the cargos that are transported, since most cargos can enter cells by 
several pathways15.  The improvement of  imaging techniques such as fluorescence 
and electron microscopy has enabled the visualization of the final intracelluar 
destination of drugs or conjugates within cells, but little is known about the initial 
stages of this interaction and what can be done to influence it.  The major uptake 
routes are discussed below but since this work focussed mainly on the initial stages 
of the interaction rather than the complicated downstream processes, the reader is 
referred to a review by Doherty et al which discusses in greater detail many of the 
proteins and processes involved15. 
 
Figure 1.1:  Diagram showing the major pathways of endocytosis, subsequent 
intracellular trafficking and final destination within cells.  Inside the boxes are listed 
some of the main molecules involved in each pathway.  CCP (clathrin coated pit), 
CDC42 (cell division cycle 42), CLIC-D (dynamin dependent clathrin independent 
carriers), CLIC-DI (dynamin and clathrin-independent carriers), EPS15 (epidermal 
growth factor receptor substrate 15), ER (endoplasmic reticulum), LE (late 
endosome), mono-Ub (mono-ubiquitylation), MVB (multi-vesicular body), PKC 
(protein kinase C), RE (recycling endosomes), TGN (trans-Golgi network), TK 
(tyrosine kinase)16. 
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1.2.1 Phagocytosis 
Phagocytosis only occurs in specialised cells such as macrophages because it is 
primarily used for the protection of the cell from agents such as bacteria and 
viruses, along with clearance of apoptotic cells from the body.  When specialized 
phagocytic cells such as macrophages, monocytes or neutrophils are exposed to 
nanoparticles coated with protein (opsonins) in the bloodstream, they will be 
engulfed into these phagocytic cells13, 15, 17.  The phagocytic route of uptake is 
generally a destructive one since it enables cells to kill bacteria.  It is also important 
in the immune response of the body to infection since the destruction of bacteria 
within the cell leads to the appearance of bacterial peptides on the surface of 
phagocytic cells, provoking an immune response.  However, the use of 
biodegradable nanoparticles such as PLGA exploits the enzymatic degradation and 
hydrolysis that occurs within these cells, since this allows the nanoparticles to be 
broken down releasing, for example, a drug13, 18. 
The other routes of cell uptake are known as the non-phagocytic pathways and they 
occur to some extent in most cells.  These pathways are clathrin mediated 
endocytosis, caveolae mediated endocytosis, macropinocytosis, and clathrin and 
caveolae independent endocytosis. 
1.2.2  Clathrin mediated endocytosis 
Clathrin mediated endocytosis occurs via the uptake of molecules into clathrin 
coated pits and it is the most common and well described route of uptake.  It can be 
receptor or non-receptor mediated but most types of clathrin mediated endocytosis 
progress through a series of steps that lead to the endolysosomal pathway15.  It 
occurs when clathrin proteins polymerise to form a basket like structure on the cell 
membrane.  These are referred to as clathrin coated pits although they consist of 
several cytosolic proteins but with clathrin as the main unit17.  Clathrin coated 
vesicles can also be formed from intracellular compartments using a range of 
different adaptor and accessory proteins which can subsequently influence the 
range of molecules that are transported within the vesicle15, 17.   
Other proteins are involved in the formation of clathrin coated pits and vesicles and 
one of the major proteins identified to play an important role is adaptor protein 2 
(AP2) which has been shown to be important for the formation of clathrin coated 
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pits and vesicles generated from the cell membrane15, 17.  Adaptor proteins such as 
AP2 help to coordinate the nucleation of clathrin in regions of the cell membrane 
that will subsequently be internalized.  CLASPs (Clathrin associated sorting 
proteins) are involved in recognising cargo and sorting signals17.  Adaptor proteins 
including AP2 and accessory proteins such as SNX9, containing the N-BAR or BAR 
domains are important for producing deformation and the formation of a curved 
structure within the membrane.  This is formed from the three legged clathrin 
structure that is assembled into Ǯǯǡǡwhich results 
in vesicle formation via their binding to clathrin and AP2 and their role in recruiting 
dynamin15, 17, 19.  A vesicle with a diameter of around 100nm is formed when the 
large GTPase protein dynamin cleaves the vesicle structure from the membrane, 
forming a clathrin coated vesicle.  Dynamin forms a helical polymer around the neck 
of the vesicle and following hydrolysis of GTP, detachment of the vesicle from the 
membrane occurs15, 20.  The diameter of the vesicle limits the size of molecules that 
can by internalized into cells by this route.  Once cleaved from the cell membrane, 
intracelluar trafficking of the vesicle begins, and the clathrin coat is removed by the 
ATP dependent protein Hsc70 along with cofactors such as auxilin and cyclin-G-
associated kinase15, 21, 22. This vesicle may eventually fuse with and deliver its 
contents to endosomes which mature and acidify into late endosomes and 
lysosomes17.   
Low density lipoprotein (LDL), transferrin and epidermal growth factor (EGF) have 
all been shown to be ligands for the receptor mediated form of clathrin mediated 
endocytosis13, 15, 17.  The transferrin receptor is widely regarded as the classical 
marker for clathrin mediated endocytosis.  It contains a tyrosine based YTRF motif 
and these motifs along with di-leucine (LL) motifs have been shown to direct 
molecules towards endosomes and lysosomes.  The motif is recognised by sites on 
AP2 proteins which can subsequently interact with clathrin leading to 
internalization via this route15, 23, 24.  Clathrin coated pits can interact with a range of 
different adaptor and accessory proteins, enabling the internalization of a number 
of different cargos within one vesicle15, 17, 19. 
Clathrin mediated endocytosis has been demonstrated to be involved in the 
internalization of a number of different types of nanoparticles including PLGA and 
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silica based systems25, 26.  In receptor independent clathrin mediated endocytosis, 
which may be exploited by some nanoparticles, substances interact non-specifically 
with the area of membrane containing clathrin leading to their uptake by this 
route18, 27.   
1.2.3  Caveolae mediated endocytosis 
Caveolae mediated endocytosis is another major endocytic pathway and is one of 
the most well characterised non clathrin mediated pathways28.  It involves the 
formation of flask shaped structures in the cell surface membrane formed from 
caveolin 1 and 2, which generally have a size of around 50-100nm.  However, 
fluorescent labelling of the protein caveolin 1 has enabled the observation of the 
joining of these flask shaped structures together and incomplete detachment from 
the cell membrane15, 17, 29.   It is also known as lipid raft endocytosis since the 
vesicles are formed from areas of the membrane rich in phospholipids, 
sphingolipids and cholesterol25, 27.   This process most commonly occurs in 
endothelial cells, adipocytes, fibroblasts and smooth muscle cells15, 29, 30.  There are 
three mammalian caveolin proteins.  Caveolin 3 is only found in muscle cells whilst 
both caveolin1 and 2 are found in non muscle cells31, 32.  The only cells that appear to 
lack caveolin of any kind are neurons and leukocytes.  Caveolin 1 is believed to be 
necessary and possibly sufficient alone to produce caveloae.  It has been 
demonstrated that overexpression of caveolin 1 in caveloae deficient cells can lead 
to the production of the flask shaped invaginations characteristic of caveolae15, 31.  
Caveolin 1 polymerises and binds to fatty acid tails of the glycosphingolipid GM115, 
33.  It can colocalize with GM1 and another glycosphingolipid, Gb3, both of which are 
found, along with their ligands cholera toxin and shiga toxin on the outer leaflet of 
the cell membrane15, 29, 34.  In contrast, caveolin 1 is found on the inner, cytoplasmic 
leaflet of the membrane but it forms a hairpin like structure that is embedded in the 
membrane31.  This allows it to interact with these molecules whilst both the N and C 
terminus remain in the cytoplasm15, 17.  Caveolae are initially formed in the Golgi 
body where they are associated with cholesterol which is then involved in the 
deposition and inducement of mobility of caveolin 1 in the membrane31.  The 
morphology of vesicles associated with caveloae uptake appears to be highly 
variable and has been shown to include large pH neutral vesicles known as 
caveosomes, along with smaller vesicles and tubules, many of which do not appear 
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to fully dissociate from the membrane15, 32.  As well as the formation of traditional 
vesicles, caveolin proteins have also been implicated in the transcytosis across 
endothelial barriers of non enveloped viruses and serum components15, 17. 
A number of different cargo have been shown to be internalized by caveolae 
mediated endocytosis including SV40 virions, cholera toxin B subunit and 
glycosylphosphatidylinositol (GPI) linked proteins15, 32, 35.  In addition, caveolae 
mediated endocytosis has been shown to be particularly important for the transport 
of cholesterol.  Along with clathrin mediated endocytosis, it also depends on the 
protein, dynamin, which is involved in the scission of the coated vesicles from the 
cell membrane.  Unlike phagocytosis and clathrin mediated endocytosis, it has been 
suggested that caveolae mediated endocytosis is not generally a destructive uptake 
route since it often avoids endosomes and lysosomes and is therefore exploited by 
some bacteria and viruses.  However this has been challenged recently and it has 
been shown that caveolae can fuse with endosomes using RAB5 and can be recycled, 
returning to the cell membrane25, 32, 35.  Caveolae mediated endocytosis has also been 
proposed as an uptake route that could be targeted when trying to deliver sensitive 
molecules such as proteins, RNA and DNA.  This targeting could be achieved by 
using molecules which are known to target the caveolae mediated endocytosis 
pathway including folic acid, albumin and cholesterol13, 18. 
1.2.4  Flotillin dependent endocytosis 
Flotillin dependent endocytosis appears to have similarities to caveolae mediated 
endocytosis since investigations using fluorescence and electron microscopy appear 
to show similar flask shaped invaginations of the cell membrane.  However, unlike 
caveolae, overexpression of flotillin does not induce the formation of these 
structures as in the case of overexpression of caveolin 115, 36.  There is a high degree 
of structural similarity between flotillin and caveolin 1 and they also form a hairpin 
structure within the cell membrane15, 17.  This suggests that flotillin may also play a 
role in the ordering and stabilising of lipid raft structure formation within the 
membrane in a similar way to caveolin 115, 37.  It is therefore thought that flotillin 
dependent endocytosis may be a stand alone pathway or it may play a role in other 
clathrin or caveolae independent pathways38.  Flotillin 1 has been shown to be 
involved in the dynamin dependent but clathrin and caveolin 1 independent uptake 
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of cell surface proteoglycans  which are found to be trafficked to late endosomes in 
structures that are positively labelled for flotillin 115, 17, 39. 
1.2.5 Macropinocytosis 
Macropinocytosis occurs in most cells to some extent but it can be induced by 
exposure to growth factors such as platelet derived growth factor that trigger 
receptor tyrosine kinases in the cell membrane13, 40.  It involves the ruffling of the 
cell surface membrane which is driven by the cytoskeletal protein, actin.  These 
ruffles form projections that then collapse onto each other or rejoin the membrane.  
When they fuse the projections encapsulate extracellular fluid which can contain a 
variety of substances including nanoparticles15 25, 40.  Unlike clathrin and caveolae 
mediated endocytosis it is not induced via ligand binding17.  Macropinocytosis has 
been identified to be dependent on the proteins rac1 and actin, which are linked to 
an ability to form membrane ruffles15.  Despite it being a well recognised process, 
the details of many of the molecules involved in the mechanism and regulation of 
macropinocytosis are either unknown or poorly characterised.  The kinase PAK1 
has been identified to be important for macropinocytosis and it is required to induce 
the process via binding and activation of GTP-bound Rac which triggers the 
formation of membrane ruffles40-42.  Other proteins believed to be important in 
macropinocytosis are PI3K, Ras family GTPases, Arf6 and src whilst N-WASP and 
SNX9 are involved in ruffle formation via their effects on actin15, 40, 41, 43. 
Macropinocytosis is known to be a cholesterol dependent process since cholesterol 
is required for the recruitment of activated rac115.  Macropinocytosis results in the 
formation of large (1-5µm), heterogeneous uncoated vesicles known as 
macropinosomes, which are filled with extracellular fluid40.  The fate of these 
vesicles varies between cell types but in most cases they are observed to acidify and 
decrease in size, and in some cases they fuse with lysosomes.  It is a particularly 
prominent route of uptake in macrophages, and has been suggested as the likely 
route of uptake for the cell penetrating peptide Tat44.  Macropinocytosis is a 
relatively non specific route of uptake and therefore has the potential to transport 
many different types of nanoparticles into cells.  Even those particles with no 
specific targeting mechanism may be internalized since if they are located near, and 
interact to some extent with the cell membrane, there is a chance that they may be 
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encapsulated by the membrane projection, and taken into the cell along with the 
extracellular fluid surrounding them13, 18, 27.   
1.2.6 Direct translocation 
Finally, one mechanism of nanoparticle entry into cells that does not involve 
endocytic pathways is that of direct translocation, also known as transcellular 
transport.  It has been suggested as a route for the uptake of some types of 
nanoparticles, especially those of a very small size containing amine groups and 
cationic moieties.  Additionally, it has also been identified as a potential route for the 
uptake of cell penetrating peptides including Tat and CADY45, 46.  It occurs when 
nanoparticles enter cells by crossing the cell membrane without using any of the 
uptake routes mentioned above.  Small, positively charged entities may enter cells in 
this way by causing transient defects in the bilayer structure.  This can increase the 
permeability of the cell membrane, enabling them to traverse the bilayer8, 47, 48.  
Since the lipid bilayer is fluid, and molecules can move around, the pores in the 
membrane are usually quickly repaired by the cell which may explain why it is not 
always a cytotoxic process.  However, at high concentrations it may become 
irreparable, leading to loss of intracellular fluid and cell death46.  This kind of 
transport has been observed for antimicrobial peptides that can form pores in the 
membrane of bacteria leading to their translocation across the membrane48. 
Inhibition studies have frequently been performed in order to try and selectively 
inhibit endocytic pathways and to discover more about the factors that influence 
them and the molecules that are involved.  However, as previously mentioned, there 
can be a high degree of overlap between pathways and inhibition of a molecule can 
affect more than one pathway despite the high level of characterisation of some of 
the pathways.  In addition, inhibition may lead to upregulation of another pathway 
by the cell and the effects of inhibitors can be highly cell line dependent, further 
complicating the results28.  One example is that of cholesterol depletion which is 
commonly performed when investigating caveolae mediated endocytosis.  
Cholesterol depletion can be achieved using a number of different molecules 
including methyl ɴ cyclodextran (MɴCD), filipin and nystatin.  However, the removal 
of cholesterol has multiple effects including a decrease in the number of caveloae in 
the membrane as well as effects on clathrin mediated endocytosis leading to a 
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decrease in the uptake of transferrin.  In addition, cholesterol depletion also results 
in a decrease in membrane ruffling which consequently affects macropinocytosis15.  
There are numerous examples of how chemical inhibitors designed to be specific for 
certain pathways can have effects on other uptake routes and also on cell 
morphology and viability.  For example, MɴCD is used as an inhibitor of caveloae 
mediated endocytosis via sequestration of cholesterol, but has been found to inhibit 
the uptake of transferrin, a marker of clathrin dependent endocytosis and has also 
been found to lead to changes in cell morphology at concentrations used for 
inhibition studies28, 49.  Statins have also been used to inhibit caveolae mediated 
endocytosis but the large decrease in cholesterol that they produce has non specific 
inhibitory effects on clathrin, macropinocytosis and phagocytosis49 Both 
chlorpromazine and K+ depletion have been used as inhibitors of clathrin mediated 
endocytosis, but K+ depletion has also been found to inhibit clathrin independent 
pathways such as caveloae, whilst chlorpromazine can reduce cell viability28.   Both 
have also been shown to lead to reduced uptake of fluid phase markers used to 
identify macropinocytosis49.  Many of the chemical inhibitors used have effects on 
the actin cytoskeleton including filipin and nystatin, used to inhibit caveloae 
mediate endocytosis, and amiloride and nystatin used to inhibit macropinocytosis.  
These global effects on actin filaments can have non-specific effects on other routes 
of endocytosis since actin is a key component in many pathways49.  In an effort to 
produce more specific inhibition of uptake routes, techniques such as RNA 
interference to silence genes, and the introduction of dominant negative proteins to 
inactivate proteins have been used.  These lead to more specific inhibition of a 
certain uptake pathway and have been exploited to try and design inhibitors that 
interact with specific proteins without affecting others28, 50.  However, it remains 
extremely difficult to isolate the effect of these inhibitory molecules to only one 
pathway because of the inevitable overlap between pathways and the desire of the 
cell to maintain life by upregulating pathways in order to gain what it needs28. 
1.3  Factors affecting cellular uptake of nanoparticles 
Nanoparticles are of great interest in the field of drug delivery since they have 
unique properties compared to bulk amounts of the same materials.  They are being 
investigated as tools that can be used to increase the efficiency of drug delivery via 
the use of new formulations, and their chemistry often means they can be easily 
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modified to include targeting moieties27, 51.  The interfacial properties of 
nanoparticles affect their interactions with their environment and these properties 
have been shown to affect the rate and extent to which nanoparticles enter cells17, 52.  
These effects are highly variable between different nanoparticles and cell types and 
depend on how the nanoparticles interact with constituents of the extracellular fluid 
and components of the cell membrane including proteins and lipids53, 54.  Improving 
the understanding of these interactions may help in the design of more efficient, 
targeted delivery systems. 
A number of factors have been identified that influence the uptake of nanoparticles 
into cells and these include cell type, membrane composition28, nanoparticle 
material27, 55, charge27, 56, size2, 57, shape58, 59 and surface chemistry57 along with the 
extracellular environment that uptake occurs in.  For instance, if one uptake route is 
blocked for any reason, another can be upregulated so that uptake still occurs and 
this ability helps cells to maintain life28.  In addition, the presence of any conjugated 
molecules such as polymers or peptides can affect the rate and route of uptake60-65.   
The interactions of nanoparticles with components of the cell membrane can lead to 
a variety of possible interactions including the formation of protein coronas around 
particles, wrapping of the particle in the cell membrane and potentially some 
biocatalytic processes66.  How nanoparticles interact with their environment is 
influenced not only by their own characteristics such as size and charge which will 
be discussed in detail later, but also through the molecules that adsorb to the 
nanoparticle surface, forming what is known as the corona.  The formation of a 
biomolecular corona, a layer around the nanoparticle surface often composed of 
lipids or proteins, can have significant effects on the interaction of the nanoparticle 
with the cell membrane and this is often different to the interaction of the bare 
nanoparticle67-69.  The corona is a dynamic structure that changes depending on the 
environment.  It ǮǯǮǯ     70.  The presence of the corona 
drastically reduces the surface energy of the nanoparticle67, 69-71.  However, although 
the surface energy is reduced, the presence of the protein, lipids and other 
biomolecules in the layer can lead to enhanced and sometimes specific interactions 
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with the membrane causing increased uptake and could potentially can be exploited 
to provide targeting of nanoparticle delivery in vivo67, 71. 69 
 Once they have been internalized into the cell, most nanoparticles will then move 
through intracellular compartments such as early and late endosomes, lysosomes, 
Golgi bodies and rough endoplasmic reticulum and their trafficking and retention 
within these compartments can be influenced by the interaction of nanoparticle 
surface groups with intracellular molecules72.  Once inside the endolysosomal 
system, the nanoparticles generally cannot escape into the cytoplasm unless they 
are specifically designed for endosomal escape via the use of additional molecules.  
For instance, it has been suggested that some cationic molecules have the ability to 
escape the destructive environment of the endolysosomal pathway enabling their 
release into the cytoplasm, which may have potential in the design of more efficient 
drug delivery systems 52, 61. 
When performing experiments to study nanoparticle uptake, it is important to note 
that that the physicochemical properties of nanoparticles vary depending on the 
media in which they are suspended.  Cell culture media contains proteins such as 
albumin which can adsorb to the surface of some nanoparticles leading to 
aggregation and reversal of a positive surface charge54.  The pH and ionic strength of 
the medium also affect the zeta potential of the particles and dispersion stability52, 
73. 
Since so many factors have the potential to influence cellular uptake of 
nanoparticles, many studies have been performed in order to try and identify which 
factors may be of greatest importance.  Many groups have looked at the effect of 
one, or a combination of these factors, but there is a great deal of variety in both the 
way the studies are performed (e.g. cell type, nanoparticle type and experimental 
conditions), and in their outcomes.  This makes it very difficult to draw any 
definitive conclusions, and it is impossible to say that one parameter will always 
affect cellular uptake in a certain way.  It is highly likely that a combination of many 
different factors is involved, and that the contribution of these different parameters 
varies between different nanoparticles and cell types54. 
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1.3.1  Size  
Nanoparticle size is a key parameter that affects their properties and it is their size 
that can impart different properties to that of the bulk material.  Size can influence 
both the route of cellular uptake and the extent and rate of uptake55, 74.  Smaller 
particles may be internalized by pinocytosis mechanism such as clathrin or caveolae 
mediated endocytosis, whilst larger particles are generally shown to be internalized 
via macropinocytosis and/or phagocytosis in specialized cells.  This is thought to be 
because the size of the vesicles produced during clathrin and caveolae mediated 
endocytosis are limited in size, generally to particles less than 200nm30.  In contrast, 
the mechanism by which cells internalize extracellular fluid and other substances by 
macropinocytosis means that much larger particles can be internalized into cells via 
this route17, 25, 57, 75, 76.   
The size of nanoparticles has also been shown to influence their final location within 
an organism.  For instance, small nanoparticles with a diameter of less than 100nm 
can escape blood vessels and this is of particular interest when considering targeted 
delivery to tumours since blood vessels in tumours are often more permeable which 
in turn leads to accumulation of nanoparticles within tumours.  In contrast, particles 
on the micron scale, with a similar size to bacteria for example, are often cleared 
rapidly from the body by macrophages via phagocytosis, consequently their 
potential for use as drug delivery tools may be limited77.  Control of size is therefore 
a key parameter in the design of nanoparticles for use as drug delivery and 
diagnostic or imaging tools.  A small size is often desirable in the latter case since 
this means the nanoparticles have a high surface area to volume ratio and a fast 
response time to changes in the environment78. 
The first step in the cellular uptake of nanoparticles involves their interaction with 
the cell membrane and this interaction is partially dependent on the size of the 
nanoparticle because a large particle interacting with a cell surface experiences the 
average effects of a variety of heterogeneous regions of the membrane whilst 
smaller nanoparticles can interact with one homogenous patch at a time (Figure 
1.2).  Cell membranes are not uniform and contain regions rich in molecules 
required for clathrin and caveolae mediated uptake therefore the interaction of 
nanoparticles with different areas of a membrane due to its size may affect uptake 
to some extent52.   
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Figure 1.2:   The cellular uptake of nanoparticles depends on a number of factors 
including the properties of the nanoparticle, how it interacts with the medium it is 
in and the biological surfaces that it encounters52. 
Nanoparticle size also impacts on the ability of the nanoparticle to interact with 
membrane proteins and receptors, and the process of membrane wrapping, which is 
involved in many forms of endocytosis.  In addition, the size of the nanoparticles 
may change during uptake as the nanoparticle encounters different environments 
both within and outside the cell, and aggregation of nanoparticles is a common 
problem observed in biological systems2, 17, 79.   
A number of studies have investigated the effect of nanoparticle size on uptake but 
the experimental conditions vary greatly, making it difficult to compare the results.  
The group of Rejman, in a detailed study, have shown that all sizes of fluorescent 
latex nanoparticles (up to 500nm) were eventually taken up by B16 cells, with 
smaller particles found in perinuclear regions and larger ones found at the 
periphery of the cell (Figure 1.3).  No internalization of particles was seen at 4oC 
indicating that an energy dependent uptake mechanism was being used.  Once the 
particles had entered cells, further trafficking appeared to be microtubule 
dependent since treatment of the cells with nocodazole, which disrupts 
microtubules, prevented intracellular trafficking of particles from early to late 
endosomes.  Nocodazole affected the uptake of the smaller particles to a greater 
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extent than the larger particles, suggesting that a different route was used for 
differently sized particles.  Another method of investigating uptake routes is to use 
cholesterol depletion which inhibits many of the routes of uptake including clathrin 
and caveolae mediated endocytosis and macropinocytosis.  In this study it was 
shown to cause a decrease in uptake as particle size increased15, 17, 57.  Both 
potassium depletion and treatment with chlorpromazine, which block clathrin 
mediated endocytosis, caused inhibition of the uptake of smaller particles to a 
greater extent than larger particles suggesting smaller particles (up to 200nm) were 
internalized by clathrin dependent endocytosis57.  
A number of reports from different groups investigating the uptake of many 
different types of nanoparticles into cells have frequently concluded that smaller 
nanoparticles are often shown to enter cells at a faster rate and to a greater extent 
than larger nanoparticles.  However, very small nanoparticles (<20nm)  have been 
found to have a lesser degree of uptake, possibly due to an increased rate of 
dissociation from the cell membrane, which results in less chance of uptake 
occurring80-84. 
The studies reviewed here are just some of the examples of the literature available 
regarding nanoparticle uptake into cells.  It is impossible to definitively say that a 
certain size of nanoparticle will be taken up exclusively by certain routes, since 
although size plays an important role in uptake, it is also dependent on the other 
factors discussed earlier.  A particular pattern of size dependent uptake that is 
observed in one cell type may not be repeated in another, since the effect of 
nanoparticle size on uptake appears to be highly cell line dependent80.  This could be 
explained by the different contributions of the various endocytic pathways to 
overall cellular uptake, since not all cells use the same routes to the same extent.   
Although it is difficult to draw firm conclusions about the effect of size on cellular 
uptake of nanoparticles, the examples discussed serve to demonstrate the complex 
nature of investigating these processes and some of the possible techniques by 
which information can be obtained. 
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Figure 1.3:  B16-F10 cells incubated with nanoparticles of (A) 50nm for one hour, 
(B) 200nm for three hours and (C) 500nm for three hours.  Insets are the 
corresponding phase contrast images57. 
1.3.2  Charge 
It has been reported by many groups that both anionic and cationic entities 
including liposomes, polymers and nanoparticles will enter cells in the absence of 
any delivery vehicle, despite the seemingly unfavourable interaction between the 
charge on anionic nanoparticles and the cell membrane2, 14, 55, 85-89.    However, 
although both anionic and cationic nanoparticles have been shown to enter cells, 
there can be differences in the extent and rate to which this occurs.  For instance in a 
number of studies, cationic nanoparticles and polymer complexes have been found 
to be more extensively taken up by cells than the anionic versions47, 90, 91.  In 
contrast, other studies have suggested that in some cases, the anionic particles 
display enhanced uptake compared to neutral particles.  The presence of a neutral 
charge or ligand, e.g. polyethylene glycol, has been shown to limit the uptake of 
nanoparticles11, 90.  A neutral charge is sometimes desirable if the nanoparticles are 
required to have minimal interaction with their biological environment.  When 
considering the effect of charge, the functional groups present that impart the 
charge to the nanoparticles should also be taken into consideration.  These groups 
influence other properties of the nanoparticles such as solubility and interactions 
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with the surrounding environment, and a change in the surface functionality 
without a change in charge can affect internalization11, 92. 
Literature reports suggest that positive charge is in itself a delivery mechanism for 
cellular uptake of entities such as nanoparticles, peptides and polymer complexes60, 
93.  Positive charge is exploited by a variety of commercial products such as 
Lipofectamine, as a means of delivering molecules into cells12.  A number of 
suggestions have been made about how positive charge leads to cell uptake but it 
probably begins with electrostatic interactions of the positively charged vector with 
regions or groups (e.g. sialic acid and proteoglycans) in the cell membrane which 
often has a slightly negative overall charge.  Positively charged molecules therefore 
may interact more strongly with the cell membrane than neutral or negatively 
charged versions.  This increased association and interaction may subsequently 
increase the chance of the particles being internalized into cells by some form of 
endocytosis11, 17, 27, 79.   
A number of groups have shown that positively charged materials such as cationic 
nanoparticles exploit this ionic interaction, causing a temporary disruption in the 
cell membrane.   This means that they may subsequently cross the cell membrane by 
generating transient holes in the bilayer62, 94, 95.  This interaction has also been 
demonstrated using AFM, where it has been observed that cationic nanoparticles 
induce the formation and growth of nanoscale holes in supported lipid bilayers.  
Complementary studies looking at cell membrane leakage of cytosolic lactate 
dehydrogenase at non toxic nanoparticle concentrations also indicate the formation 
of nanoscale holes in the membrane86.  However, many reports suggest that these 
positively charged species often display some degree of cytotoxicity due to their 
membrane effects, therefore future applications may be limited27. 
Other uptake routes have been suggested for cationic nanoparticles including 
clathrin and caveolae mediated endocytosis and macropinocytosis.  In most studies, 
the uptake of nanoparticles is considered to be an active process, requiring energy 
from the cell for the uptake of both anionic and cationic particles.  Once inside the 
cell, intracellular processing of nanoparticles is important in determining their fate 
and it has also been suggested that cationic nanoparticles have the ability to escape 
31 
 
endosomes thereby evading the degradative lysosomal pathway which has 
implications for improved drug delivery13, 85, 96. 
Positively charged nanoparticles can be produced by a variety of methods.  Schulz et 
al. demonstrated that positively charged ammonium moieties can be incorporated 
into nanoparticles and these can associate with negatively charged biological 
membranes, leading to enhanced internalization of these substances into cells12.  
The functionalisation of nanoparticles with amine groups can also provide a positive 
surface charge, and amine functionalised nanoparticles have been shown to cause 
the formation of defects in membranes, both on live and fixed cells and also on a 
model artificial membrane (Figure 1.4)27.   
 
 
Figure 1.4:  Amine functionalised cationic 50nm silica nanoparticles caused defect 
formation in model lipid bilayers (a) Schematic of an amine functionalised silica 
nanoparticle, (b) DMPC lipid bilayer, (c) addition of the nanoparticles caused defect 
formation97. 
 
As explained above, there are therefore a number of possible explanations for the 
enhanced uptake of positively charged nanoparticles.  However, a significant 
number of studies also demonstrate that negatively charged nanoparticles can enter 
cells without any additional delivery vehicles, and that this uptake is greater than 
that of unfunctionalised nanoparticles with a neutral charge27, 98.  Negative surface 
charge can be introduced onto particles via a number of methods that frequently 
include the incorporation of carboxyl groups into the nanoparticle matrix or 
conjugation onto the surface of the nanoparticles.  The increased uptake of 
negatively charged nanoparticles is more difficult to explain but it must occur as a 
result of an interaction between the nanoparticles and molecules on the surface of 
the cell, for example proteins, that lead to uptake17, 27, 55.  In addition, the 
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nanoparticles may interact with cationic regions of the cell membrane which are 
small but significant in number11.  The negatively charged nanoparticles may then 
be internalized following non specific binding91, 99.  Some uptake mechanisms, e.g. 
macropinocytosis are non specific.  If the nanoparticles associate and interact with 
the membrane to some extent and are therefore located close to the cell surface, this 
increases the chances that they may be encapsulated into a vesicle formed by cell 
membrane ruffling during macropinocytosis and enter cells by this route.  In  
studies of negatively charged silica nanoparticle uptake, this has been termed a 
pinocytosis related non-specific adsorptive endocytosis mechanism100.  Caveolae 
mediated endocytosis has also been suggested as a route of uptake for many 
negatively charged species25. 
Functionalisation of nanoparticles with a surface charge, especially a positive 
charge, therefore seems to improve their internalization into cells.  Another method 
by which a positive charge can be imparted to nanoparticles is via conjugation to 
cationic molecules.  One of the classic examples of these molecules are the cell 
penetrating peptides, which have been extensively investigated in recent years due 
to their ability to cross cell membranes. 
1.3.3  Cell Penetrating Peptides (CPPs) 
The improved uptake of various different cargo including nanoparticles, drugs, 
proteins and liposomes when conjugated to CPPs has been reported by many 
different groups44, 101, 102.   In addition to enhanced delivery of molecules into cells, 
they may also promote endosomal escape allowing for the delivery of molecules 
such as drugs to the cytosol, and from there to a variety of intracellular organelles 
including mitochondria and the nucleus103.   CPPs are also in clinical development 
for the targeted delivery of a number of different therapeutic agents  for multiple 
conditions104.  CPPs are a family of molecules that include antennapedia, 
transportan, HSV-1, VP22 and HIV-1 Tat peptide that demonstrate an ability to 
efficiently cross cell membranes with minimal disruption, whilst also delivering 
their cargo105.  However, although many studies have been carried out investigating 
the entry of CPPs into cells, the precise mechanism of uptake has been a subject of 
some controversy.   A number of different pathways have been suggested to be 
involved in CPP entry into cells including clathrin, macropinocytosis and direct 
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translocation across the membrane106.  Many groups have investigated the uptake of 
CPPs but in a similar way to the investigation into the uptake route of nanoparticles 
discussed previously, results are significantly influenced by cell line and 
experimental conditions.  This makes comparison of results and the assigning of 
uptake mechanisms difficult50, 107. 
Most  CPPs are characterized by a high proportion of positively charged amino acids, 
especially arginine and lysine.  It is believed that this abundance of positive charge 
aids their internalization, particularly because there is little structural or sequence 
homology between different peptides44, 105, 108.  However, a number of CPPs contain a 
series of alternating cationic and hydrophobic residues which means they can adopt 
an ɲ-helix conformation, enabling them to penetrate membranes.  In addition, some 
CPPs are amphipathic which also appears to aid their cellular uptake103, 106.  
 
Table 1.1:  Table listing some of the commonly used CPPs along with their 
structure, sequence and proposed uptake mechanism.  Table adapted from 103, 106.   
50, 104, 109-115 
The positive charge on the peptide leads to an electrostatic attraction between the 
peptide and components of the cell membrane such as phospholipid head groups, 
glycosaminoglycans or heparan sulphate proteoglycans (HSPG) 45, 105, 106, 116-118.  
HSPGs have been shown to be important for the uptake of some CPPs but in other 
cases have been suggested to sequester cationic CPPs, reducing their uptake103.  The 
Cell Penetrating Origin Structure Sequence Proposed References
Peptide mechanism
Tat HIV-1 transcriptional Random coil/ GRKKRRQRRRQ Direct penetration, 50, 109
activator PPII helix pore formation, multiple
endocytic routes
Penetratin Antennapedia Drosophila Amphipathic RQIKIWFQNRRMKWKK Direct penetration, 110
(pAntp) (43-68) melanogaster ɲ ?ŚĞůŝĐĂů ?ɴ ?ƐŚĞĞƚ endocytosis
Octarginine Model peptide Random coil RRRRRRRR Direct penetration, 111
(chimeric) ɲ ?ŚĞůŝĐĂů endocytosis
pVEC Murine vascular Amphipathic, LLIILRRRIRKQAHAHSK Direct penetration, 112
endothelial cadherin ɴ ?ƐŚĞĞƚ transporter-mediated
Pep-1 Chimeric Amphipathic, KETWWETWWTEWSQPKKKRKV Direct penetration, 106 113
ɲ ?ŚĞůŝĐĂů pore formation
Transportan Galanin-mastoparan Amphipathic, GWTLNSAGYLLGKINLKALAALAKKIL Endocytosis, direct 104, 106
neuropeptide ɲ ?ŚĞůŝĐĂů penetration
MAP Model amphipathic Amphipathic, KLALKLALKALKAAKLKA Multiple mechanisms 114
peptides (chimeric) ɲ ?ŚĞůŝĐĂů
MPG HIV gp41 Amphipathic, GALFLGFLFAAGSTMGAWSQPKKKRKV Direct penetration 113
ɴ ?ƐŚĞĞƚ
CADY PPTG1 peptide Amphipathic, GLWRALWRLLRSLWRLLWRA Multiple endosomal 115
derived ɲ ?ŚĞůŝĐĂů routes
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consensus opinion now appears to be that CPPs can use both direct translocation 
across the cell membrane along with a number of different endocytic routes 
including macropinocytosis, clathrin and caveolae mediated endocytosis depending 
on the peptide, cell type and any associated cargo25, 44, 50, 106.  The contribution of an 
endocytic mechanism is supported by a number of studies demonstrating reduced 
uptake of CPPs at 4oC, suggesting an active uptake mechanism is involved.  It is 
further supported by the ability of CPPs to modify the actin cytoskeleton and show 
increased uptake of markers of macropinocytosis such as dextran.  A number of 
studies have identified reduced uptake of CPPs in the presence of amiloride and 
cytochalasin D which inhibit macropinocytosis50, 101.   CPPs have been shown to 
accumulate in lysosomes but cytoplasmic labelling has also been observed, which 
may result from the escape of the peptide from endosomes or from direct 
translocation across the membrane103. 
Fluorescence microscopy is commonly used as an investigative tool for examining 
endocytosis of CPPs but care must be taken when choosing a suitable dye since it 
can modify the properties of the peptide.  In addition, the high affinity of the peptide 
for the plasma membrane and proteins in tissue culture media must also be 
considered in the experimental design.  The positive charge on many CPPs means 
that they will associate with negatively charged proteins in tissue culture media, 
reducing the proportion of free peptide that is available for cellular uptake103.  CPPs 
such as Tat have been found to strongly adhere to the cell surface membrane and 
they cannot be removed by simple washing procedures.  Instead, washes must be 
undertaken with heparin, and trypsinization performed in order to remove the 
portion of the peptide that is firmly bound to the cell surface membrane103.  
Omission of these important steps has led to inaccurate measurements of peptide 
uptake by techniques such as FACS, which does not distinguish fluorescence from 
membrane bound peptide from that of peptide within cells44.  In addition, it was 
thought for a number of years that CPPs localized to the nucleus following cellular 
uptake but this has since been shown to be due to fixation artefacts44. 
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Figure 1.5:  Tat peptide conjugated to Oregon Green accumulates in endosomes119. 
1.4 MRC-5 cells 
MRC-5 cells are human lung fibroblasts derived from normal human male foetal 
lung.  They were used in this work since they are a human lung fibroblast and 
therefore have potential to be exposed to nanoparticles from the environment via 
inhalation79.  Inhalation of nanoparticles is an important consideration since 
subsequent intracellular trafficking of the nanoparticles could lead to systemic 
exposure, and the characteristics of the nanoparticles can be an important factor in 
determining their potential for entry to the body by this route120, 121. 
Very few studies have been performed using MRC-5 cells to investigate endocytosis 
of nanoparticles, but the few studies that have been performed have indicated that 
they have the potential to spontaneously internalize cationic particles formed of 
lipopolyamines122. In addition, it has been suggested that they can perform 
phagocytosis even though they are not professional phagocytic cells via a study 
investigating the internalization of Encephalitozoon cuniculi, a spore forming 
parasite.  The spores were internalized by an actin dependent mechanism into an 
intracellular vesicle which was positive for the lysosomal membrane marker LAMP-
1123. 
Most of the studies into MRC-5 cell endocytosis have used electron rather than 
fluorescence microscopy to discover the intracellular localization of nanoparticles. 
Ng et al used TEM to demonstrate the uptake and subcellular localization of 20nm 
gold and polystyrene nanoparticles within MRC-5 cells.  The nanoparticles were 
spontaneously internalized when added to culture media and the majority of gold 
nanoparticles were found to be located within intracellular vesicles with some 
found in the cytosol.  In contrast, more of the polystyrene nanoparticles were found 
located in the cytosol124.  The same group, in a paper by Li, again showed that 20nm 
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gold nanoparticles were internalized into cellular vesicles within MRC-5 cells 
located close to the nucleus.  The nanoparticles caused damage to DNA and inhibited 
cell proliferation indicating potential cytotoxicity of these nanoparticles125.  The 
uptake of carbon black and titanium dioxide nanoparticles into MRC-5 cells has also 
been investigated using TEM and they were found to accumulate within intracellular 
vesicles but were excluded from intracellular organelles such as the nucleus and 
mitochondria.  The internalization into vesicles suggests an endocytic route of 
uptake and in this study it was suggested that macropinocytosis may be the primary 
uptake mechanism126.  
Radu et al investigated the effects of 40-60nm hematite (iron oxide) nanoparticles 
on MRC-5 cells.   The uptake and intracellular localization of the nanoparticles was 
not investigated but it was found that exposure of the cells to these nanoparticles 
led to a decrease in intracellular glutathione and an increase in lipid peroxidation 
due to oxidative stress and the production of reactive oxygen species in the cell by 
the nanoparticles127.  The same group also found that exposure of MRC-5 cells to 
very small, <20nm silica nanoparticles led to changes in cell morphology and again, 
an increase in lipid peroxidation128. 
The internalization of the cell penetrating peptide Tat, conjugated to streptavidin 
has also been investigated in MRC-5 cells using fluorescence microscopy.  It was 
found that the conjugate, which was designed as a potential delivery vector, was 
located within intracellular, perinuclear vesicles129. 
However, when considering the results of these studies, it is important to bear in 
mind that they are generally stand alone studies and may not have been subjected to 
the greatest degree of peer review and scrutiny. 
1.5  Advanced imaging techniques 
A wide range of techniques are available that enable visualization of the interaction 
and uptake of nanoparticles into cells both on in vitro and model systems.  These 
include microscopy techniques ranging from electron microscopy, such as TEM that 
can image intracellular structures, through to live cell fluorescence imaging.  In 
addition, the scanning probe techniques of AFM and SICM have proven to be 
valuable tools for studying these interactions on the nanoscale.  Few studies 
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however have combined both fluorescence and scanning probe techniques in order 
to provide an overview of the interactions and uptake occurring on both the nano 
and micron scales. 
1.5.1  Fluorescence microscopy 
There are several forms of luminescence which differ in the way the system is 
excited.  For example, in electroluminescence, the system is excited via an electric 
current; chemiluminescence occurs due to a chemical reaction and 
photoluminescence results from excitation via photons.  Photoluminescence can be 
divided into two sub groups, fluorescence and phosphorescence.  The main 
difference between fluorescence and phosphorescence is the duration of their 
luminescence.  Fluorescence ends immediately when the illumination is stopped 
whilst phosphorescence can last for longer after the excitation has ended.  Stokes 
first described fluorescence in 1852 and noted that fluorescence emission always Ǥ ? ? ? ?ǯ
of fluorophores was investigated in biological specimens for the first time. 
Since there are many vibrational states in organic molecules, a number of energy 
bands exist, causing broad absorbance and emission spectra that are produced by 
the movement of electrons between these energy bands.  Electrons can exist in 
different energy states, the ground state being a stable and low energy state.  When 
light of a certain wavelength, known as the excitation wavelength, hits a molecule, 
the photons are absorbed by the electrons in the molecule.  This causes the 
electrons to move from their ground state (S0) to a higher energy level, the excited 
state (S1) (Figure 1.6).  Electrons only remain at this higher energy level for a very 
short period of time and some of the energy of the electron is lost by thermal 
processes such as non radiative heat loss.  The electrons then leave this excited state 
and lose the remaining energy absorbed, returning to the ground state.  This energy 
is emitted as fluorescent light and it has less energy, and therefore a longer 
wavelength than the excitation light.  This change in wavelength is known as Stokes 
shift and as the Stokes shift value increases, it become easier to separate excitation 
from emission light through the use of fluorescence filter combinations.  The 
absorption and emission of energy can be seen as specific characteristics of a 
molecule130, 131. 
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Figure 1.6:  Jablonski diagram showing the movement of electrons between the 
different energy levels involved in fluorescence. 
Fluorescence imaging can be used qualitatively and quantitatively, and several 
different fluorophores can be used simultaneously, as long as they vary in their 
excitation and emission wavelengths.  In addition, colocalization and interaction 
studies can be performed using fluorescence, along with measurements of ion 
concentrations and observation of cellular processes.  
Fluorophores are molecules that when excited by specific wavelengths of light will 
emit light of another wavelength.  The likelihood of a particular fluorophore 
absorbing a photon of the excitation light is known as the extinction coefficient.  
Larger extinction coefficients indicate that the absorption of a photon in a given 
wavelength region is more likely.  The quantum yield denotes the ratio of the 
number of photons emitted compared to those absorbed (usually 0.1-1)131.  
Quantum yield values are always below one due to the loss of energy through non-
radiative pathways, such as heat or a photochemical reaction, rather than the re-
radiative pathway of fluorescence.  Extinction coefficient, quantum yield, intensity of 
the light source and fluorescence lifetime are all important factors that contribute to 
the fluorescence emission.  The development of brighter, more stable fluorophores 
has contributed to the widespread use of fluorescence microscopy for the study of 
cells and cellular processes131, 132. 
In a fluorescent microscope, light is provided either by a laser as a monochromatic 
light, or from a bright and powerful light source such as a mercury-vapour or xenon 
arc lamp.  The light passes through a fluorescence filter cube containing three main 
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components, the excitation filter, dichromatic mirror and emission filter.  The 
excitation filter is usually a short pass filter that transmits short wavelengths of 
light, or a band pass filter that transmits a band of wavelengths and blocks longer 
and shorter wavelengths.  This selects the wavelength of light which can excite the 
fluorophore in the sample.  Narrower band pass filters are useful to help  to separate 
fluorophores with similar characteristics130.  The dichromatic mirror is usually a 
long pass filter that transmits long wavelengths and reflects short wavelengths of 
light towards the sample.  The mirror is tilted at 45o with respect to the incoming 
excitation light and reflects the light through the objective and onto the sample.  
Excitation light that is reflected by the specimen is of a short wavelength and is not 
transmitted through the dichromatic mirror so will be blocked.  The emission filter 
is used when emitted light from fluorophores in the sample is gathered by the 
objective.  The emission filter only allows light of a certain wavelength to transmit, 
i.e. the light emitted by the sample.  Since fluorophores emit light of a longer 
wavelength than the excitation light, the emitted light passes through the 
dichromatic mirror and towards the detector.  In most microscopes, the excitation 
and emission filters and dichromatic mirror are incorporated into an optical cube 
which is mounted on a revolving mechanism so that multiple cubes are available to 
enable a range of fluorophores to be studied in one sample (Figure 1.7)133. 
 
Figure 1.7:  Basic set up of a filter cube indicating the excitation and emission filters 
and the dichromatic mirror133. 
The quality of the detector used is one of the key parameters in obtaining the 
highest resolution image possible since the resolution partly depends on the 
number of photons detected.  Widefield microscopes usually use a charge coupled 
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detector (CCD) which can collect photons from the whole image, whilst confocal 
systems use photomultiplier tubes.  This is because the pinhole restriction used to 
obtain high resolution images in confocal microscopy limits the number of photons 
that can be detected.  The sensitivity of the detector depends on the detection limit 
and the quantum efficiency, which is the percentage of photons collected by the 
detector131, 134.  Improving the signal to noise ratio, i.e. increasing the number of 
photons detected above background noise helps to improve image quality and 
increases the precision of any measurements performed131, 135.  Figure 1.8 shows 
fluorescent beads in a low background (A) and a high background (B) and indicates 
that when fewer photons are collected above the background level, the image 
produced (C) is of a lower quality and contrast and measurements of fluorescence 
intensity are less precise135. 
 
Figure 1.8:  A-C are images of 6µm fluorescent beads obtained using a widefield 
microscope. (A) Fluorescent beads mounted in PBS with minimal background 
fluorescence, (B) shows the same beads mounted in PBS containing a fluorophore 
with the same spectral characteristics as the fluorophore in the bead to show effects 
of increased background and (C) shows image (B) after background subtraction135. 
A wide range of fluorescent microscopes have been developed beginning with 
simple widefield systems and advancing through to confocal systems that help 
improve image quality by excluding out of focus light using pinholes.  Finally, more 
recently, the development of super resolution microscopy techniques has overcome 
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limits imposed by the diffraction barrier of light, thereby further increasing 
resolution and these are introduced in detail in Chapter 6.  In addition to 
improvements in microscope technology, other advances have been made in the 
post image acquisition analysis techniques such as deconvolution131. 
1.5.1.1 Deconvolution 
Every light source used in fluorescence microscopy will emit scattered light above 
and below the plane of the object itself (Figure 1.9)130, 135.  Deconvolution is a 
technique that is used to remove this out of focus fluorescence information and 
therefore to produce higher quality images with a better contrast.  It is the process 
of applying mathematical algorithms to the data and using these to reassign out of 
focus fluorescence to the most likely point of source131, 136.  
 
Figure 1.9:  Representation of the scattered light in the z plane from a point shaped 
object137. 
Instead of the computational processing that is required using deconvolution for 
images obtained using widefield microscopes, confocal laser scanning microscopy 
(CLSM) uses pinholes to exclude out of focus fluorescence130.  However, a high light 
intensity is required due to the small confocal volume needed to obtain the highest 
resolution136.  The benefit of this sharper image that can be achieved using CLSM is 
therefore offset by a considerable disadvantage due to the high energy from the 
laser light source which can lead to fluorescence bleaching and cell damage 
(phototoxicity).  Conventional widefield fluorescence microscope systems have 
advantages over CLSM since with the use of a lower intensity light, cells may be less 
damaged and photobleaching is less of an issue, however the resolution is worse.  
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Deconvolution is therefore useful when applied to widefield microscopy since it 
provides a convenient and fast method by which to improve the image contrast. 
There are two main approaches to deconvolution, known as iterative restoration 
and nearest neighbour deconvolution.  Iterative restoration is more time consuming 
since it reassigns out of focus fluorescence information to the point of source but it 
retains all of the image information.  Nearest neighbour deconvolution is a 
subtractive technique which can lead to a loss of signal130, 134.  Both forms of 
deconvolution require the use of point spread functions (PSFs).   These describe 
how the light from the point shaped object is spread out in the optical path.  They 
are the result of all the influences that distort the imaging of a single sphere which, 
when imaged will not produce a perfect representative image due to the problem of 
scattered light and limits of the microscope.  These influences include the 
wavelength of light, the objective and its numerical aperture and immersion media 
amongst others130, 132, 137.  PSFs can be measured or calculated for each wavelength 
and objective combination.  Each different wavelength requires a separate PSF since 
light of different wavelengths spreads differently.  These PSFs can then be applied to 
the images obtained to reassign the out of focus information resulting in a clearer 
image.  
1.5.2  Atomic Force Microscopy (AFM) 
Advanced scanning probe techniques such as AFM and SICM have only been 
developed since the 1980s.  The field of scanning probe microscopy began with a 
stylus profiler developed by Schmalz in 1929 which, in a similar way to AFM 
consisted of a probe on the end of a cantilever which was used to generate an image 
of the profile of a surface138.  In the 1970s, Young developed a non contact mode of 
this technique introducing the use of piezoelectric ceramics to the field in order to 
provide control over the tip-sample distance.  A major advance was the 
development of the scanning tunnelling microscope by Binnig and Rohrer in 1981, 
which used a metal wire tip to image the surface of a sample.  However, it was 
limited to the use of conducting samples138-141.  Binnig and others went on to 
develop AFM which led to a widespread increase in the use of scanning probe 
microscopy since it is not limited to conducting samples.  Further advances in 
different modes of imaging have increased the range of samples that can be 
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visualized using AFM138, 142, 143.  Finally, SICM was first introduced by Hansma in 
1989 and major developments in the technique have been achieved by the Korchev 
and Klenerman groups at Imperial College London and Cambridge University.  
Although it is not as widely used as AFM, it has certain advantages that are 
discussed later and is increasing in popularity due to the production of 
commercially available systems144, 145.  
AFM is a scanning probe technique that uses the force between the tip and the 
sample to produce an image.  It has many different applications including imaging of 
a wide range of samples such as supported lipid bilayers146, polymers films147, and 
the imaging of individual molecules such as proteins and DNA on the nanoscale148.  
In addition, it can be used to investigate the forces of interaction between molecules 
via the use of functionalised tips coated with a certain material, for example ligands 
and receptors149.  AFM has the potential for molecular and atomic level resolution 
imaging of some samples and it can also be used to investigate the characteristics of 
the materials in the sample150.  There are a number of different modes that can be 
used when applying AFM to the imaging of a sample surface.  These include contact 
mode, where the tip is raster scanned over the surface of a sample, and tapping 
mode where the tip is oscillated at a resonant frequency above the sample surface 
and the tip then gently taps the sample, reducing damage to the sample and tip151, 
152.  Another benefit of AFM is that samples can be imaged in different environments, 
for example air, vacuum or liquid.  This ability to image in the liquid environment 
gives AFM an advantage over other nanoscale microscopy techniques, for example 
electron microscopy such as SEM and TEM, which cannot be used for imaging of 
biological samples in their native environments153.  One of the main limitations of 
AFM is the difficulty in imaging very rough samples since the shape of the tip can 
hinder its ability to fit in between rough areas on the sample surface150. 
In AFM, a cantilever, with a sharp probe on the end, usually made of silicon or 
silicon nitride traces over the surface of the sample, providing a topography image 
of the sample surface.  A laser shines onto the back of the cantilever where the tip is 
located, and as the tip moves over the surface, a change in the height of the sample 
causes the cantilever to deflect, changing the position of the reflected laser beam on 
a photodiode consisting of four quadrants150, 153-155.  The use of a reflected laser 
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beam helps to amplify the signal and the vertical movement in the cantilever is 
calculated by measuring the difference in voltage between the upper and lower 
quadrants of the photodiode, whilst any lateral movement of the tip is measured as 
the difference between the left and right quadrants138, 150, 153.  These measurements 
in x, y and z are combined in order to produce an image of the surface of the 
sample150. 
 The sharpness and shape of the tip is one of the key parameters in achieving a high 
resolution AFM image.  This is a common problem with all scanning probe 
techniques since the AFM tip or, for example, the glass pipette used in SICM, cannot 
be infinitely sharp.  The size of the tip is usually large compared to many of the 
features being imaged, therefore it may not be able to reach and image the surface of 
a sample located in between or close to high regions of the sample.  This is due to 
inhibition of the lateral movement of the tip close to a tall feature in the sample.  The 
cantilever generally has a low spring constant, enabling fine control of the force 
between the tip and sample.  Positioning of the cantilever and tip is controlled by 
ceramic piezoelectric transducers which have the ability to control positioning with 
an extremely high degree of accuracy by virtue of their ability to change shape when 
a potential difference is applied to opposite faces of the crystal.  The deflection of the 
cantilever is influenced by Van der Waals forces between the tip and the sample and 
as the tip touches the sample surface, repulsive forces dominate.  The tip is kept in 
contact with the sample and topography images are obtained via these close range 
repulsive interactions138, 150, 153-155. 
 
Figure 1.10:  Basic principle of AFM155. 
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Scanning of soft samples such as lipid bilayers can be performed in a liquid 
environment using the tapping mode technique of AFM.  In this mode, the sample is 
gently tapped with the AFM tip rather than the tip being raster scanned across the 
sample surface as in contact mode.  In tapping mode AFM, the cantilever is oscillated 
at or near its resonant frequency using a piezoelectric crystal.  As the tip moves over 
the sample surface, changes in oscillation occur.  As the tip approaches the surface 
of the sample, the amplitude of oscillation is decreased due to the interaction forces 
such as Van der Waals between the sample and tip.  These changes in the oscillation 
amplitude are measured and feedback mechanisms are used to adjust the 
separation between the tip and the sample in order to maintain a constant 
amplitude and force and to produce the image of the sample138, 155.  Tapping mode 
AFM applies a low force from the tip onto the sample.  In addition, since tapping 
mode AFM does not Ǯǯǡ
to the sample, reducing the effect of frictional and adhesive forces.  In tapping mode 
AFM in liquid, the cantilevers normal resonant frequency is reduced.  The entire 
fluid cell is oscillated in order to lead to oscillation of the cantilever155. 
By employing a liquid environment and the tapping mode technique, very low forces 
can be used during imaging in order to avoid damaging samples and it also enables 
hydrated bilayers, used as models of the cell membrane, to be imaged156-159.   AFM 
has been used to image cells but with limited success for a number of reasons.  Cells 
are relatively high when considering movement in the z direction of the cantilever, 
compared to some other samples such as polymer films and lipid bilayers so it can 
be difficult to image the entire cell and there is a high chance of tip contamination150, 
160.  The other main problem is that since the tip exerts a force on the cell, it can lead 
to cell membrane deformation and rupture leading to reduced resolution and 
distorted images150, 161.  However, one benefit of this is that it has been used to image 
features below the cell membrane such as the cytoskeleton and other subcellular 
structures150, 162. 
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1.5.3  Scanning Ion Conductance Microscopy (SICM) 
SICM is a non contact scanning probe technique that uses changes in the ion current 
flowing through a nanopipette to track sample topography142, 163.  It is useful 
especially in the imaging of soft biological samples such as cells because they can be 
imaged in a non contact manner in a suitable medium to maintain cell survival.  An 
electrolyte solution such as PBS is used to fill a hollow glass pipette and also to 
cover the sample (e.g. a cell monolayer).  A bias voltage is applied through a silver 
chloride electrode in the pipette holder, creating an ion current between the 
solution in the pipette tip and the solution that the sample is contained in.  As the 
pipette tip approaches the sample surface, the flow of ions through the pipette is 
partially blocked, leading to a reduction in the ion flow.  The feedback control 
mechanism withdraws the pipette from the sample to maintain a constant current.  
Therefore, measurement of this ion current provides the non-contact element of 
SICM since the set point for pipette withdrawal is reached before the pipette 
touches the sample (Figure 1.11).  In the first mode of SICM that was developed, 
automatic feedback control moved the pipette up or down in order to keep the 
current flowing through the pipette constant and a constant tip-sample distance was 
maintained164. 
 
Figure 1.11:  Layout of typical SICM equipment adapted from165.  An A6 monolayer 
is grown on a membrane filter which is mounted on a 3D piezo stage controlled by 
the scan control and feedback systems.  The modulated glass pipette scans the 
monolayer to produce images of the topography of the membrane. 
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Hopping probe ion conductance microscopy (HPICM) is a technique that increases 
the height of the sample that can be imaged and it can be used to image samples 
containing significant height differences.  The pipette tip is withdrawn to a point 
high above the sample surface and it approaches the sample from above, avoiding 
any problems caused by the tip colliding sideways with the sample (Figure 1.12)164.  
When the pipette is far away from the sample, ion flow through the pipette is 
uninterrupted and the ion current is measured at its maximum.  When the tip 
approaches the sample, the ion current flow reduces due to obstruction of the 
pipette by the sample, and when it reaches a given threshold (usually 0.25-1%), the 
tip withdraws from the sample before touching it166-169.  The position of the z 
dimension actuator is recorded as the height of the sample at that point, creating a 
topography image of the sample surface163. The decrease in ion current can be 
detected when the pipette tip is approximately one radius distance away from the 
sample surface and the resolution of SICM is therefore roughly equal to the internal 
radius of the pipette opening142, 170.  HPICM has been shown to have the ability to 
image fine cellular processes such as axons without causing damage to the cell.  It 
has also enabled the development of a fast pre scan mode where the image is 
divided up into squares and the corners of each square are measured for roughness 
to determine what resolution to scan the square at.  This enables an increase in the 
imaging speed since flat, featureless areas can be scanned quickly164. 
 
Figure 1.12:  Schematic representation of the hopping mode of SICM164. 
In addition to topography imaging, SICM can also be used for investigation of 
cellular functions.  This has been achieved in a number of different ways including 
using the tip to deliver molecules,171-173 and combining it with an electrode enabling 
measurement of chemical changes on a membrane (e.g. ion channels)174. 
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1.5.4  Scanning surface confocal microscopy (SSCM) 
SICM has been combined with a number of other techniques including AFM175, 
patch-clamp recording176, and confocal microscopy177.  SSCM is a combination of 
SICM and confocal microscopy which allows the simultaneous acquisition of a 
topography image plus a fluorescence image that is in focus at the pipette tip.  This 
enables identification of fluorescent structures on the cell surface e.g. labelled 
clathrin and caveolin endocytic pits, which can be linked to indentations in the 
membrane observed using topography imaging178.  It has also been used to look at 
the endocytosis of various nanoparticles and virus like particles into cells177. 
In SSCM, a confocal microscope is combined with the scanning pipette system1, 177.   
The sample stage moves up and down in the z direction and the pipette is scanned 
in x and y.  The laser is passed up a high numerical aperture objective (100x, 1.3N.A) 
so that it is focussed at the tip of the nanopipette and a pinhole is positioned at the 
image plane so that the confocal volume is just below the pipette.  The 100x 
objective is mounted on a piezo and this allows the laser to track the pipette tip as it 
moves up and down over the sample so that wherever the pipette tip is in the z 
direction, the fluorescence image will be in focus at that point (Figure 1.13)178.   
 
Figure 1.13:  (A) SSCM set up, (B) Dotted line shows position where optical 
fluorescent image obtained as pipette moves over sample in SSCM, (C) Dotted line 
shows fluorescence image from same sample when using confocal alone177. 
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1.6  Aims and Thesis outline 
The huge diversity of nanoparticles that can be produced makes it difficult to 
definitively link a certain parameter to an effect on cellular uptake, especially 
because effect is likely to vary between cell line and environment.  However, some 
parameters, especially charge, do seem to have broadly similar effects on many cell 
lines and this work aimed to further investigate this area via the production of 
nanoparticles with varying charge.  In addition, the effect of nanoparticle 
conjugation to the cationic cell penetrating peptide Tat, was used to investigate the 
role of the peptide structure and conformation in the uptake of nanoparticles versus 
the effect of a positive charge alone.   
AFM was used to investigate the interaction of polyacrylamide nanoparticles with a 
supported lipid bilayer and SICM/SSCM were used to visualize the interaction of 
silica nanoparticles with the membrane of MRC-5 cells.  Uptake into MRC-5 cells for 
both types of nanoparticle was investigated using widefield fluorescence 
microscopy to identify the subcellular localization and to perform quantitative 
measurements of uptake. Chapters 2 and 3 introduce the synthesis routes and 
characterization of the nanoparticles.  Chapter 4 investigates the interaction of 
polyacrylamide nanoparticles with a positive and negative charge or conjugated to 
Tat peptide, with a model cell membrane using AFM.  It then goes on to visualize the 
interaction of positive and negatively charged silica nanoparticles with the cell 
membrane of MRC-5 cells using SICM and SSCM.  The effect of charge and peptide 
conjugation on cellular uptake is further discussed in Chapter 5 through the use of 
fluorescence microscopy to visualize the intracellular location and to quantify the 
uptake of the nanoparticles.  In the final chapter, the current limitations of the 
techniques used and future potential in imaging the cellular uptake of nanoparticles 
is discussed. 
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Chapter 2 Ȃ Materials, Methods and Instrumentation 
2.1 Materials 
Acrylamideǡ ǯ ied Eagle Medium (DMEM), 10x trypsin, dioctyl 
sulfosuccinate, ǡǡǯǡǯ-tetramethylethylenediamine (TEMED), 3-
(acrylamidopropyl)-trimethylammonium chloride (ACTA), Ammonium persulfate 
(APS), tetraethylorthosilicate (TEOS), aminopropyltriethoxysilane (APTES), 
magnesium chloride, 28% Ammonia water and Tris buffer were obtained from 
Sigma Aldrich.  N,N-methylene bisacrylamide and Brij 30 were obtained from Fluka 
Analytical. Sulfo-succinimidyl-4-(N-maleimidomethyl) cyclohexane-1-carboxylate 
(Sulfo-SMCC) was obtained from Calbiochem.  Hexane and absolute ethanol were 
obtained from Fisher Scientific.  Dipalmitoyl phosphatidylcholine (DPPC) was 
obtained from Avanti Polar Lipids.  Tat peptide modified with a cysteine residue at 
the N terminus and with a C terminal acid group (CGRKKRRQRRR-COOH) with a 
purity of >95% was synthesised by Cambridge Research Biochemcials.  10kDa Alexa 
488 dextran and Alexa 488 succinimidyl ester were obtained from Invitrogen.  N-
trimethoxysilylpropyl-N,N,N-trimethylammonium chloride (TMAC) was obtained 
from Gelest.  N-(3-aminopropyl) methacrylamide hydrochloride (AMPA) was 
obtained from Polysciences Inc.  
2.2 Instrumentation 
2.2.1  Dynamic Light Scattering 
Dynamic light scattering (DLS) is a particle sizing technique that has a wide range of 
detection in the nanometre size region, in some cases as low as 1nm.  It is therefore 
well suited to the measurement of nanoparticle size and provides rapid, high 
throughput measurements. 
DLS measurements are based on the light scattered from particles as they diffuse 
under Brownian motion.  Brownian motion is induced by the bombardment of the 
particles by solvent molecules that are moving due to their thermal energy.  Light 
scattering is wavelength dependent so the light source used is a laser.  A constant 
temperature is also required in order to remove the effects of convection currents 
that could lead to non random motion.  When the laser is shone through the 
suspension of particles, the light is scattered by the particles and the intensity of the 
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scattered light fluctuates at a rate that is dependent on the size of the particles.  
Small particles cause the light to fluctuate faster than larger particles.  DLS measures 
these time dependent fluctuations in scattering intensity and uses it to determine 
the translational diffusion coefficient which is converted to particle size using the 
Stokes-Einstein equation179. 
 The particle size reported is that of a sphere that scatters light identically and has 
the same translational diffusion coefficient to the observed particle.  The size 
reported is also known as the hydrodynamic diameter since it refers to the size of 
the particle in a fluid.  This often differs from the particle size obtained using 
techniques such as electron microscopy since it is affected by the presence of any 
surface structures, along with the concentration and type of ions in the suspension 
medium.  Ions in the suspension medium and the total ionic concentration can affect 
the particle diffusion speed by changing the thickness of the electric double layer.  A 
low conductivity medium produces an extended double layer of ions around the 
particle which reduces diffusion speed leading to a larger apparent hydrodynamic 
diameter.  Higher conductivity medium suppresses the electrical double layer and 
therefore decreases the measured hydrodynamic diameter. 
The Zetasizer Nano ZS uses a technology known as Non-Invasive Back-scatter 
(NIBS) where the detector that receives intensity fluctuation information is located 
at a 173o angle from the sample cuvette.  NIBS provides a higher degree of 
sensitivity of measurement and allows analysis of samples with a higher 
concentration than for typical DLS arrangements, where the detector is placed at 
90o.  When using backscatter detection, the laser does not pass through the whole 
sample and this reduces the effect of multiple scattering, where light scattered by a 
particle is also scattered by others.  It also means that the effect of large 
contaminants such as dust is removed because they scatter light mainly in the 
forward direction. 
The instrument consists of a laser used to illuminate the sample contained in a 
cuvette and a detector that measures the scattered light at 173o.  The intensity of 
scattered light must be within a specific range for the detector to successfully 
measure it.  If too much light is detected, the detector becomes saturated.  An 
attenuator is used to reduce the intensity of the laser source and therefore the 
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intensity of scattering if required, or to increase it if particles are very small or 
sample concentration is low.  To measure particle size, the scattering intensity 
signal from the detector is passed to the correlator which compares scattering 
intensity at successive time intervals to derive the rate at which the intensity is 
varying.  This information is passed to the computer where the data is analysed and 
size information is determined.  The size distribution obtained is a plot of the 
relative intensity of light scattered by particles of different diameters, therefore it is 
known as the intensity distribution.  The intensity distribution can be skewed by the 
presence of larger particles, for instance, a 50nm particle scatters light to an extent 
one million times larger than a 5nm particle.  Therefore, while intensity 
distributions are useful for identifying the different populations of particles present 
in the sample, a number or volume distribution is used to look at the relative 
importance of each of these populations.  
 
Figure 2.1:  Typical setup of the Zetasizer Nano ZS for size determination using 
NIBS at 173o to measure particle diameter179. 
2.2.2  Zeta potential  
The stability of colloidal systems is determined by the balance of repulsive and 
attractive forces.  Zeta potential is the overall charge a particle acquires in a 
particular medium and depends on the surface chemistry of the particle and the 
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dispersant.  Surface charge can arise from ionisation, ion adsorption and ion 
dissolution.  In terms of the dispersant, a change in pH or ionic strength of the 
dispersing medium will affect zeta potential. The magnitude of the zeta potential 
gives an indication of the potential stability of the system and suspensions are stable 
when they have a zeta potential of greater than +/- 30mV since particles tend to 
repel each other180.   
The layer surrounding a particle dispersed in liquid consists of two parts.  These are 
an inner region, known as the Stern layer, where ions associate strongly with the 
particle.  The second, outer layer is a region where they are less firmly associated.  
Within this second, diffuse, layer, there is a notional boundary inside which the 
strongly associated ions and the particle form a stable entity.  This means that when 
the particle moves, the associated ions also move.  The ions that are beyond this 
boundary remain with the bulk liquid phase.  The potential at this boundary is the 
zeta potential.   
During zeta potential measurements, an electric field is applied across a sample in a 
sample holder consisting of gold plated electrodes in a folded capillary cell.  When 
subjected to an electric field, the velocity of the particles is determined by the 
charge associated with the particle, the viscosity of the medium and the applied 
field.  Charged particles suspended in the liquid move towards the electrode of 
opposite charge with a velocity dependent on a number of factors including zeta 
potential.  The velocity is measured using a technique known as M3-PALS (Phase 
Analysis Light Scattering) which allows calculation of electrophoretic mobility and 
from this, zeta potential.  PALS is a variation of laser Doppler velocimetry (LDV) 
which measures the particle mobility generated when a potential is applied, using 
the frequency shift of light caused by particles moving in the cell180, 181.   
In zeta potential instruments, a single laser beam is split to provide an incident and 
reference beam.  The incident beam passes through the sample and the scattered 
light is detected at 13o, while the reference beam is diverted around the cell.  When 
an electric field is applied to the cell, any particles moving through the capillary cell 
cause the intensity of light detected to fluctuate with a frequency proportional to the 
particle speed and this information is passed to a digital signal processor.  The 
scattered light from the incident beam is combined with the reference beam to 
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create the intensity variations.  The software produces a frequency spectrum from 
which the electrophoretic mobility and the zeta potential are calculated.  The 
intensity of the detected, scattered light must be within a specific range for the 
detector to successfully measure it.  This is achieved using an attenuator, which 
adjusts the intensity of light reaching the sample.  To correct for any difference in 
the cell wall thickness and dispersant refraction, compensation optics are installed 
to maintain alignment180, 181. 
 
Figure 2.2:  Typical setup of a Zetasizer for measuring zeta potential180. 
2.2.3   Disc Centrifuge 
The CPS disc centrifuge is a particle sizing tool that can be used to size particles 
ranging from 3nm to 75µm.  It is based on the principle of differential centrifugal 
sedimentation.  In addition to the measurement of the size of particles with a 
density greater than that of water, for example gold or iron, the disc centrifuge can 
also be used to determine the size of particles such as liposomes that have a density 
similar to, or less than that of water, using the low density disc182. 
It consists of a hollow, optically clear disc and a short wavelength monochromatic 
light of 405nm.  Particle size is determined based on the time taken for the particles 
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to sediment through a sucrose gradient in the disc and to pass the light beam and 
detector located on the outside edge of the disc (Figure 2.3).  When a sample is 
injected into the disc, it strikes the back of the disc and forms a thin film which 
spreads as it accelerates radially toward the surface of the fluid.  When the sample 
reaches the surface of the fluid within the disc, it spreads over the surface and 
because of its lower density it initially floats on the higher density fluid.  While the 
dispersion media for the sample then remains on the surface of the gradient, the 
sample particles begin to sediment through the gradient within the disc at a rate 
that is dependent on a number of factors including their size and density, as well as 
the density of the gradient fluid182. 
 
Figure 2.3:  The design of the CPS Disc Centrifuge. 
2.2.3.1  Differential Sedimentation 
Sedimentation is the settling of particles under the influence of gravitational or 
centrifugal forces.  It is a well known and reliable method of particle size analysis, 
and the disc centrifuge uses centrifugal sedimentation to size particles.  Particles 
settle in a fluid under a gravitational field according to Stokes Law, at a rate that is 
proportional to the square of the particle diameter.  Particles that differ in size by 
only a few percent will therefore sediment at significantly different rates.   The time 
taken to reach the detector is used to calculate the size of the particles after 
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calibration with a standard of a known size.  The technique is known as differential 
sedimentation because only a small part of the sample is being measured at any one 
time.  Mie theory light scattering calculations are used to convert the intensity 
readings into a mass distribution183.   
 
Figure 2.4:  Differential sedimentation. 
 
2.2.3.2  Stokes law of sedimentation 
Stokes law of sedimentation determines the rate of sedimentation of spherical 
particles through a viscous medium in a gravitational field.  In the disc centrifuge, 
gravitational acceleration is replaced with centrifugal acceleration which allows for 
the faster sedimentation of small particles.  It describes how the drag force on a 
spherical particle moving through a fluid depends on the particle size, the difference 
in density between the particles and the gradient fluid, the viscosity of the fluid, and 
the strength of the centrifugal field, which is determined by rotational speed.  In the 
disc centrifuge, Stokes law is used to determine the size of spherical particles by 
measuring the time required for the particles to settle a known distance in a fluid of 
known viscosity and density183.   
Stokes showed that when particles settle in a gravitational field under a certain set 
of conditions, the forces acting on the particle are in perfect balance and the particle 
immediately attains a constant velocity for the duration of the fall.  The required 
conditions are: 
1.  The particle must be smooth, spherical and rigid enough not to deform due 
to the forces acting on it. 
2. The particle must be small compared to the container of the fluid. 
3. The particles in the fluid must be much smaller than the sample particle so 
the fluid is essentially homogenous in how it acts on the particle.  If this 
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condition is not met, Brownian motion of small particles in the fluid can 
cause problems with analysis. 
4. The settling speed must be slow enough that all viscous forces come from 
non turbulent flow.  
The Stokes equation (1) shows that the sedimentation rate of the particle is 
proportional to the square of the particle diameter, the difference in density 
between the particles and fluid, the gravitational acceleration, and inversely 
proportional to fluid viscosity.  
                                                               (1) 
Where: 
V = sedimentation rate (cm/s) Ʉ ? (poises) ɏɏɏf are the densities of the particle and the fluid respectively (g/cm3) 
g = gravitational constant (980 cm/sec2) 
D = particle diameter (cm) 
Rearranging Stokes equation shows that the diameter of a particle can be 
determined by measuring the time (t) required to sediment a known distance (X): 
Since    
 
Equation (1) becomes:
 
                                               (2) 
 
For a centrifuge running at constant speed and temperature, all of the parameters 
except time are constant during the analysis and (2) can be restated as: 
                             (3) 
where K is a combination of constants (density, viscosity and gravitational 
acceleration). 
  
K
UU
18
2 gD
V fp
 
V
X
t  
  21
18
gt
XD
fp UU
K

2
1
t
KD  
58 
 
The disc centrifuge software uses the sedimentation time for a calibration standard 
of known diameter to determine the value of the constant, K.  Each time a sample is 
analysed, a calibration standard run is used to determine a new value for K183.  
Inside the disc centrifuge, centrifugal acceleration replaces the gravitational field.  
The centrifugal acceleration increases as the particles move from the surface of the 
liquid towards the outside edge of the disc chamber, because the radius of rotation 
increases as the particles move outwards.  Even though conditions within the disc 
centrifuge are different from sedimentation under gravity, the same equation (3) 
can be used to describe both processes. 
2.2.3.3  Density determination 
Particle density is the most critical parameter for accurate measurement of particle 
size using the disc centrifuge, and is a term in Stokes equation.  If the density of the 
particle is close to that of the liquid in which it will be dispersed then it is even more 
important to get an accurate value of particle density.  The disc centrifuge can be 
used to determine the density of the particles by running the sample on two 
different gradients e.g. a sucrose gradient in water and deuterium oxide (D2O) which 
differ in density by 0.11g/cm3.  The density can be changed in the procedure 
definition for the experiment and the files recalculated in order to get a new size 
distribution for each density value.  The two distributions will overlap each other 
when the assumed particle density is correct184. 
2.2.3.4  Low density disc 
The low density disc allows measurement of samples that have a density of 
approximately 1.0 g/cm3 or lower.   A D2O based gradient is used which can measure 
particle size down to 40nm.  Unlike the normal disc, where the sample floats on the 
surface before sedimentation occurs, the sample is delivered to the outside edge of 
the disc using a special injection port into a V shaped groove in the front of the disc.  
In the base of this groove there are four capillary channels which lead to the outside 
edge of the disc chamber.  When the sample reaches the bottom of the disc it 
spreads over the outside edge of the disc and forms a band of particles.  The 
particles then float toward the surface during the analysis since they have a density 
lower than that of the gradient fluid.  The particles still follow the same equations of 
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sedimentation but with a negative value for motion.  The light source and detector 
are moved slightly more towards the centre of the disc for the analysis182.  
 
Figure 2.5:  The low density disc. 
2.2.4  Fluorescence 
In order to enable the visualization of the nanoparticles during the uptake process 
and within cells following uptake, a fluorescent dye was incorporated into the 
nanoparticle matrix which could be visualized using fluorescent spectroscopy and 
microscopy.  Alexa 488 conjugated to 10kDa dextran was trapped within the matrix 
of polyacrylamide nanoparticles.  This conjugate is too large to escape the small 
pores in the nanoparticle matrix therefore remains within the particle, protecting 
the cell from any effects of the dye.  For silica nanoparticles, the succinimidyl ester 
form of Alexa 488 was conjugated to APTES and this was incorporated into the 
nanoparticles as they formed.  APTES is an amine functionalised silane monomer 
which can polymerise with other silane monomers such as TEOS so that the 
covalently bound dye is incorporated into the nanoparticle as it forms. 
The dye used in these experiments was Alexa 488 which has a fluorescence 
emission wavelength of 520nm therefore emits in the green region.  It was chosen 
because it is a bright, stable dye and the fluorescence emission intensity is not 
affected by pH over the range (pH 4-10) that may be encountered during cellular 
uptake.  Alex Fluor dyes are generally hydrophilic and negatively charged, and they 
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have good quantum yields and long fluorescence lifetimes which helps to increase 
the ease of imaging and reduces problems associated with, for example, 
photobleaching, when attempting quantitative measurements185. 
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Figure 2.6:  Structure of Alexa 488. 
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2.3  Methods -Nanoparticle synthesis 
2.3.1  Polyacrylamide nanoparticles 
Polyacrylamide nanoparticles were synthesised by the free radical polymerisation 
of acrylamide using a reverse microemulsion technique.  Hexane was deoxygenated 
for at least 30 mins with argon.  A water in oil microemulsion was prepared by 
dissolving the surfactants polyoxyethylene(4) lauryl ether (Brij 30) (3.08g) and 
dioctyl sulfosuccinate (1.59g) in deoxygenated hexane (42 ml) under argon in a 
round bottomed glass flask and adding the prepared aqueous phase containing the 
monomers.  The      ȋ ?Ǥ ? ?Ȍ  ǡǯ-
methylene bisacrylamide (0.16g) in 2ml distilled water.  The solution was warmed 
and sonicated in a water bath to dissolve the monomers.  1.975ml of this monomer 
solution was combined with 25µl of a 5mg/ml solution of Alexa 488 dextran to 
make a total aqueous phase volume of 2ml. 
Polymerisation was initiated by the addition of 10% w/v APS, (30µl) and TEMED 
(15µl).  The reaction proceeded for two hours under argon, after which time the 
hexane was removed by rotary evaporation leaving an opaque viscous residue.  To 
remove excess reagents and dye, absolute ethanol was added and the nanoparticles 
were collected by centrifugation at 6000rpm/7750rcf for seven minutes.  The 
washing procedure was repeated six times and the nanoparticles were then 
resuspended in ethanol which was removed using rotary evaporation to leave a 
powder which was stored in the fridge186. 
2.3.1.1  Positively charged polyacrylamide nanoparticles 
To prepare positively charged polyacrylamide nanoparticles, increasing amounts of 
acrylamide were replaced with the positively charged monomer ACTA to produce 
nanoparticles containing 2, 5, 10, 15 and 20% ACTA.  For example, nanoparticles 
containing 10% AC  ? ? ?Ǥ ?ǡ  ? ? ?ǡǯ-
methylene bisacrylamide and 157.1mg ACTA which was measured out by weight 
since it was a viscous solution after taking into account the density of the solution187. 
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Figure 2.7:  Structure of 3-(acrylamidopropyl)-trimethylammonium chloride 
(ACTA). 
 
2.3.1.2  Negatively charged polyacrylamide nanoparticles 
Negatively charged polyacrylamide nanoparticles were prepared via the use of N-
acryloxysuccinimide. 5% of the acrylamide in the monomer solution was replaced 
with N-acryloxysuccinimide (56.2mg) and was incorporated into the nanoparticle 
matrix (473mg acrylamide and 160mg N,N-methylene bisacrylamide).  
Polymerisation was performed as described previously in section 2.3.1. 
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Figure 2.8:  Structure of N-acryloxysuccinimide. 
 
2.3.1.3  Amine functionalised polyacrylamide 
Nanoparticles with an amine functionalisation for Tat conjugation were prepared by 
incorporating AMPA into the nanoparticle matrix.  The monomer solution consisted ȋ ?Ǥ ? ? ? ?Ȍǡǡǯ-methylene bisacrylamide (0.16g) and AMPA (27.2mg).  
The polymerisation was carried out in the same way as for unfunctionalised 
polyacrylamide nanoparticles.  The amine functionalised particles were 
subsequently stored under argon at -20oC in order to reduce aggregation10. 
2.3.2  Tat peptide conjugation 
Tat peptide was conjugated to polyacrylamide nanoparticles via the 
heterobifunctional crosslinker Sulfo-SMCC.  Crosslinkers such as SMCC contain an 
amine reactive NHS (N-hydroxysuccinimide) ester on one end and a sulf-hydryl-
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reactive maleimide group on the other.  Sulfo SMCC is a water soluble analogue of 
SMCC that possesses a negatively charged sulphonate group on the NHS ring, 
providing water solubility of at least 10mg/ml at room temperature.  It is generally 
used to produce antibody enzyme conjugates but in this case, by modifying the 
peptide to include a cysteine group, and incorporating an amine group on the 
surface of the nanoparticle, conjugation of the peptide to the nanoparticle could be 
achieved.  The reaction occurs in the pH range 6.5-7.5188. 
   
 
Figure 2.9: Conjugation of Tat peptide to nanoparticles via SMCC. Adapted from189. 
To synthesize Tat conjugated polyacrylamide nanoparticles, 100mg of amine 
functionalised nanoparticles were resuspended in 5ml of a 2mM solution of Sulfo-
SMCC in PBS pH 7.4.  The suspension was stirred at room temperature for one hour 
then precipitated with 7ml absolute ethanol and centrifuged at 6000rpm/7750rcf 
for five minutes.  The supernatant was discarded and the nanoparticles were 
resuspended in 4ml PBS and 1ml of a 5mg/ml solution of Tat peptide (sequence 
CGRKKRRQRRR-COOH) in PBS.  The suspension was stirred for one hour at room 
temperature and then overnight at 4oC.  The nanoparticles were washed with 7ml 
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absolute ethanol and centrifuged (6000rpm/7750rcf for 5mins).  The supernatant 
was discarded and the Tat conjugated nanoparticles were dried and stored at -20oC. 
2.3.3  Silica nanoparticles 
Silica nanoparticles were synthesised via a modification of the Stober method190, 191. 
1mg of dye (Alexa 488 succinimidyl ester) was dissolved in 90µl DMSO which was 
then stirred with 2ml absolute ethanol and 15µl APTES for 45 mins at room 
temperature.   
0.15ml TEOS, 0.4ml APTES conjugated dye, 21.5ml absolute ethanol, 8.47ml water 
and 1.335ml 30% ammonia water were stirred together for one hour at room 
temperature in a small glass conical flask.  To synthesize negatively charged 
particles, 1.35ml TEOS was added and the suspension was stirred for five hours. To 
synthesize positively charged particles, 1ml of TEOS was added and then after an 
additional 30 mins, 0.35ml of TMAC, (50% in methanol) was added and the 
suspension was stirred for five hours. 
Nanoparticles were collected by centrifugation using a Hermle Z300 Universal 
Laboratory centrifuge at 6000rpm/7750rcf for 30 mins and the supernatant was 
discarded.  The pellet was resuspended in absolute ethanol and this process was 
repeated twice and the nanoparticles were then left to dry fully overnight in a 
dessicator, then stored as a dry powder at 4oC. 
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2.4  Characterization methods 
2.4.1  Zeta potential 
Nanoparticle charge was measured using the Zetasizer Nano ZS (Malvern 
Instruments).  Zeta potential was measured for a 2.5mg/ml suspension of 
polyacrylamide and a 0.25mg/ml suspension of silica in PBS, DMEM and serum free 
DMEM.  Nanoparticles were sonicated for 15 mins prior to measurement to ensure 
adequate resuspension. 
2.4.2  Size 
2.4.2.1  Dynamic Light Scattering 
Nanoparticles were sized using the Zetasizer Nano ZS.  A 2.5mg/ml suspension of 
polyacrylamide and a 0.25mg/ml suspension of silica nanoparticles were prepared 
in PBS and serum free DMEM.  1ml of solution was placed in a DLS cuvette and a 
minimum of 12 readings were obtained. Particle suspensions were filtered using a 
0.2µm syringe filter (polyacrylamide nanoparticles) or a 0.45µm filter (silica 
nanoparticles) before use.   
2.4.2.2  CPS Disc Centrifuge 
Polyacrylamide nanoparticles were prepared in a 5mg/ml solution and filtered 
through a 0.2µm syringe filter before use.  Particle size was measured using a 4-12% 
sucrose in water gradient.  Silica nanoparticles were prepared in a 0.5mg/ml 
suspension and filtered through a 0.45µm syringe filter before use.  The 
nanoparticles were sized using an 8 Ȃ 24% sucrose in water gradient. 
2.4.2.3  Statistical tests 
Statistical tests performed to investigate the significance of differences between 
populations  of nanoparticles were done using a two tailed T test with a 95% 
confidence interval using Microsoft Excel. 
2.4.3  Fluorescence 
Fluorescence intensity measurements of solutions used for DLS were taken using an 
excitation of 495nm for polyacrylamide (0.83mg/ml) and silica nanoparticles 
(0.025mg/ml) on a fluorimeter.  Fluorescence emission was measured between 
505nm and 550nm.  In preparation for the measurement of the cellular uptake of 
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the nanoparticles, fluorescence intensity of both polyacrylamide (2.5mg/ml)  and 
silica nanoparticles (0.025mg/ml) was also measured on the widefield Leica 
DMIRE2 microscope used for imaging cellular uptake of the nanoparticles so that 
any differences in particle fluorescence could be accounted for when quantifying the 
uptake of the different nanoparticles. 
2.5  Cell culture methods 
MRC-5 fibroblasts were cultured and passaged in DMEM supplemented with L-
Glutamine, Penicillin, Streptomycin and 10% FCS (all obtained from Sigma, Poole, 
Dorset, UK) in T75 flasks (Corning Costar, Nottingham).  10x Trypsin was also 
obtained from Sigma and was diluted to a 1x concentration in PBS and stored in 
aliquots at -20oC.  All reagents were purchased sterile or were sterilised before use 
via filtration through a 0.22µm Whatman sterile syringe filter.  Cells were passaged 
only when 100% confluent in order to maintain an adequate growth rate when 
replated.  When confluency was reached, the media was removed and replaced with 
3 ml of trypsin at 37oC to detach the cells.  After 5 minutes, cells were dislodged 
from the flask by gentle tapping and 7ml of DMEM was added.  The cell suspension 
was transferred to a falcon tube and spun at 200g at room temperature for 5 mins.  
The supernatant was removed and the resulting cell pellet was resuspended in an 
appropriate volume of DMEM depending on the future use.  To maintain the culture, 
cells were split 1:3 into new T75 flasks and if required for imaging, 0.5ml of cell 
suspension was added to a 35mm glass bottomed dish with 1.5ml DMEM. 
2.6  Sample preparation 
2.6.1  Atomic Force Microscopy 
Supported lipid bilayers were formed via the vesicle fusion technique192.  1ml of 
DPPC, dissolved in chloroform was evaporated and resuspended in 10mM Tris HCl 
buffer pH 7.4.  The resulting suspension was subjected to ten freeze-thaw cycles 
using liquid nitrogen and lukewarm water.  Vesicles were formed using 21 passes 
through a small volume extrusion apparatus containing a 100nm polycarbonate 
filter193.  DPPC (Tm 41oC) was extruded at a higher than ambient temperature since it 
was in the gel phase at room temperature, which made it much more difficult to 
pass through the apparatus.  The resulting vesicles were sized using dynamic light 
scattering and the CPS disc centrifuge. 
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In preparation for AFM imaging, the suspension was first diluted to 1mg/ml using 
10mM Tris buffer and 100mM MgCl2.   ? ?Ɋte 
mica and left for not less than four hours at ambient room temperature to form 
bilayers.  The resulting lipid bilayers were imaged in 10mM MgCl2 in Tris buffer 
(Sigma, Poole, Dorset, UK) in tapping mode using a Multimode AFM, with Nanoscope 
IIIa or V controller and liquid cell (Veeco, Santa Barbara, CA).  Silicon nitride V-
shaped AFM cantilevers with nominal spring constants of 0.58 N/m were employed 
(DNP cantilevers, Veeco).  Typical set point was 0.6-0.7V, drive frequency 200-
500mV, and scan rate 1Hz.   All solutions were made with HPLC grade water and 
filtered through a 0.2 µm syringe filter prior to use. 
Increasing concentrations of Tat peptide, 500nm- ? ?Ɋ, were added through the 
liquid cell before imaging following removal of the existing buffer solution. 
Polyacrylamide nanoparticle suspensions were prepared at concentrations of 1, 10, 
25 and 100µg/ml.  All suspensions were made using HPLC grade water and were 
sonicated for at least 15 minutes before use.  Before addition to the bilayer, 
suspensions were filtered through a 0.2µm syringe filter.  
Before any analysis was performed on the images, all images were flattened (first 
order) using the Nanoscope Analysis software.  Following this, section analysis was 
performed by drawing a line across certain features of interest in order to obtain a 
cross-section of the area of interest.  This was used to gain quantitative information 
about changes in bilayer height following exposure to nanoparticles and peptides. 
Further quantitative analysis was then performed using the bearing analysis 
function.  This provided information about changes in the bilayer coverage following 
exposure to the peptide and nanoparticles.  Bearing analysis is a method of plotting 
and analyzing the distribution of surface height over a sample.  It reveals how much 
of a surface lies above or below a given height, therefore by selecting a threshold 
just above the mica surface; it is possible to measure the percentage of the image 
formed by the bilayer.  It is also possible to remove the small percentage 
contributed by the nanoparticles by excluding very high features from the analysis.  
It is a better technique to use than surface roughness because that only represents 
the statistical deviation from an average height.   
68 
 
2.6.2  Scanning Ion Conductance Microscopy 
Cells were washed twice with serum free DMEM (Sigma, Poole, Dorset, UK) and left 
for one hour at 37oC.  100µg of silica nanoparticles was added to the cells in serum 
free DMEM and incubated for 30mins at 37oC.  The cells were washed three times 
with PBS and fixed using 100% ice cold methanol (Fisher Scientific, Loughborough, 
UK) at -20oC for 10 minutes before being washed with PBS and stored in the fridge 
before imaging.  Nanoparticles were filtered though 0.45µm syringe filters before 
use. 
Nanopipettes of approximately 50nm internal diameter were pulled from 
borosilicate glass capillaries of outer diameter 1mm and inner diameter 0.5mm 
(Intracell) using a laser based Brown-Flaming puller (P-2000, Sutter Instruments).  
The nanopipettes were filled with PBS filtered through PVDF 4mm, 0.22µm pore 
size Millex syringe filter (Millipore) using a Microfil 34AWG pipette filler (World 
Precision Instruments).  The fixed cell samples were immersed in sterile filtered 
PBS.  The pipettes displayed  ? ? ? ?ȳǤ  
 
Initially, SICM studies using HIPCM were performed to investigate whether it was a 
viable technique to use to look at the uptake of silica nanoparticles into live MRC-5 
cells via topography.  However, it was found that mobile membrane features 
interfered with imaging and cells could not be kept alive for long enough to get 
suitable images.  In addition, MRC-5 cells have a number of membrane components 
that are a similar size to the nanoparticles being investigated which made it difficult 
to identify the nanoparticles.  Further work therefore involved imaging cells that 
had been fixed following exposure to nanoparticles and a SSCM at Imperial College 
London was used in order to identify nanoparticles by their fluorescence.  Spots of 
fluorescence could be seen relating to nanoparticles while more diffuse, out of focus 
fluorescence, was attributed to particles that had already been taken up by the cells. 
After locating the particles using fluorescence, high resolution topography imaging 
was then performed to investigate the effect of the particle charge on the 
membrane.  Fluorescence was not used at this point since the resolution was too 
low. 
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2.6.3  Fluorescence Microscopy 
2.6.3.1  Polyacrylamide nanoparticles 
Cells were washed twice with serum free DMEM and left for one hour.  2.5mg of 
polyacrylamide nanoparticles were added to the cells in serum free DMEM after 
filtering through a 0.2µm syringe filter, and incubated for six hours at 37oC.  The 
cells were washed three times with PBS and then fixed using 4% paraformaldehyde 
for 15 mins.  Incubation time for all types of nanoparticle was chosen based on 
experience in the group and previous literature reports10, 98. 
2.6.3.2  Tat conjugated polyacrylamide nanoparticles 
Experiments to investigate the uptake of Tat conjugated polyacrylamide 
nanoparticles were carried out as described above except that nanoparticle 
suspensions were not filtered before use due to the aggregation of the 
nanoparticles.    
2.6.3.3  Silica nanoparticles 
Cells were grown to form a monolayer on a six well plate and the cells were washed 
twice with serum free DMEM and left for one hour.  50µg of particles were added to 
each well after filtering through a 0.45µm syringe filter, and incubated for three 
hours at 37oC.  Initial experiments that involved seeding the cells directly onto glass 
bottomed dishes demonstrated that the silica nanoparticles adhered to multiple 
surfaces including the glass bottom of the dish and they could not be removed by 
repeated washing with PBS.  To improve the images obtained in order to allow 
reliable measurement of intracellular fluorescence, the cells were seeded into six 
well plates and subjected to trypsinization following incubation with the 
nanoparticles.  The resulting cell and nanoparticle suspension was centrifuged at 
200g and the supernatant containing the excess nanoparticles was removed.  The 
cells were replated onto individual glass bottomed dishes, left for 24 hours to 
adhere and then fixed with 4% paraformaldehyde for 15 mins before imaging. 
2.6.3.4  Imaging 
Uptake of nanoparticles into MRC-5 cells was investigated using a Leica DMIRE2 
timelapse widefield fluorescent microscope with full stage incubation (37oC) and a 
Hammamatsu OrcaER monochrome camera and Leica CTR MIC camera controller.    
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Cells on glass bottomed dishes were imaged using a 63x oil objective.  An XBO 75 
xenon arc lamp was used with an ebx 75 electronic transformer to provide the light 
source.  An S484/15x FITC filter with a bandwidth between 469 and 499nm was 
used in conjunction with a Chroma Custom 62000 dichroic filter cube.    Excitation 
time was kept constant throughout the experiments to enable comparison of results 
(500ms).  The uptake experiments were repeated three times and the number of 
cells (referred to as the N number in Chapter 5), is the total from all three 
experiments. 
Images were deconvoluted using the Volocity 6.0 software (Perkin Elmer) with 
measured point source functions (PSFs) for the 63x objective in oil.  Measurements 
of the uptake of the nanoparticles were performed by measuring the green 
fluorescence intensity from Alexa488 within cells.  Individual cells were highlighted 
by drawing around the shape of the cell and the mean green fluorescence intensity 
from the nanoparticles for each cell was measured using Volocity 6.0 and recorded 
in Microsoft Excel.  The background level of fluorescence in the control samples was 
measured and subtracted from the measurements for each sample.  This was 
repeated for all the cells imaged and the minimum number of samples was thirty 
cells.  An average (mean) measurement for all the cells was then taken and the 
standard deviation was calculated and the background fluorescence recorded from 
the control sample was subtracted.  This value was then corrected for the difference 
in the fluorescence emission intensity of the nanoparticles themselves to provide 
the final measurement of uptake. This was done by measuring the fluorescence 
emission intensity of a suspension of nanoparticles in a glass bottomed dish on the 
Leica DMIRE2 microscope used for cellular imaging.  The intensity was recorded ten 
times for each set of nanoparticles and the mean emission intensity was calculated.  
The emission intensity was then normalized to the most fluorescent set of 
nanoparticles and the fluorescence emission recorded from the cells was multiplied 
by this value to obtain a final measurement of fluorescence.  
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Chapter 3 - Nanoparticle characterisation 
3.1  Introduction 
Polyacrylamide and silica nanoparticles were chosen for this work because they 
have previously been shown to enter cells without causing cell death186, 191.  They 
are particularly suitable for this work because the method of synthesis allows their 
chemistry  to be easily modified in order to either change the functional groups on 
the surface that interact with the cellular environment, or to impart a charge to the 
nanoparticle matrix. 
3.1.1  Polyacrylamide nanoparticles 
Polyacrylamide nanoparticles are small, hydrophilic and biocompatible 
nanoparticles.  They were first developed as a sensing tool by the Kopelman group 
in the 1990s from fibre optic sensors.  These encapsulated fluorescent dyes within a 
polymer matrix and were used for intracellular sensing.  Despite advances in the 
miniaturisation of these probes, there were significant limitations associated with 
their use.  These included the high skill of the operator and a lack of ability to do 
multiple and repeated measurements.  It was identified that only the tip of the probe 
was actually required as the sensing element and this led to the development of a 
nanoparticle sized polymer matrix based on acrylamide which could encapsulate 
the dyes.  These particles were termed PEBBLEs (Probe Encapsulated By 
Biologically Localized Embedding)194-196.  The reduced size of the nanoparticles 
compared to the probes means that polyacrylamide nanoparticles can therefore 
occupy only 1ppb of a cell, causing negligible biological effects194. 
Polyacrylamide nanoparticles were developed as diagnostic tools for detecting 
analytes such as H+, Ca2+, Mg2+ and glucose via the encapsulation of fluorescent dyes.  
Their development has enabled both measurement and also visualization of the 
uptake process of the nanoparticles and their intracellular location.  They are being 
investigated because their tuneable properties mean that they can be designed so 
they can target a particular intracellular pathway or location, enable measurement 
of analytes within a cell or deliver a therapeutic to a specific intracellular 
organelle197, 198.  They are porous, hydrophilic, inert, biocompatible nanoparticles 
with a size of less than 70nm, meaning they cause minimal cell perturbation.  The 
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fluorescent dyes used for sensing can be trapped within the nanoparticle matrix by 
virtue of their conjugation to components of the nanoparticle or to a large molecule 
e.g. 10,000MW dextran, that is trapped within the matrix.  This protects the cell 
from any effects of the dye, and also protects the dye from any cell components that 
may affect it, for example, enzymes76, 83, 199.  The porous nature of the matrix allows 
the diffusion of molecules and ions through the particles and their small size means 
that when used for measurement of intracellular analytes, response time is fast.  
Polyacrylamide nanoparticles can be easily modified during the synthesis process 
by the incorporation of different molecules into the matrix in order to provide a 
wide range of surface chemistries and functionalities.  They can also be conjugated 
to other molecules such as cell penetrating peptides, oligonucleotides and aptamers 
following synthesis of nanoparticles with the required surface functionality10, 76, 200. 
Polyacrylamide nanoparticles are produced in a reverse microemulsion technique 
via the polymerisation of acrylamide and bisacrylamide within water droplets in an 
oil phase.  The size of these water droplets and therefore the nanoparticle size 
distribution can be tightly controlled198.  Nanoparticles without any further 
modification have a slightly negative zeta potential but they can be easily modified 
via the incorporation of a positive monomer, 3-acrylamidopropyl 
trimethylammonium chloride (ACTA), to produce nanoparticles with varying 
degrees of positive charge187.  Alternatively, via incorporation of a monomer 
containing an amine group, other molecules such as cell penetrating peptides can be 
conjugated to the nanoparticles via a heterobifunctional crosslinker (SMCC)10. 
3.1.2  Silica nanoparticles 
Silica is used in a variety of forms in many different industrial applications including 
ceramics, catalysis and high tech industry such as computing201, 202. The production 
of silica nanoparticles furthered the range of possible applications and their 
properties, including a high surface area to volume ratio, large pore size and 
biocompatibility mean that they can be applied to fields such as drug delivery, 
imaging and diagnostics203.  Silica (or sol gel) nanoparticles are produced using a 
modification of the Stober method, published in 1968, and can be used to produce 
nanoparticles with a wide range of sizes depending on the reaction conditions190.  
Similarly to polyacrylamide nanoparticles,  silica nanoparticles synthesised with no 
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modifications have a negative zeta potential190, 204.  They can also be produced using 
a microemulsion technique205.  Both of these techniques provide the opportunity to 
easily modify a number of properties of the nanoparticles by incorporation of 
different reagents that may affect size, charge or surface chemistry as well as adding 
functional groups in order to conjugate molecules to the surface of the 
nanoparticle73, 128, 206.   
The Stober synthesis is the ammonia catalysed reaction of tetraethylorthosilicate 
(TEOS) with water in low molecular weight alcohol, such as methanol or ethanol, to 
produce monodisperse spherical silica nanoparticles201, 207.  Nanoparticles are 
formed by hydrolysis of TEOS and subsequent condensation of silicic acid in ethanol 
(Equations  1 and 2)208.   The rates of hydrolysis and condensation affect the size of 
the particles produced and a monodisperse population will generally be produced if 
the hydrolysed monomers produced in (1) react faster than they are produced202.  
Si(OR)4 +  4H2O              Si(OH)4 +  4ROH
Si(OH)4                   SiO2 +  2H2O   
(1)
(2)
 
Two main theories have been presented regarding how nanoparticles form during 
the Stober process.  These are monomer addition and controlled aggregation.  The 
monomer addition theory divides the Stober process into an initial stage of 
nucleation which is then followed by particle growth via the addition of the 
hydrolysed monomer to the particle surface.  The rate of particle growth is limited 
by the hydrolysis of the monomers208-211.  The second theory is known as controlled 
aggregation and is a single stage process where nucleation occurs continuously and 
the nuclei aggregate to form the particles201, 208, 212, 213.  It is unclear whether one 
theory is correct or whether combinations of both may occur to different extents 
depending on the reaction conditions.   
A number of parameters are important in the preparation of silica nanoparticles.  
These include water and ammonia concentrations, pH, rate of hydrolysis and rate of 
condensation74.  These have been shown to influence properties of the nanoparticles 
such as pore size and shape, particle size and morphology.  Water and ammonia 
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concentrations are particularly important and the rate of condensation is influenced 
by the amount of water.  Increasing the concentration of water produces larger 
particles.  Ammonia is required to produce spherical particles and increasing 
ammonia concentration has also been shown to produce larger particles190, 202.  
However, for both water and ammonia, at very high concentrations, particle size 
sometimes decreases202.  Particles produced in ethanol are double the size of those 
produced in methanol and the use of higher molecular weight alcohols tends to 
produce particles with a wider size distribution190, 201.  The rate of addition of TEOS 
also has an effect on the final size and polydispersity of the particles.  Particle size is 
a decreasing function of the rate of addition of TEOS which can be explained by a 
reduction of the nucleation period and better control of the reaction speed therefore 
particle size decreases as the rate of TEOS addition increases207.   
Silica nanoparticles have a negative surface charge due to ionisation of surface 
silanol and hydroxyl groups but this can be modified via the addition of various 
functional groups such as trimethylammonium which imparts a positive charge to 
the nanoparticles73, 128, 214.   Silica nanoparticles with covalently attached amine 
surface functionalities have been developed and they carry a net positive surface 
charge but often demonstrate colloidal instability. The incorporation of increasing 
amounts of cationic trialkyloxysilanes has been shown to result in the formation of 
larger nanoparticles with a disrupted pore structure73, 215, 216. 
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3.2  Results and Discussion 
Nanoparticle uptake into cells is dependent on a number of factors, many of which 
relate to the physicochemical properties of the nanoparticles including size, shape, 
charge and surface chemistry.  It was therefore crucial to have well characterised 
nanoparticles in order to enable reliable comparisons between the effects of these 
different parameters on nanoparticle uptake into cells.  Nanoparticles were 
characterised in terms of their size and charge using a variety of different 
techniques including dynamic light scattering, the CPS disc centrifuge and zeta 
potential. 
3.2.1  Nanoparticle charge 
3.2.1.1  Polyacrylamide nanoparticle charge 
The presence of ACTA in the nanoparticle matrix increased the zeta potential from 
approximately -7mV for unfunctionalised polyacrylamide nanoparticles to 19mV for 
the most positively charged version containing 20% ACTA (Figure 3.1).  
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Figure 3.1:  Increasing nanoparticle charge with increasing ACTA incorporation in 
PBS and serum free DMEM. 
 
Incorporation of 5% N-acryloxysuccinimide produced nanoparticles with a charge 
of -11mV in PBS and -5.5mV in serum free DMEM (Figure 3.2). 
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Figure 3.2:  Decrease in nanoparticle charge caused by the incorporation of 5% N-
acryloxysuccinimide. 
 
Resuspension of unfunctionalised, ACTA and N-acryloxysuccinimde containing 
polyacrylamide nanoparticles in serum free DMEM as opposed to PBS often 
increased the zeta potential of the nanoparticles. 
3.2.1.2   Tat peptide conjugated polyacrylamide nanoparticle charge  
Amine functionalised polyacrylamide nanoparticles conjugated to Tat peptide had a 
positive zeta potential of 6.3mV in PBS and 5.2mV in serum free DMEM (Figure 3.3). 
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Figure 3.3:  Zeta potential of Tat conjugated polyacrylamide nanoparticles 
compared to unfunctionalised polyacrylamide nanoparticles. 
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3.2.1.3  Silica nanoparticle charge 
Negatively charged silica nanoparticles had a negative zeta potential  of  -29.4mV in 
PBS and -25mV in serum free DMEM.  In contrast, nanoparticles containing TMAC 
had a positive zeta potential of 25.4mV in PBS.  In serum free DMEM, the zeta 
potential was similar (26.5mV) (Figure 3.4)   
 
Figure 3.4:  Zeta potential of negative and positively charged silica nanoparticles.   
 
3.2.1.4  Effect of serum on nanoparticle charge 
Both polyacrylamide and silica nanoparticle charge was measured in DMEM cell 
culture medium containing 10% serum proteins.  The presence of these proteins 
caused a significant suppression of the positive charge on the nanoparticles 
compared to the zeta potential when measured in PBS or serum free DMEM.  Both 
types of silica nanoparticles displayed a similar negative zeta potential in serum 
containing DMEM.  For polyacrylamide nanoparticles, although the nanoparticles 
with 10% ACTA and above retained a positive charge, it was significantly supressed 
compared to the  zeta potential of the same particles in PBS and serum free DMEM 
(Figure 3.5).  It has been suggested that this supression in surface charge is due to 
the adsorption of proteins to the surface of the nanoparticle forming a layer that 
masks the charge.  All uptake experiements were therefore performed in the 
absence of serum120, 217. 
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Figure 3.5:  Zeta potential of polyacrylamide (A) and silica (B) nanoparticles in 
serum containing DMEM.   
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3.2.2  Nanoparticle size 
Nanoparticle size distributions for polyacrylamide and silica nanoparticles were 
obtained using two different techniques Ȃ dynamic light scattering (DLS) and the 
CPS disc centrifuge. 
3.2.2.1  Polyacrylamide - Dynamic Light Scattering 
For all types of polyacrylamide nanoparticle produced, regardless of charge, a 
monodisperse population of particles was observed.   Both intensity and volume 
plots for nanoparticle size are presented since whilst the intensity plot is most 
suitable when investigating how many populations of nanoparticles are present in 
the sample, it can be distorted due to the much greater amount of light that is 
scattered by the presence of a few larger particles.  In the case of polyacrylamide 
nanoparticles, this was not a significant problem since only one population of 
nanoparticles with a size of between 37-54nm was observed following filtration.  
Intensity plots are therefore presented to show the monodisperse nature of the 
particles whilst the diameter of the particle is reported from the volume distribution 
(Figure 3.6). 
Unfunctionalised polyacrylamide nanoparticles had a diameter of 37.4 ± 0.4nm in 
PBS.  The incorporation of increasing amounts of ACTA into the nanoparticles led to 
an overall trend of a small but significant increase in nanoparticle size when the 
maximum amount of ACTA was incorporated (Figure 3.7).  Polyacrylamide 
nanoparticles containing 10% ACTA had a diameter of 39.3 ± 1.3nm which was not 
significantly different to that of the unfunctionalised nanoparticles (P>0.05) whilst 
the nanoparticles containing 15% and 20% ACTA had a diameter of 41.2 ±0.9nm 
and 53.4 ± 1.5nm respectively which both differed significantly from the 
unfunctionalised nanoparticles (P<0.05).   
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Figure 3.6:  Intensity and volume distributions of (A) unfunctionalised (Intensity 
54nm, Volume: 37nm) and (B) 15% ACTA (Intensity: 59nm, Volume: 42nm) 
polyacrylamide nanoparticle diameter in PBS. 
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Figure 3.7:  Diameter of polyacrylamide nanoparticles with increasing proportion 
of ACTA in PBS and serum free DMEM. 
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Negatively charged polyacrylamide nanoparticles containing 5% N-
acryloxysuccinimide had a diameter of 40.3 ± 1.7nm in PBS and 39.2 ± 1nm in serum 
free DMEM (Figures 3.8 and 3.9). 
0
2
4
6
8
10
12
14
16
18
1 10 100 1000
In
te
n
si
ty
/
V
o
lu
m
e
 (
a
.u
)
Diameter (nm)
Intensity
Volume
 
Figure 3.8:  Intensity and volume distributions of polyacrylamide nanoparticle 
diameter containing 5% N-acryloxysuccinimide (Intensity 76nm, Volume 39nm). 
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Figure 3.9:  Diameter of unfunctionalised and 5% N-acryloxysuccinimide 
polyacrylamide nanoparticles in PBS and serum free DMEM. 
 
The diameter of polyacrylamide nanoparticles did not change when resuspended in 
serum free DMEM compared to PBS for all types of particle (Figures 3.7 and 3.9). 
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3.2.2.2  Tat conjugated polyacrylamide Ȃ Dynamic Light Scattering 
Tat peptide conjugated nanoparticles aggregated in both PBS and serum free DMEM 
and multiple populations of particles could be observed.  In serum free DMEM, one 
population had a diameter of approximately 40-50nm, which is typical of the 
polyacrylamide nanoparticles produced in this work.  There was a second, larger, 
population of particles with a size of 500-600nm, representing aggregates of 
nanoparticles.  Finally, there was another small population of particles with a size of 
approximately 5000nm (Figure 3.10). 
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Figure 3.10:  Intensity and volume distributions of Tat conjugated polyacrylamide 
nanoparticles in serum free DMEM. 
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3.2.2.3  Polyacrylamide - CPS Disc Centrifuge 
The CPS disc centrifuge was also used to measure the size of polyacrylamide 
nanoparticles.  A similar trend was observed to the DLS data, where particles 
containing up to 15% ACTA had a similar size to unfunctionalised polyacrylamide 
nanoparticles which had a diameter of 33nm (Figure 3.11).   Nanoparticles 
containing 15% ACTA also had a diameter of 33nm whilst nanoparticles containing 
20% ACTA tended to have a larger diameter of 40nm, although this was not 
significant (P>0.05). 
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Figure 3.11:  Polyacrylamide nanoparticle diameter (A) unfunctionalised (33.8nm) 
and (B) 15% ACTA (33.2nm). 
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The diameter of unfunctionalised polyacrylamide nanoparticles was reported to be 
similar using both techniques, 37nm via DLS versus 33nm on the disc centrifuge but 
for nanoparticles containing 15% ACTA, the reported size was lower using the disc 
centrifuge (33nm vs 41nm on DLS).   
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Figure 3.12:  Polyacrylamide nanoparticle diameter in PBS and serum free DMEM 
on disc centrifuge. 
 
3.2.2.4  Aggregation of polyacrylamide nanoparticles 
During cell uptake experiments, nanoparticles were incubated with cells for six 
hours in serum free DMEM at 37oC.   Some literature reports suggest that 
nanoparticles may aggregate during prolonged exposure to cell culture medium17, 
120.  To investigate whether this affected particle size, aggregation studies were 
performed to investigate the size of nanoparticles over time using the CPS disc 
centrifuge.  Polyacrylamide nanoparticles were left for six hours at 37oC in serum 
free DMEM and then sized using the disc centrifuge to see if aggregation had 
occurred. 
For unfunctionalised polyacrylamide nanoparticles, after six hours in serum free 
DMEM, a monodisperse population of particles was observed with a diameter of 
32nm.  This was similar to the particle size measured directly after sonication 
indicating that aggregation did not occur.  Polyacrylamide nanoparticles containing 
85 
 
15% ACTA also showed a similar distribution to the original, with a single peak at 
33nm after six hours in serum free DMEM.   
3.2.2.5  Silica Ȃ Dynamic Light Scattering 
Reliable, repeatable production of silica nanoparticles with the required size and 
surface charge proved to be difficult.  The nanoparticles produced tended to vary 
greatly in their size and morphology therefore a number of different synthesis 
routes were attempted in order to achieve nanoparticles with opposite charges but 
with a similar diameter.  This was important since the diameter of the particles 
needed to be similar in order to be able to fully investigate the effect of charge on 
the interaction and uptake of the nanoparticles.  It was found the use of a small 
conical flask with a high stirring rate and a rapid rate of addition of TEOS led to the 
production of roughly 300nm silica nanoparticles.  The incorporation of TMAC into 
the basic silica nanoparticle matrix after thirty minutes of synthesis did not 
subsequently affect particle diameter, and nanoparticles were produced with an 
average size of 290 ± 5.4nm for negatively charged silica nanoparticles and 292 ± 
2.9nm for positive silica nanoparticles (Figure 3.13). 
It has been demonstrated previously by other groups that a rapid rate of TEOS 
addition can lead to the production of smaller nanoparticles, possibly due to the 
production of a large number of smaller nuclei onto which the TMAC can then add to 
in order to impart a positive charge.  The presence of the ammonia is required in 
order to produce spherical particles and the use of ethanol also helps to produce 
smaller particles.  
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Figure 3.13:  (A) Negatively charged (290nm) and (B) positively charged (292nm) 
silica nanoparticle diameter in PBS.   
 
Resuspension of silica nanoparticles in serum free DMEM as opposed to PBS did not 
affect particle diameter (Figure 3.14). 
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Figure 3.14:  Comparison of size of negative and positively charged silica 
nanoparticles in PBS and serum free DMEM. 
 
3.2.2.6  Silica - CPS Disc Centrifuge 
Relative weight distributions for negatively charged silica nanoparticles showed one 
main population with a size of 361nm with an additional small peak at 426nm.  
Positively charged silica nanoparticles displayed a polydisperse population of 
particles with peaks at 325, 291 and 242 nm.  Both negative and positively charged 
silica nanoparticle distributions displayed additional peaks compared to the DLS 
distributions.  These peaks may have been present in the DLS samples but the disc 
centrifuge is much better at resolving populations of similarly sized particles which 
may account for their appearance in the disc centrifuge results (Figure 3.15 B). This 
is because as particles sediment in the disc centrifuge, they sediment at a rate that is 
proportional to the square of the particle diameter, therefore particles that differ in 
size by only a few percent will settle at significantly different rates. 
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Figure 3.15:  Representative traces of (A) negative and (B) positively charged silica 
nanoparticle diameter in PBS measured using the CPS disc centrifuge. 
 
Using the disc centrifuge it was again shown that resuspension of the particles in 
serum free DMEM did not affect size (Figure 3.16). 
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Figure 3.16:  Comparison of negatively charged and positively charged silica 
nanoparticle diameter in PBS and serum free DMEM. 
 
The diameter reported for negatively charged silica nanoparticles was larger 
(361nm) on the disc centrifuge than that from DLS (290nm). The main peak for the 
positively charged silica particles (291nm) correlated well with the diameter 
obtained using DLS (292nm). 
 3.2.2.7  Aggregation of silica nanoparticles 
The aggregation of silica nanoparticles after three hours in serum free DMEM was 
assessed using the disc centrifuge.  After three hours at 37oC, negatively charged 
silica nanoparticles did not aggregate and remained at a similar size (356nm).  
Positively charged nanoparticles displayed a change in the number and size of 
populations of nanoparticles, with two main peaks at 355nm and 419nm (Figure 
3.17). 
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Figure 3.17:  (A) Negatively charged and (B) positively charged silica nanoparticle 
diameter after three hours in serum free DMEM.  
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3.2.3  Calculating nanoparticle density using the CPS disc centrifuge 
When measuring nanoparticle size using the CPS disc centrifuge, one of the most 
important parameters for accurate sizing is the density of the nanoparticle.  This is 
because density is one of the factors that determine how quickly the particles settle 
in the gradient and it is a parameter in Stokes law of sedimentation: 
 
 
The density of the nanoparticle therefore influences the size distribution obtained 
using the disc centrifuge, so the density of both silica and polyacrylamide 
nanoparticles was calculated in order to gain accurate size distributions.  The 
density of nanoparticles can be calculated using the disc centrifuge by obtaining a 
particle size distribution in gradient fluids of two different densities.  The two 
reported size distributions will only overlay exactly when the assumed density of 
the particle is correct and the distributions can be recalculated at different densities 
until they do.  In these experiments, particles were analysed on both water based 
and deuterium oxide (D2O) based 8-24% sucrose gradients which differ in density 
by approximately 0.11g/cm3. 
In A, B and C in Figure 3.18, the particles are the same and measured on a water 
(blue) and D2O based gradient (red), but because different densities are assumed, 
the reported size distributions are different.  If a lower density (1.3g/cm3, Figure 
3.18 A) than the actual density is used, the particles sediment faster than expected 
so the size appears to be larger (size is inversely proportional to the time taken to 
sediment).  Conversely, if a higher density (2.0g/cm3, Figure 3.18 C) is used, the 
particles sediment slower than expected so the size appears to be smaller.  Only at 
1.6g/cm3 do the reported distributions in water and D2O overlay exactly indicating 
that the density of the particles is 1.6g/cm3. 
   gD XVXt fp UU
K
  2
18
92 
 
0
0.2
0.4
0.6
0.8
1
1.2
0.05 0.5
In
te
n
si
ty
Diameter  (µm)
H2O
D2O
 
0
0.2
0.4
0.6
0.8
1
1.2
0.05 0.5
In
te
n
si
ty
Diameter (µm)
H2O
D2O
 
0
0.2
0.4
0.6
0.8
1
1.2
0.05 0.5
In
te
n
si
ty
Diameter (µm)
H2O
D2O
 
Figure 3.18:  Diameter of silica nanoparticles in water and D2O calculated at 
different densities: (A) 1.3g/cm3, (B) 1.6g/cm3, (C) 2.0g/cm3. 
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Similarly, the density of polyacrylamide nanoparticles has also been calculated using 
a 4-12% sucrose gradient in water and D2O, and the density was found to be 
approximately 2.3g/cm3, which was higher than had been expected given the 
density of similar materials such as polyacrylamide gels (Figure 3.19)218.  The 
separation between peaks for the polyacrylamide nanoparticles was less 
pronounced than for silica nanoparticles, therefore only an approximation of the 
density is given.  
 
Figure 3.19:  Diameter of polyacrylamide nanoparticles in water and D2O calculated 
at different densities (A) 1.3g/cm3, (B) 1.7g/cm3, (C) 2.0g/cm3 and (D) 2.3g/cm3. 
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3.2.4  Fluorescence 
A fluorescent dye, Alexa 488, was incorporated into the nanoparticle matrix in order 
to allow tracking of nanoparticle uptake into cells using fluorescence microscopy.     
3.2.4.1  Polyacrylamide nanoparticle fluorescence 
There was no correlation between polyacrylamide nanoparticle charge and the 
intensity of fluorescence emission from the particles when measured at pH 7.4 using 
both the fluorimeter and the microscope although the pattern of fluorescence 
emission intensity was different (Figure 3.20 and 3.21).  There was an 
approximately 2.5 fold difference between the most and least fluorescent 
nanoparticles when measured using the fluorimeter (Figure 3.20).  However, when 
measured using the microscope, most particles had similar fluorescence intensity 
(Figure 3.21).  The nanoparticles containing 5% N-acryloxysuccinimide and those 
conjugated to Tat peptide displayed a lower intensity of fluorescence emission but 
this was accounted for in quantitative measurements of nanoparticle uptake.  Only 
one set of particles were significantly different in the intensity of emission when 
measured on the microscope, those containing 10% ACTA (Figure 3.21).  The results 
indicate that the charge on the particle or functionalisation with different groups to 
enable conjugation did not affect the incorporation of dye into the matrix, therefore 
any difference in emission intensity can be attributed to experimental variation.  
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Figure 3.20:  Fluorescence intensity of polyacrylamide nanoparticles with different 
charge measured on fluorimeter. 
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Figure 3.21:  Fluorescence intensity of polyacrylamide nanoparticles on widefield 
microscope.
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3.2.4.2  Silica nanoparticle fluorescence 
Fluorescence intensity at pH 7.4 for positively charged silica nanoparticles was 
found to be approximately three times that of the negatively charged silica 
nanoparticles when measured using the fluorimeter with an excitation wavelength 
of 495nm (Figure 3.22).  This has previously been reported and is thought to be 
related to the properties of Alexa Fluor dyes, since the dyes frequently carry a 
negative charge, therefore may be attracted to the positive charge in the particle and 
enhanced entrapment into the nanoparticle may occur 185, 219.   
To investigate this further, the fluorescence of silica nanoparticle was also measured 
on the microscope that cellular uptake measurements were performed on.  
However, this produced very different results to the fluorimeter and indicated that 
both types of silica nanoparticle had similar fluorescence emission intensity (Figure 
3.23).  This could be due to the use of a different excitation sources and the use of 
bandwidth filters and a dichromatic mirror in the microscope. 
 
Figure 3.22:  Fluorescence intensity of silica nanoparticles on fluorimeter. 
 
0
50
100
150
200
250
300
350
400
450
500
500 510 520 530 540 550 560
In
te
n
si
ty
 (
a
.u
)
Wavelength (nm)
Negative
Positive
97 
 
 
Figure 3.23:  Fluorescence intensity of silica nanoparticles on widefield fluorescent 
microscope. 
 
Both the CPS disc centrifuge and DLS have been demonstrated to be useful 
techniques to use to investigate polyacrylamide and silica nanoparticle size and size 
distribution.  In general they appear to produce complementary data but the CPS 
disc centrifuge has the added advantage that it has better resolving power for 
similarly sized populations due to the way in which it measures size.  Since 
sedimentation varies with square of particle diameter, similarly sized populations 
are more easily resolved when using the disc centrifuge than when using DLS.  The 
disc centrifuge was particularly useful when measuring the size of silica 
nanoparticles and resolving populations, but it was often more problematic to use 
when characterising polyacrylamide nanoparticles because their small size required 
a long run time causing some problems with background noise towards the end of 
the experimental run 
The reverse microemulsion technique of polyacrylamide nanoparticle synthesis 
technique was found to reliably and repeatedly produce nanoparticles of 30-60nm 
but the incorporation of additional monomers was found to affect particle size as 
observed following the incorporation of 20% ACTA.  The synthesis of the silica 
nanoparticles was more troublesome and it proved to be difficult to produce 
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nanoparticles of the same size and charge repeatedly.  Further investigation is 
required in this area in order to identify a reliable method of production. 
 
Table 3.1:  Summary table of polyacrylamide and silica nanoparticle diameter (nm) 
in PBS and serum free DMEM (SF DMEM) measured using Dynamic Light Scattering 
(DLS) and the CPS Disc Centrifuge.  (-) indicates batches of nanoparticles not 
measured using the CPS Disc Centrifuge. 
 
 
Table 3.2:  Summary table of the zeta potential (mV) of polyacrylamide and silica 
nanoparticles in PBS, DMEM and serum free DMEM (SF DMEM). 
 
3.3  Conclusion 
Silica and polyacrylamide nanoparticles with varying charge and surface 
functionalisation have been synthesised and their size and charge have been well 
characterised using a number of methods.  The density of the nanoparticles has 
been calculated using the CPS disc centrifuge.  Nanoparticle fluorescence has been 
characterised using two methods in order to be able to eliminate any differences in 
Diameter (nm) in PBS Diameter (nm) in SF DMEM
DLS CPS DLS CPS
Polyacrylamide Unfunctionalised 36.5 ± 1.7 33.8 ± 0.8 38.1 ± 1.0 32.5 ± 0.3
2% ACTA 32.2 ± 1.1 (-) 33.0 ± 0.5 (-)
5% ACTA 38.0 ± 0.3 (-) 38.3 ± 0.7 (-)
10% ACTA 39.3 ± 1.3 (-) 40.0 ± 0.1 (-)
15% ACTA 41.2 ± 0.9 33.2 ± 1.0 42.4 ± 0.3 30.4 ± 1.0
20% ACTA 53.4 ± 1.5 39.8 ± 0.8 54.7 ± 0.2 39.8 ± 0.8
Silica Negative 290.9 ± 5.4 360.9 ± 0.1 315.5 ± 32.0 360.4 ± 2.0
Positive 291.8 ± 2.9 293.0 ± 1.8 293.6 ± 20.9 290.2 ± 0.7
Zeta Potential (mV)
PBS DMEM SF DMEM
Polyacrylamide Unfunctionalised -3.5 ± 0.1 -5.2 ± 0.7 -3.3 ± 0.7
2% ACTA -2.3 ± 1.5 -3.2 ± 0.6 1.8 ± 0.7
5% ACTA 5.6 ± 0.8 -0.1 ± 0.5 6.9 ± 1.7
10% ACTA 12.3 ± 1.3 5.9 ± 0.5 13.2 ± 0.6
15% ACTA 15.0 ± 0.7 6.4 ± 0.5 17.6 ± 2.3
20% ACTA 19.0 ± 0.7 3.9 ± 0.3 18.6 ± 1.9
Silica Negative -29.4 ± 2.0 -10.7 ± 0.8 -25.0 ± 1.5
Positive 25.4 ± 0.9 -8.9 ± 0.2 26.5 ± 2.7
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particle fluorescence from the measurement of nanoparticle uptake which was 
calculated using the measured fluorescence intensity within cells. 
  
100 
 
Chapter 4 - Scanning Probe Microscopy  
Atomic Force Microscopy and Scanning Ion Conductance 
Microscopy 
4.1 Introduction 
The first step in the uptake of nanoparticles into cells involves their interaction with 
the cell membrane and this interaction is an important factor in the route of uptake 
of the nanoparticles.  In addition, the subsequent subcellular trafficking of 
nanoparticles can be influenced by their interaction with intracellular components.  
There are many factors that govern this interaction and these have been discussed 
in the introduction but briefly, they include nanoparticle size, shape, surface 
chemistry and charge, along with cell dependent factors including cell type and 
membrane components.  Increasing the understanding of how nanoparticles 
interact with cell membranes on the nano and micron scale will help to increase 
understanding of the uptake processes and may be useful in the development of 
more efficient drug delivery systems.  
The development of scanning probe microscopy techniques such as AFM and SICM 
have enabled this interaction to be visualized in real time at the nanoscale.  AFM has 
been used extensively to investigate how nanoparticles and peptides interact with 
supported lipid bilayers.  These results have often been shown to correlate well with 
in vitro studies of nanoparticle uptake into cells.  New technology is beginning to 
enable the imaging of cells using AFM, which has previously been extremely difficult 
due to the force applied to the cell membrane by the AFM tip.  More recently, the 
development of the non contact scanning probe technique, SICM, has enabled the 
visualization of the interaction of nanoparticles with a real cell membrane both on 
cells that have been chemically fixed as uptake occurs, and also on live cells163. 
In this work, two scanning probe techniques were used to image the interaction of 
polyacrylamide and silica nanoparticles with model and real cell membranes.  SICM, 
combined with fluorescence microscopy in a technique known as Scanning Surface 
Confocal Microscopy (SSCM), was used to investigate the interaction of silica 
nanoparticles with cell membranes of MRC-5 cells.  It was not possible to repeat this 
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work using polyacrylamide nanoparticles since the resolution of the SSCM was not 
high enough.  Instead, the interaction of polyacrylamide nanoparticles was 
investigated using supported lipid bilayers (SLBs) composed of 
dipalmitoylphosphatidylcholine (DPPC), which were imaged using tapping mode 
atomic force microscopy (AFM) in liquid. 
4.1.1  Cell membranes 
Cell membranes are complex structures that surround cells, and components of the 
membrane play a crucial role in maintaining the intracellular environment.  They 
contribute to many of the processes that cells undergo, including transport of 
molecules, signalling and migration11, 220.  The membrane is composed of a number 
of molecules including phospholipids, sphingolipids, cholesterol and proteins 17.  
Phospholipids are amphiphilic lipids that form the majority of the cell membrane 
through their association into a lipid bilayer.  They consist of hydrophilic head 
groups and hydrophobic fatty acid chains.  These lipids spontaneously form the 
membrane bilayer when the hydrophobic chains of two phospholipids associate and 
face each other leading to the exclusion of water.  Differences in these fatty acid 
chains such as level of saturation and length can affect the structure of the 
membrane and influence parameters such as the packing of lipids, affecting the 
fluidity of the bilayer.  There are a number of different phospholipids that can be 
found in cell membranes and these include phosphatidylcholine and 
phosphatidylethanolamine.  The different head groups on these lipids give them 
specific properties, which therefore influence the properties and functions of the 
bilayer they reside in.  The upper and lower leaflets of the bilayer are usually 
asymmetric in terms of their lipid and protein composition, and the presence of 
these different molecules confers different functions to these parts of the bilayer150, 
221.  
The cell membrane is not a static structure, it is fluid and can move and change 
shape depending on conditions.  It has been suggested that unlike previously 
thought, this movement is not random but that the membrane consists of defined 
regions that have a distinct protein and lipid composition e.g. caveolae rich regions 
and lipid Ǯǯ222.  In addition to lateral 
movement in one half of the bilayer, proteins and lipids can flip between the upper 
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and lower leaflets of the bilayer150, 221, 222.  Bilayers are sensitive to temperature and 
also to the effects of molecules such as cell penetrating peptides and these 
interactions can lead to changes in the phase of the bilayer.  The bilayer can exist in 
a number of different phases including a fluid, liquid state and a more rigid gel-like 
state223-225.   
4.1.2  Supported lipid bilayers 
AFM studies of cell membranes are difficult due to their delicate nature and the 
force that is applied by the AFM tip during imaging.  This force can lead to 
deformation of the cell, damage to the membrane and the transfer of components 
from the membrane onto the tip which affects imaging resolution.  Studies that use 
AFM to investigate the interaction of molecules with cell membranes therefore 
generally use model membranes150, 157.  Supported lipid bilayers (SLBs) are model 
cell membranes that can be produced by a number of methods that result in the 
formation of a phospholipid bilayer on a solid surface.  These bilayers can then be 
imaged using AFM156, 157, 159, 223, 226-229.    SLBs are a useful tool for investigating the 
interaction of molecules with cell membranes since information about changes in 
surface topography and bilayer thickness can be obtained53, 93, 230-232.  
The vesicle fusion technique is a simple technique that can be used to form bilayers 
and involves the formation of small, unilamellar lipid vesicles via freeze- thawing 
and extrusion.  These vesicles adsorb to a mica support and over time, they collapse 
and fuse to form a symmetrical bilayer.  When bilayers are formed by this method, 
other molecules such as proteins can be included if required but one drawback is 
that only symmetrical bilayers can be produced146, 156, 157.  The composition of the 
membrane chosen is important because nanoparticles have been found to interact 
differently with bilayers composed of a single phospholipid compared to a more 
complex model endothelial cell membrane233.   
4.1.3  Atomic Force Microscopy 
AFM has proved to be a very useful technique for the study of interactions of 
different substances with SLBs.  It has been used to investigate the effect of a wide 
range of molecules and particles such as dendrimers, cell penetrating peptides and 
nanoparticles95, 231, 234.  The interaction of these molecules with the bilayer can lead 
to effects such as changes in the height of the membrane, changes in the phase of the 
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bilayer between fluid and gel phases, and changes in topography such as the 
formation and expansion of holes in the bilayer which can be observed and 
measured234, 235.  Measurement of changes in height can be particularly useful for 
identifying changes in the phase of the bilayer.   
4.1.3.1  Investigating the effects of nanoparticles using AFM 
AFM has been used to assess the interaction of many different nanoparticles with 
SLBs.  A variety of cationic nanoparticles, cell penetrating peptides and polymers 
have been shown to enter cells, and AFM studies have indicated that these 
nanoparticles lead to varying degrees of bilayer disruption (Figure 4.1)97, 234.   
 
Figure 4.1:  The effect of the cationic polymer poly-L-lysine on a DMPC supported 
lipid bilayer.  The addition of the polymer caused the appearance of defects in the 
bilayer which are indicated by the white arrows 234. 
 
Cationic nanomaterials may interact with bilayers via insertion into the bilayer if 
their size is very small, or more commonly via electrostatic interactions between the 
material and the head groups of phospholipids in the bilayer53, 233.  In contrast, 
neutral and negatively charged molecules appear to induce minimal bilayer 
disruption234.   Changes that can be observed following exposure to cationic 
particles include the formation and/or expansion of holes in the bilayer and changes 
in the height of the bilayer.  Membrane thinning and erosion, and hole formation in 
lipid bilayers due to cationic nanoparticles is commonly observed regardless of the 
size, chemical composition or shape of the nanoparticle86, 97, 236, 237.  In addition to the 
formation of holes, changes in the phase of the bilayer, for example fluidisation, have 
also been observed following interactions with nanoparticles.  These changes can be 
caused by the interaction of molecules with the head groups of lipids, leading to a 
change in the tilt angle of the lipid in the membrane97, 235.  To demonstrate the 
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importance of using multiple different lipids in a SLB to imitate the different regions 
observed in a cell membrane, Peetla et al. used a model endothelial cell membrane.  
They found that cationic nanoparticles interacted to a greater extent with the liquid 
phase region leading to condensation of the regions via insertion into the membrane 
or electrostatic interaction53. 
Relating the changes observed in SLBs using AFM to in vitro cell studies can help to 
explain what may be happening during uptake, for example, the formation of holes 
in a model membrane may explain the cytotoxicity of some nanoparticles.  It has 
been shown that the degree of SLB disruption correlates well with in vitro studies of 
enzyme leakage, nanoparticle uptake and cytotoxicity97.  The nanoscale nature of 
AFM also means that the subtle nature of differences in these interactions can be 
observed, for example Leroueil et al. found that more highly charged polymers have 
been found to expand pre-existing defects and form new defects, whilst polymers 
with a lower charge accumulated around the edge of pre-existing defects97.  
In addition to topography imaging of model cell membranes with AFM, it can also be 
used to investigate the forces of interactions between molecules, e.g. ligands and 
receptors or protein interaction and unfolding238.  AFM has been used to measure 
the force of attraction between nanoparticles and the cell membrane, and to 
correlate this force to the cellular uptake of nanoparticles.  Vasir et al. used AFM to 
look at the internalization of nanoparticles over time and the effect on membrane 
height and general topography.  Additionally, it was used to measure the force of 
interaction using nanoparticle functionalised tips.  PLGA nanoparticles 
functionalised with the cationic peptide poly-L-lysine were found to display a five- 
fold greater force of adhesion with the cell membrane and their internalization was 
rapid compared to unmodified nanoparticles.  Time lapse images of live cells imaged 
using tapping mode AFM showed rapid uptake of the poly-L-lysine functionalised 
nanoparticles whereas cell surfaces remained covered with unfunctionalised 
nanoparticles since they were not internalized.  The nanoparticles used in the study 
were negatively charged under the experimental conditions, indicating that 
electrostatic interactions were not important, adhesion was more likely to be due to 
nonspecific interactions such as hydrogen bonding61. 
 
105 
 
4.1.3.2 Investigating the effects of cell penetrating peptides using AFM 
As discussed in the main introduction, cell penetrating peptides are a class of 
molecules that have been shown to effectively transport cargo including 
nanoparticles across the cell membrane.  They include Tat, an arginine and lysine 
rich peptide derived from the HIV-1 protein192, 239, 240.  The mechanism by which Tat 
transports cargo molecules across the cell membrane has been a subject of much 
debate, although it is now believed that macropinocytosis may play a role50, 108.  By 
using AFM to visualize the interaction of Tat peptide with cell membranes on the 
nanoscale, this may help to increase the level of understanding about the processes 
involved.   
Tat (transactivating transcriptional activator) peptide is derived from the HIV-1 Tat 
protein, an 86 amino acid protein involved in replication of the HIV-1 virus.  It 
consist of an acidic N terminal region involved in transactivation, a DNA binding 
domain and a basic region containing a nuclear localization signal241.  Tat peptide is 
the most well studied CPP and it is popular because it has a short sequence and is 
very efficient at crossing membranes11, 105, 242.  Only a small region of the full protein 
is required for its cell penetrating ability.  This small peptide contains a basic region 
of amino acids with a highly cationic cluster comprising 6 arginine and 2 lysine 
residues (GRKKRRQRRRQ)45, 48, 101, 217.   
The interaction of Tat peptide with model cell membranes has been extensively 
studied using AFM.   The mechanism by which Tat peptide interacts with model 
membranes is a subject of controversy with some groups suggesting that it can 
insert into the bilayer causing the formation of raised regions as the bilayer 
reorganises to accommodate it.  In one study on model membranes composed of a 
liquid and gel phase lipids to model the lipid rafts in cell membranes, Tat peptide 
was found to cause expansion of the taller, gel-phase regions via insertion into the 
bilayer243.  Other work indicates that it does not insert into the bilayer, but interacts 
with the negatively charged head groups of lipids in the bilayer, causing a change in 
the tilt angle of the lipids and reorganisation of the bilayer45.  
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Figure 4.2:  (a) Space filling model of Tat, (b) DMPC bilayer before addition of Tat, 
(c) and (d) are subsequent images taken over 20mins showing the formation and 
expansion of defects in the bilayer97. 
Although Tat peptide is cationic and therefore may be expected to interact through 
electrostatic interactions with the head groups of lipids, it has few hydrophobic 
residues compared to many other CPPs, and this may decrease the likelihood of it 
inserting into bilayers192, 243.   
4.1.3.3  Peptide conjugated nanoparticles 
Cell penetrating peptides such as Tat have been shown to be able to transport a 
wide range of cargos into cells including gold64, polymeric nanoparticles244, 245 and 
lipoplexes246.  The cationic nature of Tat and the presence of a nuclear localization 
signal make it an attractive molecule for potentially enhancing the delivery of 
molecules such as DNA that need to reach the nucleus to be effective246.     
It is generally observed that provided the peptide maintains its conformation upon 
attachment to the nanoparticle, the presence of the peptide leads to enhanced 
uptake into cells when compared to nanoparticles alone, even if they are cationic or 
amine functionalised93, 217.  The addition of a conjugated cargo to the Tat protein 
transduction domain has been shown to lead to association of the cargo with cell 
membrane lipids and increased association of the Tat peptide with the membrane.  
The presence of the cargo may therefore affect the way in which the peptide is 
presented to the membrane, leading to a different interaction.  Alternatively, the 
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cargo itself may have some effects on the bilayer which subsequently affect the 
interaction of the peptide with the membrane239.   
Peetla et al.  investigated the effect of Tat peptide conjugation to nanoparticles, the 
Tat peptide sequence and the amount of peptide on the nanoparticle.  They showed 
that these factors significantly affected the biophysical interaction of the 
nanoparticles with a model endothelial cell membrane.  It was found that the Tat 
peptide conjugated to poly(L-lactide) nanoparticles had a greater effect on the 
membrane, measured using surface pressure than the peptide alone.  This indicated 
that the conjugate was interacting with the membrane to a greater extent than 
either of the components alone, either via insertion into the membrane or 
electrostatic interactions.  Tat conjugated nanoparticles became embedded in the 
membrane and caused fluidisation of the endothelial cell membrane.  It was 
suggested that this may be due to the interaction of the hydrophobic tyrosine 
residue on the Tat peptide with the bilayer, along with electrostatic interactions 
with the anionic phospholipids in the membrane.  Since Tat peptide and 
nanoparticles alone did not display the same interaction despite similar cationic 
charges, the way in which the nanoparticles interact with cell membrane lipids 
when conjugated to the CPP must play a role in their internalization. The AFM 
studies corresponded well with in vitro work showing increased uptake of the 
nanoparticles when conjugated to Tat.  However, the peptide sequence was 
important since when the same experiment was repeated with scrambled Tat 
peptide that exposed different residues to the bilayer, the interaction was 
comparable to that of unconjugated nanoparticles93.  
4.1.4  Scanning Ion Conductance Microscopy 
The use of SICM increases the range of experimental techniques that can be 
performed to investigate nanoparticle uptake.  The non contact nature of the 
technique means that it is better suited to the imaging of cells than AFM since it will 
not cause damage to the cell.  In addition, it is more suited to relatively high and 
rough samples such as cells due to a greater z range, and it can be used to image 
larger areas of a membrane.  SICM has been used to look at delicate, eukaryotic cells 
that have proven to be difficult to image using other scanning probe techniques such 
as AFM.  The hopping mode of SICM has been used to image neuronal cells with fine 
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processes such as axons at high resolution without damage164.  As well as imaging, 
the hollow pipette used in SICM allows for the delivery of molecules to specific areas 
of the sample.  SICM has been used to image ion channels on the surface of cells and 
to investigate the interaction of various particles with cells168, 172, 176, 177.  In addition 
to topography imaging, the development of SSCM has enabled the simultaneous 
imaging of changes in topography and fluorescence, allowing tracking of 
nanoparticles during cellular uptake.  However, despite these advantages, the 
resolution and imaging speed of SICM is generally lower than AFM, meaning that 
live cell studies can be difficult161. 
 
4.1.4.1  Investigating the effects of nanoparticles using SSCM 
 
Gorelik et al. used SSCM to image the uptake of virus like particles into COS-7 cells 
and showed that SSCM could combine high resolution topography imaging with 
fluorescence imaging in order to identify the location of the nanoparticles on the cell 
surface and to monitor them during internalization (Figure 4.3). 
 
Figure 4.3:  COS-7 cells exposed to virus like particles (green fluorescence) showing 
uptake of the particles over a four hour time period.  The red star indicates the 
beginning of the scanning for fluorescence and VLPs indicates when the fluorescent 
virus like particles (VLPs) were added177. 
SICM has also been used to investigate the effect of amine functionalised 
polystyrene nanoparticle size, surface chemistry and charge on the topography of 
the cell membrane of human alveolar epithelial type 1-like cells (AT1).  It was found 
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that exposure to the amine modified nanoparticles caused damage to the cell 
membrane, characterized by the appearance of holes in the membrane.  The 
nanoparticles were also found to lead to some disruption of the contacts between 
cells, and it was suggested that nanoparticle inhalation therefore has the potential to 
cause damage to lung cells.  These effects on the cell were not observed with other 
types of nanoparticles (unmodified and carboxyl modified) which, following 
incubation with the cells showed that they retained a flat, mainly featureless 
membrane. The effects of the nanoparticles on the cell membrane correlated well 
with complementary studies that were performed looking at cytotoxicity54.   
SSCM has also be used to investigate latex nanoparticle uptake in primary human 
alveolar type 2 (AT2) cells and immortalized AT2 cells that showed at AT1-like 
phenotype.  It was found that charge, rather than size was the key factor in 
nanoparticle uptake and that negatively charged particles were internalized to a 
greater degree by AT1 cells, which form the majority of the alveolar surface.  SSCM 
demonstrated that internalization of the 50nm particles occurred in areas enriched 
with microvilli1. 
Recently, the use of SSCM to investigate clathrin mediated endocytosis has shown 
that uptake by this route may involve additional protrusions and processes on the 
cell membrane than those previously identified.  This highlights the benefits of 
scanning probe techniques such as AFM and SICM which help to reveal the 
nanoscale nature of the interactions of nanoparticles and cells163.      
4.1.5  Comparison between AFM and SICM 
Whilst both AFM and SICM are undoubtedly useful techniques for imaging the 
interaction and uptake of nanoparticles with model membranes and cells, there are 
limitations to both techniques and one or the other may be better suited for a 
particular experiment.  In a study that compared the ability of both AFM and SICM to 
image MRC-5 cells, the height of the cell was underestimated using AFM due the 
force applied by the AFM tip during imaging.  A lateral force was also applied by the 
AFM tip, and this was observed as a shift in the trace and re-trace of the AFM profile.  
In contrast, SICM enabled the visualization of protruding features on the cell surface 
which were dislodged by the AFM tip.  Using AFM, more subcellular features such as 
the cytoskeleton were visible although this was also influenced by the fixation 
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procedure.  Both AFM and SICM face difficulties when imaging structures with large 
height differences such as the step up from the cell culture dish to the edge of the 
cell161.   
SICM has also been used to image various samples including collagen fibres and 
HeLa cells and the images were compared to those obtained using AFM.  SICM was 
found to produce high resolution images indicating the presence of delicate surface 
features on HeLa cells and enabled the real time monitoring of changes in the cell 
surface over time.  Although AFM produces images with a better resolution than 
SICM, the restriction in the Z range of AFM means that the hopping mode of SICM 
may produce better images of samples with sudden, steep changes in height and 
may cause less damage to the sample than the AFM tip.  In addition, AFM is often 
restricted in the size of sample it can image before it encounters problems with 
lateral forces and restrictions at the edge of the imaging area247. 
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4.2  Results and Discussion  
4.2.1  AFM results 
4.2.1.1  Characterisation of liposomes 
Suspensions of liposomes used to form SLBs were analysed using the low density 
disc on the CPS Disc Centrifuge (see section 2.6.1).  A 1mg/ml suspension of 
liposomes was analysed on a 4-12% sucrose in D2O gradient.  The diameter of DPPC 
liposomes was 118nm. 
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Figure 4.4:  Diameter of DPPC liposomes obtained using the low density disc.  
 
4.2.1.2  Interactions of nanoparticles with SLBs 
SLBs composed of the gel phase lipid DPPC were imaged following exposure to a 
range of polyacrylamide nanoparticles.  In Figure 4.5 darker areas represent the 
mica surface whilst lighter coloured areas represent areas covered by the bilayer.  
Lipids can exist in different phases depending on their composition and 
temperature.  The behaviour of the lipid is determined by the main gel-fluid 
transition and a number of transient intermediate states can also be formed159, 235.  
DPPC is in the gel phase at room temperature since it has a transition temperature 
of around 41oC.  In AFM imaging, this was identified by examining bilayer thickness 
since gel phase bilayers are approximately one nanometre higher than fluid phase 
bilayers.   Literature reports indicate that a height of 4.5 Ȃ 5.8nm is characteristic of 
a DPPC bilayer159.  The results from this work show a rather wide range in bilayer 
thickness of 5.9 Ȃ 6.9nm.  However, a thin water layer is known to exist between the 
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mica and the lower surface of the bilayer and may account for this232, 248.  The DPPC 
gel phase bilayer formed regions of continuous bilayer with defects exposing the 
underlying mica and was stable when imaged over time.  
 
Figure 4.5: (A) DPPC bilayer, (B) cross section of DPPC bilayer as indicated by white 
line in (A).  Bilayer height is 6.3nm. 
 
4.2.1.3  Interactions of polyacrylamide nanoparticles with SLBs 
Unfunctionalised polyacrylamide nanoparticles (37nm) with a charge of -6mV did 
not change the appearance or height of the bilayer and adsorbed to the mica surface 
(Figure 4.6).  This is consistent with data obtained from cellular uptake experiments 
discussed in Chapter 5.2.1, which show that unfunctionalised polyacrylamide 
nanoparticles with a slightly negative zeta potential were not significantly taken up 
by MRC-5 fibroblasts.   
Positively charged polyacrylamide nanoparticles containing 5% ACTA (6.9mV) were 
imaged on mica (Figure 4.6).  Nanoparticle size was analysed using the particle 
analysis function in the Nanoscope software which indicated that the particles had a 
mean diameter of 32nm with a range between 22 and 64nm.  This correlated well 
with the nanoparticle size data obtained using DLS and the CPS disc centrifuge 
presented in Chapter 3.2.2.1 and 3.2.2.3. 
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Figure 4.6:  	    ? ? ?ɊȀ    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Ǥ ? ?ɊǤ 
 
Positively charged polyacrylamide nanoparticles were found to cause limited 
reorganization of the DPPC lipid bilayer.  This was only observed at relatively high 
nanoparticle concentrations and was characterized by changes in topography such 
as the fusion of some bilayer defects.  However, the majority of the nanoparticles 
were again found to be present on the mica surface and around the edge of defects 
in the bilayer (Figure 4.7).  At the highest concentration of 25µg/ml, the positively 
charged nanoparticles caused several bilayer defects to merge and form larger holes 
in the DPPC bilayer.  However, these events were isolated and the widespread 
formation of new holes was not observed. 
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Figure 4.7: AFM images of a DPPC lipid bilayer exposed to increasing 
concentrations of positively charged polyacrylamide nanoparticles. (A) The DPPC 
bilayer was relatively stable over time and when exposed to 20µl of HPLC grade 
water (B).  Images C to F show the effect of exposure to increasing concentrations of 
positively charged nanoparticles (C) 1µg/ml, (D) 10µg/ml and (E) 25µg/ml.  (F) was 
taken 30 minutes after (E).  Scan size 5 x 5 µm. 
 
The slightly reduced height of the nanoparticle observed in the cross section (Figure 
4.8 B1) is likely to be due to tip deformation of the nanoparticle and the 
nanoparticle being pushed into the soft bilayer surface by the AFM tip. 
 
 
500nm
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Figure 4.8:  Cross sections of DPPC bilayer exposed to positively charged 
nanoparticles demonstrate the nanoparticle addition had no effect on bilayer 
thickness.  (A) DPPC bilayer before particle addition, height is 4.8nm.  (B) DPPC 
bilayer following the addition of 25µg/ml positively charged nanoparticles, height is 
5.0nm..  Scan size 5µm x 5µm. 
 
Figure 4.9 shows an enlarged area of a small section of Figure 4.8 to show in detail 
the association of the positively charged nanoparticles with the edge of the bilayer 
and with the mica surface.  This is consistent with the results of Leroueil et al. who 
showed that cationic entities with a relatively low degree of positive charge tended 
to accumulate at the edge of bilayers without causing many defects.  The mica 
surface and bilayer itself often carry a slight negative charge, causing the 
nanoparticles to be attracted to these regions of the bilayer97.   The elongated shape Ǯǯ
that the tip can drag the nanoparticle across the bilayer surface due to the presence 
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of only a weak attraction between the bilayer and the particle.  This can lead to the 
tip depositing the particle at the edge of the bilayer or on the mica surface. 
 
Figure 4.9:  Enlarged area of Figure 4.8B to show detail of positively charged 
polyacrylamide nanoparticles associated with the edge of membrane defects and 
mica.  Scan size 2 x 2 µm. 
 
Bearing analysis to look at the coverage of the bilayer was performed using the 
Nanoscope software.  It showed that the area of mica covered by the bilayer was not 
significantly affected by the addition of the nanoparticles, indicating that no 
solubilisation of the bilayer occurred due to nanoparticles.  This again shows that 
the positively charged nanoparticles had limited effects on the structure of the DPPC 
bilayer.  Initial bilayer area in Fig 4.7A was 60% whilst in Fig 4.7F the area covered 
by the bilayer was 59%.  
The interaction of positively charged polyacrylamide nanoparticles with a model 
cell membrane composed of DPPC therefore appeared limited when the particles 
possessed a low level of charge.  This correlates well with in vitro studies presented 
in Chapter 5 that show limited uptake of the same positively charged particles into 
MRC-5 cells.  The effect of the polyacrylamide nanoparticles produced with a higher 
level of charge on SLBs was not investigated due to time constraints.  However, it 
would be expected that they would cause increased effects on the structure of the 
bilayer such as increased fusion of holes and the formation of new defects.  The 
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nanoparticles are unlikely to insert into the bilayer due to their size, therefore the 
effects are more likely to occur via the interaction of the charged groups on the 
nanoparticle with the head groups of the lipid causing some change in the 
organisation of the lipids forming the bilayer235. 
4.2.1.4  Interactions of Tat peptide with SLBs  
Initially, the addition of low concentrations of Tat peptide did not cause dramatic 
changes in surface topography, but led to a small change in the height of the bilayer.  
Following exposure to higher concentrations of Tat, the formation of raised regions 
around bilayer defects was observed.  In addition, Tat catalysed the formation of 
holes in the bilayer and enlargement of existing defects (Figure 4.10). 
 
Figure 4.10: AFM images of the effects of Tat peptide on a lipid bilayer. (A) DPPC 
bilayer and (B) following addition of 20µl HPLC grade water shows some mobility 
but few changes in bilayer structure.  Images C to F show the bilayer following 
exposure to increasing concentrations of Tat peptide.  (C) 1µM, (D) 2.5µM, (E) 5µM 
and (F) 10µM.  The formation of higher domains is observed around the edge of 
bilayer defects.   ? ?ɊǤ 
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Figure 4.11 shows a smaller scale area (2 x 2µm) showing in detail the effect of Tat 
peptide on the DPPC bilayer.  In Figure 4.11 E especially, it can be clearly be seen 
that there are distinct regions of different height within the bilayer which can be 
identified by different shades of colour.    
 
Figure 4.11:  AFM images of a smaller area of the same DPPC bilayer as in Figure 
4.10.  (A) DPPC bilayer, (B) following addition of 20µl HPLC grade water, (C)  1µM 
Tat, (D) 2.5µM Tat, (E) 5µM Tat showing raised domains around edge of defect.  (F) 
10µM Tat with further coverage of raised domains.  White arrows indicate the same 
defect in the bilayer which gradually expands along with the merging of other 
defects. Scan size 2 x 2µm. 
 
In Figure 4.12 the white lines are cross sections of the bilayer showing that the 
height of the bilayer increased by approximately one nanometre following Tat 
exposure at 5µM.  A1 shows a 4.2nm bilayer, which is representative of a DPPC gel 
phase bilayer.  B1 shows an increase in bilayer height with a raised region at the 
edge of the bilayer defect, approximately 0.8nm above the bilayer. 
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Figure 4.12:  Cross sections of DPPC before (A) and after exposure (B) to 5µM Tat 
peptide.  Original height of bilayer is 3.6nm, in B1, bilayer height is 4.6nm and the 
height of the bilayer where Tat peptide acts is 5.7nm, approximately 1nm higher. 
Scan size 2 x 2µm. 
 
Bearing analysis of bilayer area was also performed on these images.  Overall, 
bilayer area was again not affected to a great extent by the addition of Tat peptide, 
similarly to that observed for the positively charged nanoparticles.  Initial bilayer 
area in Figure 4.10A was 55% whilst in Figure 4.10F, the area was 53%.  The 
average measurement of bilayer coverage produced from all images (not shown) at 
each concentration of Tat shows that bilayer coverage on average decreased from 
54 ± 1.6% to 53 ± 1.1%.  Similarly in Figure 4.11A, area covered by the bilayer was 
84% which decreased to 74% in Figure 4.11F but the average decrease for the 
whole series of images was from 79 ± 7.7% to 71 ± 1.0%.  However, it was 
interesting to see that although the overall coverage of the bilayer was only 
marginally changed, the area of the raised regions in Figure 4.10E and Figure 4.11E 
could be easily measured using the bearing analysis function.  In Figure 4.10E this 
was 21.2% and in Figure 4.11E the area was 37.3%, providing a quantitative 
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measurement of the area of the bilayer that changed in height following the addition 
of Tat peptide. 
The increases in bilayer height caused by the addition of Tat peptide may be 
attributed to the insertion of the peptide into the bilayer, causing reorganisation and 
condensation of lipids45, 48.  However, some groups argue that this is unlikely due to 
the lack of hydrophobic residues on the peptide and the densely packed acyl chains 
of the phospholipids present in the bilayer243.  If Tat does interact with the 
membrane in this manner, as it inserts into the bilayer, there is less space for the 
lipid molecules, so they become more ordered to accommodate the presence of the 
peptide leading to an increase in bilayer thickness.  However, there may also be a 
decrease in bilayer thickness caused by solubilisation of the lipid.  This would be 
expected as the lipid reorders following insertion of the Tat peptide.   An alternative 
explanation for the effect of Tat peptide is through surface adsorption via 
electrostatic interactions that may result in the formation of raised domains via 
membrane restructuring or lipid tilt.  Tat is a basic cationic peptide carrying 
multiple positive charges and may therefore be expected to interact with the 
zwitterionic lipid head groups of the phospholipids.  The raised regions could 
therefore represent aggregates of peptide on the bilayer or a change in the way the 
lipids pack in the bilayer due to the interaction of the peptide with the head groups 
192, 239, 242.  
4.2.1.5  Interaction of Tat peptide conjugated nanoparticles with SLBs 
Tat peptide conjugated polyacrylamide nanoparticles have been shown to cross the 
cell membrane and do not require any additional techniques to be delivered into 
cells10, 186.  Following exposure of the bilayer to a 1µg/ml suspension of Tat 
conjugated nanoparticles with a charge of 5.5mV, no changes were observed in the 
topography of the bilayer.  Increasing the concentration of Tat conjugated 
nanoparticles to 10µg/ml led to the appearance of small holes in the bilayer.   
Exposure to a higher concentration (25µg/ml) resulted in significant changes in the 
bilayer including the formation of new holes, expansion of pre-existing defects and 
solubilisation of the bilayer over time (Figure 4.12). 
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Significantly more lipid reorganisation was observed to be caused by the Tat 
peptide conjugated nanoparticles than by Tat peptide alone or positively charged 
polyacrylamide nanoparticles alone. Although some catalysis of pore coalescence 
was observed using positively charged nanoparticles, this was limited and the 
widespread formation of new defects was not observed.   Both types of nanoparticle 
caused some solubilisation of the bilayer and enlargement of pre-existing defects, 
but this was much more pronounced with the peptide conjugated nanoparticles in 
localised areas of the DPPC bilayer (Figures 4.7 and 4.13). 
The presence of the nanoparticle conjugated to Tat peptide may affect the way in 
which Tat interacts with the bilayer, leading to more pronounced effects on the 
bilayer structure.  For instance, nanoparticles may cause fluidisation of the bilayer, 
leading to a greater interaction with Tat due to the fluid nature of the bilayer, or the 
conjugation of the nanoparticle may affect the conformation in which Tat is 
presented to the bilayer.  Alternatively, the presence of the peptide may cause 
changes in the bilayer itself as the peptide inserts into or interacts with the bilayer.  
This change in bilayer structure may then allow for a greater interaction of the 
nanoparticle with the bilayer.  The results obtained using AFM correlate well with 
the in vitro fluorescence uptake studies which demonstrated enhanced uptake of Tat 
conjugated nanoparticles (Chapter 5.2.2.). 
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Figure 4.13:  AFM images of the interaction between Tat conjugated 
polyacrylamide nanoparticles and a DPPC lipid bilayer. (A) DPPC, (B) following 
addition of 20µl HPLC grade water, (C) 1µg/ml Tat conjugated nanoparticles, (D) 
10µg Tat conjugated nanoparticles caused the appearance of small holes in the 
bilayer and exposure to higher concentrations such as 25µg/ml (E) led to the 
formation of new defects and solubilisation of the bilayer over time.  Image (F) was 
taken one hour after (E) Scan size 5 x 5 Ɋ. 
 
Exposure of a DPPC bilayer to Tat conjugated nanoparticles also led to a change in 
the height of the bilayer (Figure 4.14).   Initially, the cross section shows the bilayer 
to have a height typical of a DPPC bilayer of 5.7nm.  Following exposure to the Tat 
conjugated nanoparticles, some raised regions can be observed around the edge of 
bilayer defects as was seen using Tat peptide alone (Figure 4.11 and Figure 4.14 B1 
circled).  In addition, particles can be observed and the height of the bilayer was 
reduced to 4.8nm. 
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Figure 4.14:  (A) DPPC bilayer before exposure to Tat conjugated nanoparticles, 
(A1) cross section indicated by white line on (A).  (B) DPPC bilayer following 
exposure to 25µg/ml Tat conjugated nanoparticles, (B1) Cross section indicated by 
white line on (B) showing particles and changes in bilayer height.  Original bilayer 
height in (A) is 5.7nm and following exposure to Tat peptide conjugated 
nanoparticles, bilayer height reduces to 4.8nm and particle height is 21.5nm (B1). 
  
Figure 4.15 clearly shows the dramatic change in the bilayer in a region significantly 
altered by the addition of Tat conjugated nanoparticles.  It can again be observed 
that although the nanoparticles do not appear to be associated with the bilayer as 
was the case with the positively charged nanoparticles, there is a much greater 
effect on the bilayer than with the positively charged nanoparticles alone.  This 
suggests that the presence of the Tat peptide, which is too small to be observed 
using AFM in these images, is having an additional effect on the bilayer as the 
particles move over the bilayer surface. 
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Figure 4.15: AFM images of the interaction between Tat conjugated polyacrylamide 
nanoparticles and a DPPC lipid bilayer. (A) DPPC, (B) following addition of 20µl   
HPLC grade water, (C) 1µg/ml Tat conjugated nanoparticles, (D) 10µg Tat 
conjugated nanoparticles caused the appearance of small holes in the bilayer and 
exposure to higher concentrations such as 25µg/ml (E) led to the formation of new 
defects and solubilisation of the bilayer over time.  Image (F) was taken one hour 
after (E) Scan size 2 x 2 Ɋ. 
 
Bearing analysis of the area covered by the bilayer confirmed what can be observed 
in Figures 4.13-15.  In Figure 4.13A the bilayer covers 60% of the image and this 
value decreases to 55% in Figure 4.13F.  This decrease in relatively small because 
some regions of the bilayer are dramatically altered by the addition of the Tat 
conjugated nanoparticles whilst other areas are left relatively intact, for instance the 
bottom third of the images in Figure 4.13 remains relatively constant.  The average 
change in bilayer coverage in these images was from 59 ± 0.1% to 52 ± 0.2%.   
However, when an area that is obviously affected by the addition of the 
nanoparticles is analysed, there is a more significant change in surface coverage.  In 
Figure 4.15, the solubilisation of the bilayer as the concentration of the Tat peptide 
conjugated increases is much more apparent, and bilayer area decreases from 64% 
in Figure 4.15A to 32% in Figure 4.15F. 
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In summary, negatively charged polyacrylamide nanoparticles were found to adhere 
to the mica surface and did not insert into the bilayer.  Positively charged 
polyacrylamide nanoparticles led to small changes in the bilayer characterised by 
the fusion and enlargement of bilayer defects.  Tat peptide alone caused some 
changes in the bilayer including the formation of raised regions around bilayer 
defects and solubilisation of some areas along with fusion of small defects.  In 
contrast, nanoparticles functionalised with Tat peptide caused significant 
rearrangement in the bilayer through the formation of new holes, expansion of 
previous defects in the bilayer and the acceleration of the coalescence of smaller 
pores into larger ones.  This work correlates well with in vitro studies indicating the 
uptake of positively charged and Tat conjugated nanoparticles into cells.  It suggests 
that AFM studies of SLBs on mica can be a good model for predicting the effects of 
nanoparticles on more complex cell systems.   
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4.2.2  SICM Results 
The interaction of positively and negatively charged 300nm silica nanoparticles was 
imaged using SSCM.   In addition, the effect of larger, 1µm positively charged 
nanoparticles was also briefly investigated.  The use of SSCM enabled the 
simultaneous gathering of topography and fluorescence imaging with the 
fluorescence images in focus at the pipette tip.  This enabled detection of the 
nanoparticles on or near the cell membrane via fluorescence.  It had previously 
proven to be very difficult to detect the nanoparticles via topography imaging alone, 
due to the presence of nanoscale features on the membrane.  Once identified, high 
resolution imaging of smaller areas of the membrane where the nanoparticles had 
been identified was used in order to visualize the nanoscale interaction between the 
particles and the cell membrane.  This imaging was done using topography alone 
since the resolution of the fluorescence microscope was too low at this point.   
4.2.2.1  Control images of MRC-5 cells 
Control samples of fixed MRC-5 cells not exposed to nanoparticles showed that the 
cells possessed a relatively flat membrane with a few raised surface features and no 
visible holes or defects in the cell membrane (Figure 4.16).  The cytoskeleton was 
often visible under the cell membrane and this was probably due to the dehydrating 
fixation process of ice cold methanol that was  used161.  
Although it initially appeared that it would be possibly to identify the nanoparticles 
using topography alone given the relatively flat and featureless membrane of the 
membrane on a large scale, it was later found that this was not possible, hence the 
need to use SSCM.  This may be because the addition of the nanoparticles induced 
some response in the cell leading to changes in the membrane structure which then 
complicated the imaging of small areas of the membrane.  For example, if membrane 
blebbing occurred, it may be difficult to distinguish this from the nanoparticles. 
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Figure 4.16:  MRC-5 cells control samples (A) large area of multiple MRC-5 cells and 
(B) a smaller area both showing relatively flat membrane.  The cytoskeleton can be 
observed in (A). 
 
4.2.2.2  300nm negatively charged silica nanoparticles 
Negatively charged silica nanoparticles containing Alexa 488 with a zeta potential of 
-25 mV in serum free DMEM and a size of 290 nm were easily located by their 
fluorescence using SSCM (Figure 4.17).  Since the cells were fixed after a relatively 
short incubation time (30 mins), some nanoparticles were captured as they crossed 
the cell membrane, whilst some had already entered the cell.  Nanoparticles on the 
membrane could be seen as discrete spots whilst those that had already been taken 
up by the cell produced diffuse areas of fluorescence, since the fluorescence image 
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was in focus at the pipette tip.  The nanoparticles were very difficult to identify by 
topography alone because extensions of the cell membrane were found to envelop 
the nanoparticles as they were taken up by the cell, making them difficult to identify 
and resolve.  In addition, some of the cell membrane features had a similar size to 
the nanoparticles.  The nanoparticles appeared to be present mainly as aggregates 
of approximately 1-5µm on the cell membrane.   
 
 
Figure 4.17:  (A) Topography image of MRC-5 cell exposed to negatively charged 
silica nanoparticles, (B) Corresponding fluorescence images showing nanoparticles 
and aggregates of nanoparticles (green).  (C) Overlaid image of fluorescence and 
topography. 
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Higher resolution scans of a smaller area of the cell membrane revealed a number of 
features including aggregates of nanoparticles which were detected by their 
fluorescence.  A number of possible holes or defects in the membrane could also be 
observed along with some features of the cytoskeleton.  It appeared that most of the 
negatively charged silica nanoparticles were associated with extensions of the cell 
membrane (Figure 4.18).  Due to their size, which excludes their uptake by clathrin 
and caveolae mediated endocytosis, this could suggest that the negatively charged 
silica nanoparticles may enter cells by a route of endocytosis such as 
macropinocytosis.  Macropinocytosis is associated with the formation of projections 
on the cell membrane that encapsulate extracellular fluid and any surrounding 
particles, and it has been suggested in the literature as a possible route of uptake for 
500nm silica nanoparticles191. 
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Figure 4.18:  Smaller area scan of MRC-5 cell exposed to negatively charged silica 
nanoparticles (A) Topography, (B) corresponding fluorescence and (C) overlaid 
image of fluorescence and topography showing multiple negatively charged silica 
nanoparticles (green) associated with the cell membrane. 
 
Figure 4.19 shows a smaller area of membrane highlighting the interaction of a 
single negatively charged silica nanoparticle with a protrusion of the cell membrane. 
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Figure 4.19:  A topography image that indicates the interaction of a single 
negatively charged silica nanoparticle with the cell membrane.  The nanoparticle is 
indicated by the arrow. 
 
4.2.2.3  Positively charged silica nanoparticles 
1.3µm Positively charged silica nanoparticles 
1.3µm silica nanoparticles created a discrete area of damage in the cell membrane 
but left surrounding areas of the membrane largely undamaged (Figure 4.20).  
Although not extensively investigated in this work by other techniques due to their 
size, this data is included since it was interesting to note the different effects of the 
large, micron sized particles compared to the nanoparticles. 
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Figure 4.20:  Effect of 1.3µm silica nanoparticles on MRC-5 cells.  This image was 
taken using hopping mode only at Nottingham.  The arrow indicates the damaged 
area of the cell membrane. 
 
300nm positively charged silica nanoparticles 
Positively charged silica nanoparticles appeared to induce more changes in the 
topography of the cell surface membrane of MRC-5 cells than the negatively charged 
silica nanoparticles. Unlike negatively charged silica nanoparticles, positively 
charged nanoparticles (27mV) with a similar size of 292nm led to the formation of 
multiple large holes in the cell membrane (Figure 4.21).  This indicated that the 
interaction of the nanoparticles with the bilayer caused damage to the cell 
membrane.  These holes were clearly visible on the topography image, whilst diffuse 
intracellular fluorescence indicated that some nanoparticles had already entered the 
cell (Figure 4.21).   
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Figure 4.21: (A) Topography image of MRC-5 cells exposed to positively charged 
silica nanoparticles, (B) corresponding fluorescence image.  (C) is the overlaid image 
showing holes visible in the cell membrane plus diffuse fluorescence from positively 
charged silica nanoparticles. 
 
Although positively charged silica nanoparticles were also found associated with 
extensions of the cell membrane to some extent (Figure 4.22), they were also 
frequently found isolated on the membrane (Figure 4.23).  The presence of isolated 
positively charged nanoparticles may suggest an alternative uptake mechanism to 
the negatively charged particles.  For instance, direct translocation across the 
membrane via the formation of holes by the particles may play a role along with 
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other mechanisms such as macropinocytosis.  However, the relatively large size of 
the nanoparticle makes a mechanism of direct translocation unlikely, although if it 
did occur it would be potentially damaging to the cell and produce holes such as 
those seen in Figure 4.21.  Macropinocytosis may be suggested by Figure 4.22 since 
the nanoparticle is clearly associated with an extension of the cell membrane as it 
enters the cell. 
 
Figure 4.22:  Positively charged silica nanoparticle (indicated by the arrow) 
partially embedded in membrane and also associated with a region of the 
membrane. 
 
Figure 4.23 shows a single positively charged silica nanoparticle that is embedded in 
the cell membrane but it is not associated with any extensions of the cell membrane.  
This may indicate that an active uptake process is not required or the nanoparticle 
may have been captured at a different stage in the uptake process, perhaps when 
any extensions of the cell membrane have rejoined the membrane and are no longer 
visible. 
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Figure 4.23:   Isolated positively charged silica nanoparticle partially embedded in 
the cell membrane.  
 
It appears that regardless of charge, silica nanoparticles of approximately 300nm 
caused some damage to the cell membrane of MRC-5 cells as demonstrated by the 
formation of defects in the membrane structure.  Positively charged nanoparticles 
caused more extensive damage which could be observed as an increased number of 
holes in the membrane (Figure 4.21).   The size of the nanoparticles appeared to be 
important since larger, micron sized particles caused discrete areas of damage 
(Figure 4.20).  In general, negatively charged nanoparticles were more often 
associated with extensions of the membrane. In contrast, positively charged 
nanoparticles, whilst also associated with membrane processes to some extent were 
also found isolated and embedded into the membrane.  The results indicate that 
extremes of both positive and negative charge on silica nanoparticles lead to 
interaction with the cell membrane and subsequent cellular uptake, which 
correlates well with the results of the fluorescence uptake experiments described in 
the following chapter.   
4.3   Conclusion 
Both AFM and SSCM proved to be useful techniques to image the interaction of 
nanoparticles with either a real or model cell membrane.  Both techniques were 
suitable for the nanoparticles used and could resolve both the individual 
nanoparticles and features of the membrane or bilayer.   Changes in the structure 
and height of the bilayer or membrane could be observed following interaction with 
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nanoparticles and the results gained help to provide more information about the 
initial stages of the interaction of nanoparticles with cell membranes.  Advances in 
both techniques could enable improvements in the range of samples that can be 
imaged.  Improving the resolution and speed of imaging would enable the processes 
to be investigated on live cells in real time.  These developments are discussed in 
Chapter 6. 
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Chapter 5 - Fluorescence microscopy 
5.1  Fluorescence microscopy and nanoparticle uptake 
5.1.1  Imaging nanoparticle uptake with fluorescence 
Nanoparticles can be labelled with a range of fluorescent dyes by a variety of 
methods.  These include physical entrapment within the nanoparticle matrix or 
conjugation to the monomers used to form the nanoparticles.  This labelling enables 
the cellular uptake route of the nanoparticles to be monitored using fluorescence 
microscopy.  It also allows further investigation of the subsequent subcellular 
localization of nanoparticles, via colocalization studies.  These can be performed 
following the fluorescent labelling of intracellular organelles such as endosomes, 
lysosomes, mitochondria and the nucleus28.  In addition to imaging, fluorescent dyes 
sensitive to certain analytes such as hydrogen, calcium or oxygen can be 
encapsulated in the nanoparticle.  For example, FITC can be used to measure 
changes in pH.  Changes in the fluorescence emission of these dyes in response to 
alterations in the level of the analyte enable intracellular measurements of the 
analytes to be performed219, 249.  Future applications of this technology may enable 
the development of real time monitoring systems, for example, a glucose sensitive 
system for diabetes250-252. 
In this work, the fluorescent dye Alexa 488 was encapsulated within polyacrylamide 
and silica nanoparticles and their uptake into MRC-5 cells was investigated and 
quantified using widefield fluorescence microscopy. 
5.1.2  Cellular uptake of polyacrylamide nanoparticles 
Polyacrylamide nanoparticles have the potential for a number of biological 
applications including diagnostic measurements of intracellular analytes, imaging 
and measurement of intracellular processes, and they are also being investigated for 
use as a delivery system for photodynamic therapy76.  The polyacrylamide 
nanoparticle matrix can be used to trap dyes, protecting cells from any potentially 
toxic effects of the dye, and also protecting the dye from any interference by cellular 
components.  Despite their small size, they can contain multiple dyes, enabling 
ratiometric and simultaneous measurements of different analytes to be 
performed200, 219.   In addition to dyes, they have also been used to entrap other 
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molecules such as aptamers 200.  The size, charge and chemistry of polyacrylamide 
nanoparticles can be readily modified via the incorporation of different monomers 
in order to improve their uptake and targeting83, 219.  Their small size causes minimal 
cell perturbation and therefore negligible biological effects and they have been 
shown to be biocompatible with a range of cells186, 253.  Another benefit of their small 
size is that they have a high surface area to volume ratio which allows changes in the 
environment to be measured rapidly. as analytes only need to diffuse a small 
distance through the nanoparticle219. 
Polyacrylamide nanoparticles may enter cells by a variety of routes depending on 
their surface chemistry and the presence of any targeting molecules e.g. cell 
penetrating peptides.  Their size means that they are likely to be taken into cells via 
some form of pinocytosis mechanism such as receptor independent clathrin or 
caveloae mediated endocytosis or macropinocytosis, since their size should help 
them to evade uptake and clearance by phagocytosis76.  The mechanism of cellular 
uptake will also depend on cell type, for example only some cells perform 
phagocytosis.  In the body, nanoparticles have the potential to accumulate in 
tumours via the enhanced permeability and retention effect.  This effect is when 
nanoparticles of a similar size to polyacrylamide (<200nm) have been shown to 
escape blood vessels with increased permeability in tumours, leading to potential 
applications in targeted drug delivery to tumours76, 254.  Besides uptake by 
endocytosis, polyacrylamide nanoparticles can also be delivered into cells using 
specific delivery techniques such as cationic liposomes (Lipofectamine), 
picoinjection, gene gun  and conjugation to cell penetrating peptides186. 
Previous work investigating the uptake of polyacrylamide nanoparticles into cells is 
relatively limited.  A number of studies have investigated measurement of the 
concentration of intracellular analytes using fluorescent dyes trapped within the 
polyacrylamide matrix but most do not investigate the uptake mechanism and 
interaction of the nanoparticles with the cell membrane.  Literature reports suggest 
that following internalization into cells, polyacrylamide nanoparticles generally 
display fluorescence within cells as punctate spots, suggesting they are not 
dispersed throughout the cytoplasm but may reside in an intracellular 
compartment, for example endosomes10, 76, 186.  This indicates that uptake occurs by 
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a route that delivers nanoparticles to the endolysosomal pathway and these include 
the major pinocytosis pathways.  Kuruppuarachchi et al. synthesised a range of 
polyacrylamide nanoparticles for use as a delivery system for photodynamic 
therapy.  They studied the uptake of unfunctionalised polyacrylamide nanoparticles, 
polylysine bound tetrasulfonato-aluminium phthalocyanine entrapped 
polyacrylamide nanoparticles and the same nanoparticles conjugated to a porphyrin 
based photosensitizer into HT29 cells.  It was found that all three types of 
nanoparticles readily entered the cells without any additional delivery vehicle.  The 
punctate, granular appearance of the fluorescence from the nanoparticles indicated 
that they were encapsulated in endocytic vesicles within the cell, although further 
investigations to identify the route of uptake were not performed76. 
Some studies have looked at the effects of positive charge and Tat peptide 
conjugation on the internalization of polyacrylamide nanoparticles. Sun et al. 
synthesised cationic polyacrylamide nanoparticles containing the positively charged 
monomer 3-(acrylamidopropyl)-trimethylammonium chloride (ACTA).  The cationic 
nanoparticles were found to be internalized into HepG2 cells without the need for 
any special delivery vehicle.  It was suggested that the presence of the quaternary 
ammonium ion in ACTA led to an electrostatic interaction between the 
nanoparticles and the cell membrane, leading to enhanced uptake of the 
nanoparticles into cells 187.  In two studies by Coupland et al. into the uptake of Tat 
conjugated polyacrylamide nanoparticles, flow cytometry and confocal microscopy 
were used to show that the nanoparticles entered mesenchymal stem cells and CHO-
K1 cells without leading to effects on cell morphology or viability.  The appearance 
of granular areas of fluorescence indicated that the nanoparticles were present in 
endosomes or lysosomes.  pH measurements using FITC, and colocalization studies 
performed also suggested a lysosomal location for the nanoparticles.  
Unfunctionalised polyacrylamide nanoparticles with no surface conjugation did not 
appear to enter the cells10, 186.  Conjugation of the nanoparticle cargo to the peptide 
appeared to alter its uptake, since when the peptide was conjugated to FITC alone, 
the subcellular localization of the conjugate was different to that of the peptide 
conjugated nanoparticles10. 
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5.1.3  Cellular uptake of silica nanoparticles  
Much more literature is available on investigations into the cellular uptake of silica 
nanoparticles of varying size, shape and charge, and they have been more 
extensively investigated as drug delivery tools.  However, the results are 
complicated by the wide variety of methods used to produce the nanoparticles, their 
composition, surface chemistry and size191, 255, 256.  Silica nanoparticles are 
biocompatible and have also been used for intracellular sensing257.  The 
encapsulation of fluorescent dyes inside silica nanoparticles is useful since they are 
hydrophilic, biocompatible and optically transparent.  In addition, their chemistry 
can be readily modified with various different fluorescent probes and other 
molecules to impart a charge or provide conjugation to molecules such as cell 
penetrating peptides209, 214.  Multiple studies have found that silica nanoparticles 
rapidly enter many different cell types including HeLa, 3T3 and stem cells via an 
actin dependent active uptake mechanism such as clathrin or caveolae mediated 
endocytosis or macropinocytosis.  Uptake has been shown to be significantly 
reduced when the experiments were performed at 4oC compared to 37oC and in the 
presence of actin destabilising agents such as cytochalasin D26, 214, 256, 258-260.  Begum 
et al. found that 90nm silica nanoparticles entered HeLa cells by clathrin dependent 
endocytosis26.  Slowing et al.  suggested that the functionalisation of silica 
nanoparticles with different surface groups led to uptake by different routes.  They 
suggested that unfunctionalised 150nm (-35mV) and N-folate-3-aminopropyl 
functionalised (+13mV) silica nanoparticles entered cells by clathrin mediated 
endocytosis whilst 3-aminopropyl (-5mV) and guanidinopropyl (-3mV) 
functionalised nanoparticles were internalized by a caveloae mediated 
mechanism256  . 
The effect of size on silica nanoparticle internalization has been investigated and 
silica nanoparticles with different sizes (80nm and 500nm) have been shown to 
enter human dermal fibroblast cells to different extents.  This suggests that the rate 
and amount of uptake of silica nanoparticles is dependent on size to some extent, 
and that particles of different sizes may use different uptake mechanisms.  Figure 
5.1 shows that the 80nm nanoparticles were found colocalized with lysosomes to 
some extent but did not enter the cell nucleus.  This exclusion from the nucleus is 
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expected due to the presence of the nuclear envelope which prevents many 
molecules accessing the nucleus191.   
Genistein, an inhibitor of clathrin independent endocytosis, was shown to reduce 
the uptake of 80nm silica particles but not 500nm particles, again suggesting that 
different mechanisms of uptake are involved for differently sized particles.  Uptake 
of 500nm silica particles was found to depend more on the macropinocytosis 
pathway, a result that may be expected due to the size limits of the clathrin and 
caveolae mediated mechanisms of endocytosis191.   A study by Lu et al. found that 
uptake of silica nanoparticles into HeLa cells was greatest for particles with a 
diameter of 50nm and uptake decreased at both smaller and larger diameters 
(30nm and 110nm)74.  This finding was in agreement with the literature in general 
which demonstrates a rapid uptake of small nanoparticles and a decrease in uptake 
of larger nanoparticles as size increases.  A number of literature reports have also 
concluded that very small nanoparticles can display a decrease in cellular uptake4, 82, 
91, 261.  The use of silica nanoparticles has also been investigated as a drug delivery 
tool to help to enhance the delivery of poorly soluble drugs.  It was found that the 
use of silica nanoparticles in a tablet formulation for oral delivery resulted in 
enhanced drug permeability and a higher release rate of the drug compared to a 
tablet composed of silica microparticles.  Cellular uptake studies on Caco-2 cells, 
used as a model of intestinal absorption, showed that silica nanoparticles could be 
internalized but uptake of microparticles was not observed262.   
 
Figure 5.1:  80nm silica nanoparticles in human dermal fibroblasts cells (A) bright 
field, (B) RITC-silica nanoparticles (red) (C) Merge of RITC-silica particles and 
LysoTracker Green, (D) Merge of RITC-silica particles and DAPI (blue)191. 
Literature reports in general suggest that positively charged silica nanoparticles 
show enhanced uptake into cells26, 214.  100nm silica nanoparticle uptake into 3T3-
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L1 and hMSCs cells was shown to be increased by the presence of a positive surface 
charge and endocytosis occurred via a clathrin and an actin dependent mechanism.  
However, the effect of blocking a particular route of uptake using  phenylarsine 
oxide to inhibit clathrin and cytochalasin D to inhibit macropinocytosis, was 
different between the cells, indicating that each type of cell internalized the particles 
by a different mechanism214.  Similarly to polyacrylamide and other nanoparticles 
and polymers, some studies have suggested that the presence of a positive surface 
charge can lead to escape of the particles from endosomes into the cytoplasm, which 
has implications for enhancing drug delivery applications263, 264.  A number of 
studies have indicated this pattern of increased uptake of nanoparticles with 
increasing positive charge and the possible reasons for this have been discussed 
previously.  However, a number of studies investigating the uptake of 
unfunctionalised silica nanoparticles, which naturally carry a high degree of 
negative charge, have indicated that they can also enter cells.  It has been suggested 
that this uptake occurs via non specific pinocytosis uptake mechanisms since the 
nanoparticles have also been shown to reside in endosomes98, 255.  Graf et al. 
synthesised silica nanoparticles with a range of zeta potential from highly negative 
to positive values.  Positively charged particles were found to enter HeLa cells and it 
was suggested that this occurred following their increased association with the 
negatively charged cell membrane.  However, positive charge in itself was found to 
be inadequate for the uptake of silica nanoparticles synthesised with an alternative 
monomer and containing a different functional group that caused aggregation99.  
These results indicate that one parameter, i.e. size or charge cannot be considered in 
isolation in regard to cellular uptake.  The presence of polyethylene glycol (PEG), 
which confers neutrality onto many nanoparticles, was found to inhibit uptake.  PEG 
is often used to stabilise nanoparticles since it helps to maintain colloidal stability 
and minimise biological interactions.  However, it has often been found to inhibit the 
cellular uptake of nanoparticles due to these reduced interactions with the 
environment around the particle11, 99. 
200nm silica nanoparticles have also been conjugated to Tat peptide and flow 
cytometry studies have shown that internalization of Tat conjugated particles 
occurred at a faster rate and to a greater degree than nanoparticles not conjugated 
to the peptide102, 217.  Internalization of both unfunctionalised and Tat conjugated 
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nanoparticles was inhibited by low temperature, indicating an active uptake 
mechanism was involved.  With more Tat peptide present on the particle surface, it 
was found that a larger number of particles were internalized217.  In addition, Pan et 
al. found that conjugation of the peptide to the nanoparticle is required for uptake 
and that simultaneous incubation of free nanoparticles and peptide does not lead to 
enhanced uptake265.  Although it is clear that Tat delivers cargo such as silica 
nanoparticles to cells, the mechanism by which this occurs is unclear.  Again, there 
may be different mechanisms depending on the cargo.  For example small cargo may 
be able to enter cells via energy independent electrostatic interactions or size 
limited clathrin or caveolae mediated endocytosis, whilst larger cargos may require 
a mechanism such as macropinocytosis10, 217. 
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5.2  Results and Discussion 
5.2.1  Polyacrylamide nanoparticles 
Polyacrylamide nanoparticles with a size of 40-50nm and a range of charges 
between -3mV and 18mV were internalized into MRC-5 cells within a six hour time 
period.  A strong positive correlation was observed between the degree of positive 
charge on the nanoparticles and the level of uptake into cells which was measured 
using the green fluorescence intensity from the nanoparticles within the cells.  Cells 
exposed to unfunctionalised polyacrylamide nanoparticles and nanoparticles 
containing 2-5% ACTA displayed low levels of fluorescence, indicating minimal 
cellular uptake.  In cells exposed to polyacrylamide nanoparticles containing 
between 10% and 20% ACTA and with a charge greater than 13mV, bright areas of 
green fluorescence could be observed within the cells (Figure 5.2).   
Although the resolution of the fluorescent microscope used does not allow 
observation of the individual nanoparticles, fluorescence from the particles was 
observed throughout the cell and generally appeared as a punctate, granular 
distribution.  This distribution pattern has previously been observed in other 
studies and it suggests that the nanoparticles are not dispersed throughout the 
cytoplasm, but may be present within intracellular compartments such as 
endosomes or lysosomes10, 186.  At high levels of positive charge, the nanoparticles 
were often found to be particularly concentrated in endosomes or lysosomes in the 
perinuclear region of the cell.  However, in no cases did the nanoparticles cross the 
nuclear membrane and enter the nucleus itself.  Uptake of the nanoparticles was 
generally observed to be similar across all the cells in a sample, although in some 
cases where nanoparticles with a higher charge were used, more differences were 
observed between cells.    
 
145 
 
 
Figure 5.2:  Representative images showing polyacrylamide nanoparticles (green) with increasing positive 
charge in MRC-5 cells.  Images are shown in pairs of green fluorescence alone beside the green fluorescence 
and brightfield merged images. (A) Control, (B) Unfunctionalised (-3.3mV), (C) 2% ACTA (1.8mV), (D) 5% 
ACTA (6.9mV), (E) 10% ACTA (13.2mV), (F) 15% ACTA (17.6mV) (G) 20% ACTA (18.6mV). 
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Figure 5.3:  Example images of MRC-5 cells exposed to polyacrylamide 
nanoparticles to show perinuclear, punctate distributions of nanoparticles (green) 
indicating an endocytic route of uptake.  (A) 5% ACTA containing polyacrylamide 
particles and (B) enlarged area from white box in (A).  (C) 20% ACTA containing 
polyacrylamide nanoparticles and (D) enlarged area from white box in (C). 
 
Green fluorescence intensity measurements within the cells displayed an overall 
trend of an increase in fluorescence intensity as positive charge on the nanoparticles 
increased.  This trend was retained following correction to account for differences in 
the batch to batch fluorescence emission of the nanoparticles, indicating that 
increasing the positive charge on the nanoparticle increased uptake into cells 
(Figure 5.4).  The effect was especially pronounced for nanoparticles containing 
15% and 20% ACTA, suggesting that the correlation was non linear and that 
increasing charge beyond a threshold level had even greater effects on enhancing 
uptake.  As mentioned previously, the uptake of nanoparticles containing 20% ACTA 
was not as uniform across different cells as for the other particles, leading to a high 
standard deviation for the sample. 
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Figure 5.4:   Increase in cellular uptake of polyacrylamide nanoparticles with 
increasing charge. N= 50. 
The results correlate well with many studies in the literature that show that positive 
charge leads to enhanced uptake of a variety of molecules2, 14, 54, 62, 85, 98.  This 
increase in uptake is probably due to increased affinity and interaction of the 
positively charged nanoparticles with the cell membrane.  This enhanced interaction 
may increase the opportunity for nanoparticle uptake into the cell via endocytosis.  
The size range of polyacrylamide nanoparticles produced means that they could 
enter cells by any of the main routes of endocytosis.  They may be able to interact 
with areas of the membrane involved in clathrin or caveloae mediated endocytosis 
and their increased association with the membrane would increase the likelihood of 
their encapsulation into a macropinosome as it formed on the cell membrane.  Since 
the nanoparticles appeared to be localized to intracellular vesicles following uptake, 
this also supports an endocytic uptake mechanism such as clathrin mediated 
endocytosis or macropinocytosis.  This is because these routes of uptake direct the 
substances they transport into endosomes and lysosomes.  Alternatively, as 
suggested by some literature reports, the positive charge on the nanoparticles and 
their small size may also mean that they can enter the cell without the need for a 
specific route of uptake by forming transient holes in the cell membrane11, 86, 97.  This 
is supported by the results discussed in Chapter 4.2.1.3 using AFM. However it 
would be expected that if the nanoparticles did enter cells by this route then the 
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appearance of fluorescence from the particles may be more diffuse and spread 
throughout the cytoplasm.   
The enhanced uptake observed with some highly cationic nanoparticles is also 
linked to an increase in cytotoxicity.  If the nanoparticles do cause increased 
permeabilization of the membrane in order to enter the cell, this can lead to leakage 
of intracellular fluid and molecules which can lead to cell death.  This may have been 
the case for the nanoparticles containing 20% ACTA since the particles appeared to 
have effects on cell morphology and the high variation in uptake that was observed 
may have been caused by damage to the cell by the nanoparticles.  This could be 
investigated further through the use of cell viability and cytotoxicity studies55.  
Limited internalization of slightly negatively charged and near neutral 
polyacrylamide nanoparticles into MRC-5 cells was observed.  This correlates well 
with literature reports that indicate that nanoparticles with a neutral and near 
neutral charge, or those functionalised with neutral molecules such as PEG, show 
limited biological interactions and reduced uptake into cells11.  
Following this observation that a positive charge of around 18mV increased uptake 
of the nanoparticles, it was decided to try and investigate the effects of imparting a 
greater negative charge onto the nanoparticle.  However, it proved to be difficult to 
obtain nanoparticles with the charge required so uptake studies were performed 
using the most negatively charged nanoparticles that could be produced.  The aim of 
the experiment was to try and identify whether a high degree of positive charge was 
required to enhance uptake, or whether extremes of charge, either positive or 
negative could influence nanoparticle uptake.   
Polyacrylamide nanoparticles containing 5% N-acryloxysuccinimide with a charge 
of -5.5mV in serum free DMEM entered cells to a small extent over the time course 
of the experiment.  The level of uptake was less than that of the unfunctionalised 
polyacrylamide nanoparticles with a charge of -3.3mV.  The intracellular 
distribution of the few nanoparticles that could be observed within MRC-5 cells 
following uptake displayed a similar pattern to the other polyacrylamide 
nanoparticles investigated (Figure 5.5).  They showed a punctate appearance 
indicating localization into an intracellular vesicle and were again excluded from the 
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nucleus.  The nanoparticles appeared to be distributed throughout the cell within 
these intracellular vesicles, although some were still found in the perinuclear region.  
No nanoparticles were found to adhere to the cell membrane.  
 
Figure 5.5:  (A) Green fluorescence from Alexa 488 containing nanoparticles within 
MRC-5 cells, (B) Brightfield and green fluorescence overlaid image showing 
intracellular localization of polyacrylamide nanoparticles containing 5% N-
acryloxysuccinimide. 
 
Measurements of the green fluorescence intensity within cells following incubation 
with polyacrylamide nanoparticles containing 5% N-acryloxysuccinimde showed 
that these cells displayed a lower fluorescence than those incubated with 
unfunctionalised nanoparticles (Figure 5.6).  The slightly higher level of negative 
charge therefore appeared to inhibit the internalization of the nanoparticles.  This 
effect may have been caused by a decrease in the association of the nanoparticles 
with the cell membrane due to the unfavourable charge interaction, reducing the 
likelihood of uptake.  In addition, the negative charge may reduce the rate of uptake 
significantly so that over the short time course of the experiment, overall uptake of 
the negatively charged nanoparticles appeared reduced.  It would be interesting to 
observe in future whether an increased incubation period may increase 
internalization of the negatively charged polyacrylamide nanoparticles.   
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Figure 5.6:  Comparison of the green fluorescence intensity of 5% N-
acryloxysuccinimide (NAS) polyacrylamide nanoparticles (-5.5mV) and 
unfunctionalised polyacrylamide nanoparticles (-3.3mV) in MRC-5 cells. N=55. 
5.2.2  Tat conjugated polyacrylamide nanoparticles 
Tat conjugated polyacrylamide nanoparticles with a charge of 5.2mV entered cells 
to a greater degree than positively charged polyacrylamide nanoparticles with a 
similar or higher charge.  Only the nanoparticles containing 20% ACTA entered cells 
to a greater extent (Figure 5.7).  Similarly to the other polyacrylamide nanoparticles 
investigated, the Tat conjugated nanoparticles displayed a punctate intracellular 
appearance indicating encapsulation into endosomes or lysosomes.  These were 
again often found to be concentrated in the perinuclear region but did they not enter 
the nucleus itself (Figure 5.8).   
Despite the aggregation of the Tat conjugated nanoparticles which produced a 
population of 500-600nm particles in addition to the typical polyacrylamide 
nanoparticle population at 30-50nm, no nanoparticles were observed adhered to 
the cell membrane. 
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Figure 5.7:  Representative image of MRC-5 cells containing Tat conjugated 
polyacrylamide nanoparticles (5.2mV).  
 
 
Figure 5.8:  (A) MRC-5 cells with Tat conjugated nanoparticles and (B) enlarged 
area from (A) to show intracellular distribution of nanoparticles close to the 
nucleus. 
 
Compared to positively charged polyacrylamide nanoparticles containing 5% and 
15% ACTA which had a similar and higher positive charge (6.9mV and 17mV 
respectively), more Tat conjugated nanoparticles were internalized into MRC-5 cells 
(Figure 5.9).  Only the nanoparticles containing 20% ACTA were found to display a 
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higher level of uptake.  However, the increased size due to aggregation of the Tat 
conjugated polyacrylamide nanoparticles complicates the analysis of the results to 
some extent.  This is because size has also been shown to affect the internalization 
of many different types of nanoparticles.  Despite this, the increased size of the Tat 
conjugated nanoparticles did not appear to, in this study, inhibit uptake of the 
particles.  This may have been expected since previous studies in the literature have 
identified a reduced rate and overall uptake of larger nanoparticles.  The effect of 
the peptide may therefore be significant in enhancing the uptake of larger 
nanoparticle aggregates.     
 
Figure 5.9:  Comparison of the green fluorescence intensity in cells after exposure 
to nanoparticles containing increasing amounts of ACTA or conjugated to Tat 
peptide. Unfunctionalised (-3.3mV), 15% ACTA (17.6mV), 20% ACTA (18.6mV), Tat 
peptide conjugated (5.2mV). N=35. 
The enhanced uptake of nanoparticles upon conjugation to cell penetrating peptides 
such as Tat has been demonstrated in the literature93, 217.  The presence of the 
peptide on the nanoparticle surface must in some way influence the interaction of 
the nanoparticles with the cell membrane.  This could occur either by effects on the 
way the nanoparticle is presented to the membrane or from effects on the 
membrane by the peptide, which then influences how the membrane interacts with 
the nanoparticles.  This could include changes in the phase of the membrane such as 
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fluidisation and increased permeability following interaction with the peptide.  Tat 
peptide has previously been shown to induce the formation of holes in a model lipid 
bilayer and this increased permeability of the membrane has been shown to lead to 
translocation of the peptide and associated cargo across the membrane45, 48.  The 
results presented in Chapter 4.1.3.3 indicate that Tat peptide conjugated 
nanoparticles can lead to significant changes in the structure of a lipid bilayer and 
this would support the suggestion of a mechanism of direct translocation across the 
membrane.  However, this route of uptake is potentially cytotoxic at high 
concentrations and again, it would be expected that nanoparticle fluorescence 
would be more widespread and diffuse than that observed in the fluorescence 
uptake studies.  Alternatively, it has previously been indicated that Tat peptide may 
enter cells via routes of endocytosis especially macropinocytosis50, 108.  Conjugation 
of a cargo to Tat peptide may be able to influence the endocytic pathway used for 
internalization and this is believed to be due to the difference in size between the 
peptide alone and the nanoparticle-peptide conjugate10.  This was also 
demonstrated in this work using AFM as discussed in Chapter 4.1.3.3 where it was 
observed that Tat conjugated nanoparticles had much greater effects on a model cell 
membrane than the peptide alone.  Since the Tat peptide conjugated polyacrylamide 
nanoparticles used in this work were prone to significant aggregation, it is possible 
that they entered cells via a different or additional uptake mechanism than that 
observed for the positively charged polyacrylamide nanoparticles.  For instance, the 
monodisperse population of approximately 40-50nm positively charged 
polyacrylamide nanoparticles could enter cells by mechanisms such as receptor 
independent clathrin or caveolae mediated uptake.  Larger aggregates of Tat 
conjugated nanoparticles are unable to enter cells by this route but their cationic 
nature and the presence of the peptide on the surface, along with their increased 
size may mean that they have a high degree of association and subsequent 
interaction with the cell membrane, possibly via the Tat peptide.  These 
nanoparticles are unlikely to rapidly dissociate from the membrane which has been 
observed with some smaller nanoparticles.  This, in theory, could increase the 
chance of the internalization of an aggregate, composed of multiple nanoparticles 
into a cell via a route such as macropinocytosis and account for the enhanced uptake 
that was observed266, 267. 
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5.2.3  Silica nanoparticles   
Unlike polyacrylamide nanoparticles, which showed a clear dependence on positive 
charge for internalization into MRC-5 cells, both negatively charged (-25mV) and 
positively charged silica (27mV) nanoparticles entered MRC-5 cells within three 
hours (see Chapter 3.2.1.3 for details).   Both types of silica nanoparticle had a 
similar diameter of 290m, and 292nm respectively. Negatively and positively 
charged silica nanoparticles displayed a similar intracellular distribution and the 
nanoparticles were not dispersed throughout the cytoplasm but were observed as 
punctate spots in the perinuclear region (Figure 5.10 and 5.11).  This granular 
appearance of the nanoparticles within the cells again indicated that they were 
present in intracellular vesicles such as endosomes or lysosomes.  Neither the 
negatively or positively charged silica nanoparticles were found to cross the nuclear 
membrane since no fluorescence was observed in the cell nucleus.  In addition, even 
with a high level of positive or negative charge present on the particles, no changes 
in cell morphology were observed in contrast to the polyacrylamide nanoparticles.  
This indicates that the silica nanoparticles may be biocompatible with MRC-5 cells 
at this concentration and this could be confirmed using cell viability and toxicity 
studies. 
Initial studies to try and quantify the uptake of the silica nanoparticles into cells 
were complicated by a high degree of association of the nanoparticles with the cell 
membrane and the glass bottom of the cell culture dish.  This remained even after 
repeated and extensive washing of the cells.  It was necessary to find a way to 
remove these excess nanoparticles in order to be able to perform accurate 
measurements of internalization of the nanoparticles.  This was achieved by the 
incorporation of some additional steps in the sample preparation procedure where 
trypsin was used to remove the cells from the dish following incubation with the 
nanoparticles.  The cells were resuspended in media and then centrifuged to create 
a pellet and the supernatant containing the excess nanoparticles could then be 
removed.  Following replating of the cells onto new dishes, it was observed that the 
excess nanoparticles had been removed.  This enabled clearer images to be obtained 
of the nanoparticles internalized into the cells, therefore allowing measurements to 
be performed.  However, during the analysis of the results, it must be noted that 
although it was assumed that when the cells were replated there were no 
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nanoparticles adhered to the membrane, if this was the case and nanoparticles were 
still attached, the actual time course of the experiment for both types of silica 
nanoparticle would be 27 hours.   
 
Figure 5.10:  (A) Pair of images showing green fluorescence from negatively 
charged silica nanoparticles (-25mV) in MRC-5 cells and the merged green 
fluorescence and brightfield image.  (B) Green fluorescence from positively charged 
silica nanoparticles (27mV) in MRC-5 cells and merged green fluorescence and 
brightfield image.  
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Figure 5.11:  Images showing in greater detail the intracellular localization of silica 
nanoparticles in MRC-5 cells.  (A) Negative silica nanoparticles and (B) enlarged 
image of region in (A) showing perinuclear localization of nanoparticles.  (C) 
Positive nanoparticles and (D) enlarged region of (C) again showing a perinuclear 
distribution. 
Quantification of the uptake of silica nanoparticles was performed by measurement 
of the green fluorescence intensity from the nanoparticles within cells as explained 
in Chapter 2.6.3.4.  This showed that both the negatively and positively charged 
nanoparticles entered cells to a similar degree during the time course of the 
experiment (Figure 5.12).  This is in contrast to the results obtained for 
polyacrylamide nanoparticles which showed a dependence on positive charge for 
internalization.    
157 
 
 
Figure 5.12 Green fluorescence intensity within cells incubated with negative and 
positively charged silica nanoparticles. N=45 
 
A similar effect of charge on the internalization of silica nanoparticles has been 
observed previously although the monomers used to impart charge were different 
to those used in this work, and the size of the nanoparticles was approximately 
50nm.  Chen et al. demonstrated that negatively and positively charged silica 
nanoparticles with a similar zeta potential to those used in these experiments 
showed roughly equivalent internalization into HeLa cells.   However, they also 
suggested that the differently charged nanoparticles were found in different 
intracellular locations, whilst in this work it appears that the nanoparticles display 
similar intracellular destinations.  They found that whilst the positively charged 
nanoparticles were found in the cytosol, negatively charged nanoparticles were 
found in endosomes, leading them to conclude that the positively charged 
nanoparticles entered cells via direct translocation across the membrane, or were 
able to escape endosomes following uptake resulting in their cytosolic location98. 
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Figure 5.13: Confocal microscope images of (A) negatively charged phosphate 
functionalised and (B) positively charged quaternary ammonium functionalised 
silica nanoparticles in HeLa cells showing the nanoparticles (containing FITC and 
RITC), FM4-64 is a marker for endosomes and the merged imaged shows 
colocalization of the negatively charged but not the positively charged nanoparticles 
with endosomes98. 
 
The similar levels of uptake observed in this work may indicate that both types of 
silica nanoparticle were internalized into cells via the same route of uptake.   The 
route used is unlikely to be influenced by charge since unlike polyacrylamide 
nanoparticles, it did not appear that the presence of the negative charge inhibited 
the rate or overall extent of uptake of the silica nanoparticles.  A non specific route 
of uptake such as macropinocytosis may be indicated for these nanoparticles since 
their size of approximately 300nm means they are unlikely to be internalized 
through either of the common routes of clathrin or caveolae mediated endocytosis.  
Uptake of a variety of negatively charged nanoparticles, whilst less commonly 
reported than uptake of positively charged nanoparticles, has been observed by a 
number of groups17, 25, 27, 55, 98, 99.  Both positive and negatively charged nanoparticles 
can interact with components of a cell membrane, for example proteins and lipids.  
The heterogeneity of cell membranes means that in different regions, nanoparticles 
may be able to interact to a greater or lesser extent.  Any association with the 
membrane can increase the chance of internalization, for instance it could interact 
with a region rich in proteins used for clathrin mediated uptake or just by virtue of 
its association with the membrane it could be encapsulated by macropinocytosis.  In 
addition, if the excess nanoparticles were not fully removed from the cell membrane 
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during the trypsin treatment, they could continue to be internalized into cells during 
the following 24 hour period. This may mean that even if one type of nanoparticle 
was internalized at a slower rate than the other, overall uptake levels would be 
equivalent once all the remaining particles had been internalized.  
5.3  Conclusion 
An increase in the positive surface charge on polyacrylamide nanoparticles via 
incorporation of ACTA was found to lead to an increase in the uptake of the 
nanoparticles into MRC-5 cells.  This may be due to increased interactions of the 
nanoparticles with the membrane or direct translocation of small, highly charged 
particles across the membrane.  Negatively charged and near neutral 
polyacrylamide nanoparticles entered cells to a very limited extent, and this may be 
due to a reduced association with the membrane due to an unfavourable charge 
interaction.  It would be interesting in future to synthesise polyacrylamide 
nanoparticles with a higher level of negative charge in order to investigate whether 
an extreme of negative charge has the same effect on polyacrylamide nanoparticle 
uptake as it did for silica nanoparticles.  The hypothesis that high levels of charge 
lead to increased internalization is also supported to some extent by the results 
observed with polyacrylamide nanoparticles.  Cell uptake at low levels of positive 
and negative charge was limited and only at higher charges, over 15mV, did the 
uptake begin to increase significantly.   
Both negative and positively charged silica nanoparticles were taken up into MRC-5 
fibroblasts to a similar level, indicating that extremes of charge may lead to 
enhanced cellular uptake, but the mechanism by which this uptake occurs is 
uncertain.  In addition to the effects of extreme positive and negative charge 
observed in this work, it would have been interesting to observe the effect of 
neutralising the charge on silica nanoparticles on their uptake.  Nanoparticles with a 
neutral surface charge often display reduced cellular interaction and internalization 
due to limited interactions with their biological environment.   
It is possible that although similar intracellular distributions were observed for 
polyacrylamide and silica nanoparticles, different mechanisms of uptake may be 
employed.  This is because of the size difference between the nanoparticles and the 
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fact that a dependence on charge for uptake was only observed for the 
polyacrylamide nanoparticles. 
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Chapter 6 Ȃ Conclusions and Future Perspectives 
6.1  Conclusion 
The work presented in this thesis aimed to investigate the uptake of nanoparticles 
into cells and to visualize the initial stages of this process using scanning probe 
techniques.  AFM and SSCM were used image the interaction on the nanoscale, 
before progressing to look at uptake of the nanoparticles on a whole cell scale.  The 
results from the fluorescence microscopy studies of cellular uptake correlate well 
with the observations gained using the model and fixed cell membranes imaged 
using the scanning probe techniques of AFM and SSCM. 
Polyacrylamide nanoparticles displayed a clear dependence on positive charge for 
uptake into cells.  Negatively charged polyacrylamide nanoparticles entered cells to 
a very small extent, indicating that the presence of a negative surface charge 
inhibited internalization and/or slowed the rate of uptake significantly.  A low level 
of positive charge (6.9mV) on nanoparticles containing 5% ACTA showed a small 
increase in the level of uptake into cells compared to unfunctionalised 
polyacrylamide nanoparticles.  This correlated well with AFM studies which showed 
that these particles caused some changes in the model cell membrane including 
some limited reorganisation of the bilayer along with the fusion of small defects to 
form larger holes in the bilayer.  This might suggest that these particles could 
directly cross the membrane without any additional endocytosis machinery via the 
formation of transient holes in the membrane.   
Tat conjugated polyacrylamide nanoparticles displayed enhanced uptake into cells 
compared to positively charged polyacrylamide nanoparticles with a similar or 
higher surface charge.  This was again supported by the AFM studies which 
demonstrated significant effects of these particles on the bilayer including changes 
in the height of the bilayer, possibly caused by the insertion of the peptide or 
electrostatic interactions.  In addition, catalysis of the fusion of small holes in the 
bilayer, and the formation of new defects was observed, which occurred to a much 
greater extent than with the positively charged particles alone.  The presence of the 
peptide on the surface of the nanoparticle must therefore play a role in the 
interaction of the conjugate with the membrane and the subsequent uptake of the 
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nanoparticles, other than just carrying a positive charge as discussed in detail in 
Chapters 4 and 5. 
In contrast, silica nanoparticles with a high degree of both positive and negative 
charge entered cells to a similar extent and displayed a similar intracellular 
localization.  This was supported by the results obtained using SSCM which showed 
that both negative and positive silica nanoparticles had significant effects on the 
membrane of MRC-5 cells observed as the development of multiple holes in the 
membrane.  However, the use of SSCM provided additional information about the 
possible route of uptake since the association of the particles with the membrane 
was sometimes different.  Negatively charged particles were found to be mainly 
associated with projections of the cell membrane that were wrapped around the 
nanoparticles, whereas positively charged nanoparticles, although associated with 
membrane projections to some extent were also found isolated on the membrane.  
This could indicate that both types of silica nanoparticle can be internalized by a 
mechanism such as macropinocytosis where projections of the cell membrane 
encapsulate extracellular fluid and membrane associated molecules, leading to their 
internalization. 
Both scanning probe techniques therefore seem to be good methods to use to image 
the nanoparticle Ȃ cell interaction on the nanoscale and they correlate well with the 
results of in vitro cell uptake studies.  However, the model membrane used for AFM 
experiments requires significant enhancement, for example by the use of 
combinations of different lipids and other components to produce a more realistic 
biological membrane.  SICM is currently limited by the imaging speed and resolution 
of the pipette tip therefore advances in SICM that could enable faster imaging would 
provide better monitoring of fast processes such as endocytosis and will widen the 
range of experiments to which it could be applied.   
Fluorescence imaging of nanoparticle uptake into cells enabled visualization of the 
intracellular localization of the nanoparticles and quantitative measurements of 
nanoparticle uptake were performed.  Advances in fluorescent microscopy 
technology may help to improve the resolution of images obtained allowing better 
colocalization studies of particles and intracellular organelles to be performed and 
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more precise quantitative data to be obtained.  These, and further possible advances 
in all the techniques used in this thesis are discussed in the next section. 
6.2  Technical limitations of equipment and future advances 
Difficulties in this work arose from the fact that some of the instruments were used 
at the limits of their resolution.  For instance, both SICM and fluorescence 
microscopy cannot resolve individual polyacrylamide nanoparticles.  All the 
techniques used have the potential to be improved in order to increase resolution, 
speed of imaging, and conditions for cells in order to enable better imaging of the 
nanoscale interactions in real time on live cells. 
6.2.1  Scanning Ion Conductance Microscopy 
SICM is a relatively new technique for imaging cellular uptake processes and 
therefore there are a number of limitations which affect the ability of the equipment 
to achieve the desired results.  Initially it was intended to use SICM to image cellular 
uptake of nanoparticles in live cells, however, due to a number of limitations, this 
was not possible within this project and some adjustments had to be made in order 
to achieve the most out of the equipment within the limitations present. 
One of the major limitations was the rate of imaging achievable with the equipment 
in the hopping mode.  Two factors limit this rate - the settling time of the XY piezo 
scanner and the rate at which the Z piezo brings the pipette towards the sample 
surface (fall rate).  If the fall rate is too high it creates a large amount of background 
noise, and therefore the hopping mode technique requires dampening of the 
mechanical vibrations caused by the motion of the piezo.  Faster, more stable piezos 
may help to reduce noise and increase imaging speed. This limitation in imaging 
speed means that it can take a relatively long time to image a small area of a cell 
membrane at the high level of resolution required.  This may mean that the cell 
begins to die, since there was no incubator available on the equipment used in this 
thesis, and also that the uptake processes may be missed as they often occur within 
minutes.  Recently, the development of a heating unit that can be incorporated into 
the SICM stage that can maintain cells at 37oC has been reported.  Morphological 
studies of cell spreading at 22oC and 37oC using SICM demonstrated significant 
differences, highlighting the importance of temperature in live cell experiments268.    
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It was not possible to carry out the desired imaging on the equipment available in 
Nottingham since the MRC-5 cells used had a number of features on the cell 
membrane that were of a similar size to the nanoparticles being investigated.  The 
only way to identify the particles of interest was by the use of the combined 
Scanning Surface Confocal Microscope (SSCM) located at Imperial College, London.  
This group has used SSCM for similar work and are one of the pioneers of the SICM 
technique.  They have been able to image the uptake of fluorescent nanoparticles 
into live AT1 cells but this was only possible because the cells have a very smooth 
surface meaning imaging times are fast and nanoparticles are easy to identify1.   
A limitation of SICM that was not investigated in this work is that of the resolution of 
the pipette tip and the material it is made from.  Decreasing the inner diameter of 
the glass pipette used for imaging leads to an increase in resolution since the 
resolution of the system is directly related to the internal radius of the pipette.  
Quartz pipettes have been used to try and obtain very small diameters.  However, at 
very small inner diameters, problems can occur which means that the resolution 
will eventually be limited to a level where the problems caused by the narrow 
pipette opening outweigh the benefits of a potentially higher resolution image.  
Imaging with nanopipettes with an internal diameter of 13nm has been reported 
but imaging with these very small diameter pipettes can be difficult269.  One of the 
reasons for this is that the ion current flowing through these smaller pipettes is low, 
around 100pA compared to approximately 0.7nA for pipettes with an internal 
diameter of 70nm.   The pipette to sample imaging distance is also reduced since the 
change in ion current flow will only be detected when the pipette is much closer to 
the surface.  The use of these pipettes therefore requires a SICM design with a high 
degree of mechanical stability in order to decrease the effects of noise.  Since the ion 
current flow is much lower and the pipette is much closer to the sample, mechanical 
or acoustic noise could lead to reduced feedback control which may cause the 
pipette to come into contact with the sample142.  
6.2.2  Advances in Atomic Force Microscopy 
AFM has previously been very limited when it comes to imaging live cells because of 
the nature of the contact between the tip and the soft cell surface.  To achieve the 
best images, the tip must be scanned very gently over the surface of the cell using 
165 
 
the tapping mode technique with a soft, flexible cantilever in order to minimise 
damage to the tip and sample.  Sharp tips are not particularly useful since they can 
puncture the cell membrane.  Imaging of cells using AFM also requires the imaging 
of a larger sample area than for many other AFM samples which can lead to 
problems with drift, or non-linearity, in the piezoelectric scanner150.   
Although AFM is primarily known as a contact technique, non contact AFM (NC 
AFM) modes have been developed that have extended the range of samples that can 
be investigated.  NC AFM was first developed in 1987 and was designed in order to 
maintain tip sharpness since the AFM tip is often quickly blunted as it moves over 
the sample and to obtain the best resolution for most samples, the tip needs to be as 
sharp as possible.  Along with imaging, NC AFM can also be used for quantifying tip-
sample forces and interaction potentials and also to manipulate individual atoms.  
As well as protecting the tip, NC AFM is also particularly useful for soft biological 
samples such as cells since normal AFM studies of cells are often damaging to the 
sample and difficult due to the deforming effects of the AFM tip on the sample270, 271. 
NC AFM works via the   Ǯ ǯ Ǥ   Instead of 
contact AFM, where the tip is in contact with the sample surface and repulsive 
interactions dominate, in NC AFM, the tip is oscillated at a frequency slightly above 
its resonant frequency and the amplitude of oscillation is typically only a few 
nanometres.  At this point above the surface of the sample, attractive Van der Waals 
forces dominate the interaction and these forces cause a decrease in the resonant 
frequency of the cantilever.  These deflections are too small to be observed using 
traditional direct current detection methods so an alternating current detection 
method is used which is more sensitive, increasing the resolution of NC AFM150, 270, 
271. 
In addition to NC AFM, living cells have also been imaged using fast scanning AFM  Ǯǯ  	Ǥ  	-scanning AFM was developed to be able to image 
processes such as the movement of motor proteins which occur at a faster rate than 
standard AFM technology can image at the required resolution.  It also uses a sharp 
probe and a high sensitivity of feedback control, minimising the force applied to the 
cell272ǤǮǯ	needle grown on a standard AFM cantilever 
to overcome the decreased resolution that can be encountered when performing 
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AFM imaging in a liquid environment.  By immersing the sample in a minimal level 
of liquid, the nanoneedle can reach the sample whilst the cantilever remains in air 
and its sensitivity is maximised.  The nanoneedle can have a diameter as low as 
20nm.  It has been shown to produce AFM images of cells without deformation or 
imaging of the cytoskeleton273. 
Other developments of AFM have involved the combination of an AFM with another 
form of microscopy such as SICM, SNOM, Raman or electron microscopy 150.  These 
combinations help to increase the data that can be obtained about a sample, 
enabling better characterisation.  The combination of AFM with other microscopy 
techniques would, in a similar way to the use of SSCM in this work, allow for the 
simultaneous tracking of topography and fluorescence during particle interaction 
and uptake. 
6.2.3  Fluorescence microscopy 
Although there have been many advances in fluorescent microscopy since it was 
first developed, further improvements could be made that would improve the 
imaging capability further.  These include increasing the resolution, enabling the 
observation of small objects that are beyond the resolution of current systems.  
Other areas where improvements could be made are on how the laser affects cells in 
order to try and reduce phototoxicity.  This would help to keep cells alive longer, 
allowing long term imaging and thereby avoiding the need to fix cells and removing 
the associated artefacts.   
Despite the advances achieved in fluorescent microscopy, the commonly used 
techniques such as widefield and CLSM are limited in their resolution by the 
diffraction limit of light, which restricts the information that can be captured using 
standard equipment, mainly the objective. Resolution is defined as the largest 
distance at which the image of two point shaped objects seems to amalgamate.  The 
diffraction limit of light means that optical techniques cannot distinguish between 
two objects that are separated by a distance which is less than half the wavelength 
of the light used to image the sample.  For confocal microscopy, this means that the 
maximum resolution is limited to half the wavelength of blue light, approximately 
200nm.  The maximum resolution is rarely obtained since there are interfering 
factors from the environment and sample.  Electron microscopy has a higher 
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resolution since it uses electrons rather than photons and the wavelength is 105 
times smaller, but it is limited by the conditions required for the sample, removing 
the ability to image live cells136.  
A wide range of new fluorescent microscopy techniques have been developed such 
as Total Internal Reflectance Microscopy (TIRF) which has a good signal to noise 
ratio but only looks at the area of the cell close to the membrane.  Near-field 
scanning optical microscopy (NSOM) avoids the diffraction limit of light by scanning 
samples with small probes.  Both of these techniques work close to the cell surface 
but other techniques have been developed, known as far-field methods which have a 
greater range of applications and can be used alongside existing techniques for 
sample preparation.  These techniques, such as STED and STORM have been           ǯ
diffraction barrier based on stimulated emission to inhibit fluorescence for 
molecules at the edge of the excitation point spread function 274.  They have the 
potential for much higher resolution than standard CLSM, enabling visualization of 
processes such as caveolae mediated uptake which has been difficult to image using 
conventional techniques (Figure 6.1)30, 136, 275.  
 
Figure 6.1:  Resolution of different microscopy techniques. 
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6.2.3.1  Stimulated Emission Depletion Microscopy (STED) 
STED is a form of super resolution fluorescent microscopy that uses the process of 
de-excitation, or suppression of fluorescent dyes, in order to overcome the 
resolution limit imposed by the diffraction of light.  By doing this it effectively 
decreases the diameter of the laser spot and increases resolution274-276.   Instead of 
the spontaneous relaxation which is usually used to produce fluorescence emission, 
a molecule can also be returned to its ground state by a process known as 
stimulated emission.  If a fluorophore in the excited state is irradiated with light of a 
similar wavelength to the fluorescence light, known as a red-shifted de-excitation 
beam, electrons can immediately return to the ground state.  During this process a 
photon of exactly the same wavelength and momentum of the light used is emitted, 
preventing the spontaneous emission of a fluorescence photon.  To separate the 
light originating from the spontaneous decay and the stimulated emission, filters are 
used. 
 
Figure 6.2:  Diagram to show basic principle of STED136. 
 
A STED microscope therefore uses a pair of synchronised laser pulses.  Initially, the 
laser is raster scanned over the sample, in a similar way to CLSM, and excitation 
light is provided by a short laser pulse at the required wavelength for the dye in the 
sample136.  The excitation pulse produces an ordinary diffraction limited spot of 
excited molecules similar to that observed using CLSM.  However, in STED 
microscopy, the excitation pulse is immediately followed by the red-shifted, lower 
energy laser pulse, known as the depletion or STED pulse.  This leads to quenching 
of the fluorophores to their ground state277.  The overall effect of the STED pulse is 
that the excited molecules that the STED pulse acts on cannot fluoresce because 
their energy is lost.  STED achieves greater resolution than CLSM by arranging the 
169 
 
STED pulse in a ring or doughnut shape which is generated by a phase plate in the 
light path of the laser  (Figure 6.2)275, 277.  This means that fluorescence is selectively 
inhibited for the molecules at the periphery of the spot.   In the centre of the 
doughnut or ring shape, where the STED pulse is absent, fluorescence remains 
unaffected.  As the intensity of the STED pulse increases, the size of the central 
region where molecules can still fluoresce becomes smaller, whilst the inhibition of 
fluorescence around the edge of the ring is increased.  Therefore, by increasing the 
intensity of the STED pulse, the fluorescent spot can be progressively narrowed 
down, potentially to the molecular level although currently, a resolution of less than 
20nm can be achieved136, 276, 277. 
 
Figure 6.3:  HeLa cells stained with antibodies against the nuclear pore complex 
protein Nup153 and secondary antibodies conjugated with ATT0647N on a 
standard confocal (CLSM) and a TCS STED Confocal microscope (Leica)136. 
6.2.3.2  Stochastic Optical Reconstruction Microscopy ( STORM) 
STORM microscopy is a localization based super resolution microscopy technique 
and has also been shown to achieve a resolution of 20nm.  It is part of a family of 
related techniques including Photoactivated Localization Microscopy (PALM) and 
Fluorescence Photoactivation Localization Microscopy (FPALM), all of which are 
based on very similar theories and modes of operation.  They work based on the 
principle of limiting the number of particles that are simultaneously excited, to 
avoid detecting particles with overlapping signals131, 132, 278.  Following excitation, a 
point source function is applied to the images. 
This process is known as stochastic activation and it activates small numbers of 
fluorescent molecules that are optically resolvable using low intensity light, and this 
is used to obtain localization information in 3D.  Multiple cycles of exposure are 
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used and in each exposure a unique set of fluorophores are excited275, 276.  Over time, 
as the images are combined, this enables a complete image to be constructed with 
the positions of many different fluorophores reported.  Photobleaching is used in 
between exposures to enable separation (Figure 6.4)136.  
 
Figure 6.4:  Diagram of the basic principle of STORM136. 
Although STORM uses a basic widefield microscope setup, it requires the use of 
specialised dyes, some of the most commonly used ones are cyanine dyes since they 
are photoswitchable or phtotactivatable so that only some are visible at any time in 
a single frame131, 275.  This means they can be made to both fluoresce and deactivate 
using light of different wavelengths.  Dedicated fluorescent dye pairings containing 
an activator (short wavelength) and a reporter (long wavelength) are used, enabling 
various colour combinations to be observed. These dyes are used as probes to 
separate overlapping images of individual molecules in order to improve resolution 
since the activated fluorescent molecules must be separated by a distance that 
exceeds the Abbe diffraction limit of around 250nm. Images of each subset of 
fluorescent molecules activated are captured rapidly until they spontaneously 
photobleach or re-enter a dark state278.   
 
Figure 6.5:  TdEosFP-Pallaxin expressed in Hep G2 cells to label adhesion 
complexes on lower surface using TIRF and TIRF/STORM combined136.  
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Both STED and STORM require special fluorophores and STED requires a high laser 
power, therefore live cell imaging is currently restricted but in future, as the 
techniques develop, there is the potential that nanoparticles such as small, 50nm 
polyacrylamide particles could be observed within live cells and better 
colocalization studies could be performed to further investigate their intracellular 
localization131, 276. 
6.3  Future work 
Much of this work in this thesis requires further investigations in order to be able to 
draw definitive conclusions about the effects of some of the parameters investigated 
on cellular uptake. 
It would be interesting to extend the current work in order to further investigate the 
effects of nanoparticle charge on uptake.  This could be achieved by creating a larger 
library of both polyacrylamide and silica nanoparticles with a wider range of both 
positive and negative charges, possibly via the incorporation of different functional 
groups to those used in this work.  Additionally, the effects of conjugation to cell 
penetrating peptides could be further investigated by using a number of different 
cell penetrating peptides with different sequences and structures. 
Another important area of research that may aid the future design of the 
nanoparticle systems would be to investigate in much greater detail the specific 
routes of endocytosis that are employed by the different nanoparticles.  This 
requires the use of specific pharmacological inhibitors of different endocytic 
pathways in order to try and identify the effects on cellular uptake of blocking 
pathways.  Alternatively, in more recent studies that block specific endocytic 
pathways, some groups have moved more towards the development of siRNA 
probes that can deplete intracelluar endocytic proteins.  These probes may prove to 
be a more specific and suitable method for investigating endocytosis since some 
pharmacological inhibitors can have multiple effects on the cell via the inhibition of 
molecules involved in more than one endocytic pathway50.  More advanced studies 
could also be carried out into colocalization of the nanoparticles with intracellular 
compartments such as endosomes and lysosomes and also with markers of certain 
uptake pathways such as transferrin (clathrin) or dextran (macropinocytosis). 
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The use of some of the more advanced imaging techniques that are described in this 
chapter would help to improve the quality of the images obtained.  This applies to 
both the topography and fluorescence imaging of the nanoparticle-cell interaction.  
Improving the imaging and hence the quality of data obtained would help to provide 
more detail of this interaction on the nanoscale.  One of the best ways to get the 
most out of the imaging techniques is to combine a number of techniques, for 
example, as was done using SICM combined with confocal microscopy in SSCM.  
Many manufacturers are now moving towards combined systems as demand for 
better images increases and there are now numerous combinations of scanning 
probe and fluorescent microscopy techniques that can be employed depending on 
the specific experiment being performed.  
Other techniques that could have been used in this work to support the data 
obtained include fluorescence activated cell sorting (FACS) which would give a more 
global view of the uptake of the nanoparticles into cells.  It measures the 
fluorescence of many cells in a sample and would provide measurements much 
faster than doing individual measurements using images obtained from a widefield 
microscope.  Electron microscopy techniques such as transmission electron 
microscopy (TEM) could also have been performed for silica nanoparticles in order 
to investigate intracellular localization of the nanoparticles since it can produce high 
resolution images of subcellular structures. 
With the use of better imaging techniques, it may be easier to perform quantitative 
measurements of analytes within cells.  This can be achieved by the use of 
combinations of dyes entrapped in the nanoparticles, some sensitive to analytes 
such as H+, Ca2+ or O2, and others insensitive to the same analytes.  These enable 
intracelluar measurements to be performed via the measurement of changes in 
fluorescence.  The use of an analyte insensitive dye means that ratiometric 
measurements can be taken which remove any inaccuracies associated with uneven 
particle or dye distribution within the cell.  It would have been interesting to use a 
pH sensitive nanoparticle system to investigate the change in pH during the uptake 
process and to link these images to topography changes. 
Finally, cytotoxicity studies need to be performed in order to investigate the effect of 
the internalization of the nanoparticles on the cells.  Many studies in the literature 
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link increased uptake of highly charged nanoparticles and cell penetrating peptides 
with increased cell death.  If any of these systems were ever to be developed for a 
biological use, this effect would need consideration and the nanoparticles may need 
to be adapted in order to ensure cell survival. 
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